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List of abbreviations 
 
ALS  Amyotrophic lateral sclerosis  
AMP  Adult muscle precursor 
APF  After pupae formation 
BDSC  Bloomington Drosophila Stock Center 
bZIP  basic-region leucine zipper 
C9ORF72 Chromosome 9 open reading frame 72 
C21ORF2 Chromosome 21 open reading frame 2 
Cas9  CRISPR associated protein 9 
Caz  Cabeza 
CCNF  G2/mitotic-specific cyclin-F 
cDNA  complementary DNA 
CHCHD10 Coiled-coil-helix-coiled-coil-helix domain-containing 
protein 10 
CHOP  C/EBP homologous protein  
CMCM CRISPR/Cas9-mediated conditional mutagenesis 
CNS  Central nervous system 
CRISPR Clustered regularly Interspaced Short Palindromic 
Repeats 
DAMs  Dorsal abdominal muscles 
DDIT3  DNA Damage Induced Transcript 3 
DFMs  Direct flight muscles 
Dlg1  Discs large 1 
DLMs  Dorsal longitudinal muscles 
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DNA  Deoxyribonucleic acid 
DSBs  DNA double-strand breaks 
DSHB  Developmental Studies Hybridoma Bank 
dsRNAs double-stranded RNAs 
Duf  Dumbfounded 
DVMs    Dorsoventral muscles 
EAAT2  Excitatory amino acid transporter 2 
EcR  Ecdysone receptor 
Egfr  Epidermal growth factor receptor 
ER     Endoplasmic reticulum 
EWS   Ewing sarcoma 
FALS    Familial amyotrophic lateral sclerosis 
FCs     Founder cells 
FCMs    Fusion-competent myoblasts 
FDA  Food and Drug Administration 
FET   FUS/TLS, EWS, TAF15 
FGF     Fibroblast growth factor 
FLP     Flippase 
FRTs    FLP recombinase target sites 
FTD     Frontotemporal dementia 
FUS/TLS    Fused in sarcoma/translocated in liposarcoma 
G     Glycine 
GAL4-UAS    Galactose-responsive transcription factor 4- 
Upstream activator sequence 




GO      Gene ontology 
gRNA  Guide RNA 
GWAS    Genome-wide association studies 
Hbr/Dof    Heartbroken/Stumps/Downstream of FGFR 
HDAC1    Histone deacetylase 1 
hnRNP    Heterogeneous nuclear ribonucleoproteins 
HR     Homologous recombination 
HRP    Horseradish peroxidase 
Htl     Heartless 
IFMs    Indirect flight muscles 
IMAGO    Integrase-mediated approach for gene knock-out 
KO     Knock-out 
LLPS    Liquid-liquid phase separation 
LMN    Lower motor neuron  
LoxP    Locus of X-over P1 
MAPT    Microtubule-associated protein tau 
MATR3    Matrin-3 
MCEP2    Methyl CpG binding protein 2 
Mhc     Myosin heavy chain 
miRNA    micro-RNA 
MECP2 methyl CpG binding protein 2 
mRNA    messenger RNA 
MS     Mass spectrometry 
NEK1    NIMA (never in mitosis gene a)-related kinase 1 
NLS     Nuclear localization signal 
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NMJ     Neuromuscular junction  
OMIM    Online Mendelian Inheritance in Man 
PARP     Poly-ADP-ribose polymerase 
PCR   Polymerase chain reaction   
PG  Prothoracic gland 
Pyr  Pyramus 
QGSY    Glutamine, Glycine, Serine, Tyrosine 
qPCR    Quantitative PCR 
Rab1a    Ras-related protein Rab-1a 
RGG    Arginine, Glycine, Glycine  
RBPs    RNA-binding proteins 
RNA    Ribonucleic acid 
RNAi    RNA interference 
RNAP II    RNA polymerase II 
RRM    RNA-recognition motif 
SALS    Sporadic amyotrophic lateral sclerosis 
SARFH    Sarcoma-associated RNA-binding Fly Homolog 
SEM    Standard error of the mean 
SGs     Stress granules 
SMA     Spinal muscular atrophy 
SMN1    Survival of motor neuron 1 
SOD1    Superoxide dismutase 1 
Sty     Sprouty 
TAF15    TATA-binding protein-associated factor 2N 




TARDBP/ TDP-43   Tar DNA-binding protein-43 
TBPH    Tar DNA-binding protein-43 homolog 
TBK1    TANK-binding kinase 1 
Ths  Thisbe 
TRN     Transportin 
TUBA4A    Tubulin alpha-4A chain 
U1-snRNP   U1 small nuclear ribonucleoprotein 
UBQLN1/ UBQLN2   Ubiquilin 1/ Ubiquilin 2 
UMN    Upper motor neuron 
USP  Ultraspiracle 
UTR  Untranslated region 
Wg  Wingless 
WT     Wild-type 
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ALS: Amyotrophic Lateral Sclerosis 
 
Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s 
disease, was first described by the neurologist Jean-Martin 
Charcot. It is a neurodegenerative disease characterized by 
progressive degeneration of upper and lower motor neurons 
(UMN and LMN, Figure 1). It mostly affects adults, with an onset 
in mid-adulthood (at a mean age of 55 years), but ALS also 
includes early onset cases or can emerge in later life [1]. Patients 
can show a limb-onset, UMN and LMN weakness or a bulbar-
onset with speech and swallowing difficulties. Although some 
forms of the disease display a slower progression, death typically 
occurs within 3-5 years [2]. 
The worldwide incidence of ALS is described in recent studies 
between 0.6 and 3.8 per 100,000 person-years; in Europe, the 
incidence is slightly higher ranging from 2.1 to 3.8 per 100,000 
person-years [3]. 
 
ALS can be divided into 90% sporadic ALS (SALS) and 10% 
familial ALS (FALS) cases, showing a Mendelian inheritance 
pattern [1, 2]. Mutations in several genes cause FALS, with 50% 
of the cases linked to four genes: SOD1, C9ORF72, TARDBP 
and FUS/TLS [4]. 
Mutations in SOD1 gene, encoding the ubiquitously expressed 
cytoplasmic enzyme Cu/Zn superoxide dismutase 1, that 
catalyzes the conversion of toxic superoxide radicals to 
hydrogen peroxide or oxygen were first described by Rosen et 
al. in 1993 [5]. To date, over 180 different mutations have been 
described with many variants retaining either partial or full 
enzyme activity (https://alsod.ac.uk/). All these variants result in 






toxicity, endoplasmic reticulum (ER) stress, mitochondrial 
dysfunction and disruption of axonal transport [6]. 
 
Figure 1. Simplified overview of ALS. Upper and lower motor neurons are 
affected and a progressive atrophy and weakness of muscles is observed. 
Several independent genome-wide association studies (GWAS) 
identified one of the most common genetic causes of ALS as a 
pathogenic expansion of a hexanucleotide repeat in C9orf72 [7, 
8]. The physiological function of C9orf72 is poorly understood. 
However, Webster and colleagues showed that C9orf72 
interacts with Rab1a and Unc-51-like kinase 1 autophagy 
initiation complex in cell lines [9]. Intranuclear neuronal RNA foci 
have been observed in ALS. It has been shown that toxicity of 
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specific RNA binding proteins, leading to significant 
dysregulation of RNA processing [10].  
 
Different RNA binding proteins have been linked to ALS. 
Mutations in the gene encoding TAR DNA-binding protein 43 
(TARDBP) and Fused in Sarcoma/Translocated in liposarcoma 
(FUS/TLS) have been found in ∼5% of FALS cases each [4]. 
Neumann et al. reported that pathologic TDP-43 is ubiquitinated 
and forms cytoplasmic inclusions in affected neurons, and that 
the protein is not detectable in nuclei of neurons with inclusions 
[11]. 
TDP-43 and FUS belong to the hnRNP family of proteins that 
regulate RNA metabolism, which is reflected in a defect in RNA 
biogenesis in ALS pathogenesis [1, 4]. Interestingly, TDP-43 
also has a critical function in muscles, it is required during normal 
skeletal-muscle formation and associates with sarcomeric 
mRNAs to facilitate regeneration [12].  
 
Recently seven novel genes, associated with ALS, have been 
identified: MATR3, CHCHD10, TBK1, TUBA4A, NEK1, 
C21orf2 and CCNF. These genes code for proteins involved in 
different pathways, including altered RNA metabolism, 
mitochondrial dysfunction or DNA damage accumulation [13].  
Despite an increasing knowledge about the molecular 
mechanisms underlying the pathology, no treatments, that can 
stop or reverse the disease progression, are available. Currently, 
Riluzole is the only FDA-approved drug treatment that slows the 








“Dying-forward” and “dying-back” hypothesis 
 
Despite the observation of progressive degeneration of UMNs 
and LMNs, it is not yet established where ALS begins. There are 
two main hypotheses: either a “dying-forward” or a “dying-back” 
mechanism has been proposed.  
The “dying-forward” hypothesis states that UMNs mediate 
anterograde degeneration of LMNs via glutamate excitotoxicity; 
cortical hyperexcitability has been shown to precede the clinical 
onset of FALS [2]. The “dying-back” hypothesis proposes that 
pathological changes in motor axons or at the neuromuscular 
junction (NMJ) precedes motor neuron degeneration. 
Observations that synaptic denervation precedes the onset of 
motor neuron degeneration were described in SOD1-ALS mouse 
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FUS/TLS 
 
Fused in Sarcoma/Translocated in Liposarcoma was first 
identified as an oncoprotein in liposarcoma. Fusion of the N-
terminus of FUS with the dominant inhibitor of transcription called 
CHOP (C/EBP Homologous Protein) promotes tumorigenesis 
[17]. In 2009, FUS was described for the first time as a genetic 
cause of ALS [18, 19].  
FUS belongs to the FET protein family together with Ewing 
sarcoma (EWS) and TATA-binding protein-associated factor 15 
(TAF15) and, like the other members, FUS/TLS is a ubiquitously 
expressed RNA- and DNA-binding protein [20]. FUS/TLS 
structure consists of an N-terminal transcriptional 
activation/prion-like domain (QGSY-rich region), a highly 
conserved RNA-recognition motif (RRM), a zinc finger motif 
(Znf), three Arg-Gly-Gly (RGG) repeat domains and a C-terminal 
nuclear localization signal [21] (Figure 2A). It is mainly a nuclear 
protein and can bind to single- and double-stranded DNA, and it 
plays a role in transcriptional and post-transcriptional regulation 
both in the nucleus as well as in the cytoplasm [22, 23].  
 
FUS/TLS autoregulates its expression, binding to exon 7 and the 
flanking introns of its own pre-mRNA; the cytoplasmic 
mislocalization of FUS, due to mutations within the nuclear 
localization signal, leads to a loss of function of the protein in the 
nucleus and a failure in the regulatory process, which may 
aggravate the accumulation of ALS-associated FUS mutants in 
the cytoplasm [24]. Through the QGSY-rich region at the N-
terminus, FUS regulates transcription by binding active 






polymerase II (RNAP II), controlling its phosphorylation during 
transcription [26].  
Moreover, FUS plays a major role in pre-mRNA splicing, it is 
required for the interaction between RNAP II and the splicing 
factor U1 small nuclear ribonucleoprotein (U1-snRNP) [27]. More 
than 5500 RNA targets have been identified in human and 
mouse brains using high-throughput sequencing approaches, 
FUS/TLS prefers to bind to long introns and it was shown to 
interact with the 3′ UTR of several transcripts involved in the 
pathogenesis of ALS and other neurodegenerative disorders, 
including the genes encoding superoxide dismutase 1 (SOD1), 
the glutamate transporter EAAT2 (EAAT2), ubiquilin 1 and 2 
(UBQLN1 and UBQLN2), and the microtubule-associated 
protein tau (MAPT) [28]. 
 
Figure 2. Schematic diagrams of the domain structure of FUS and caz. A. 
Human FUS/TLS showing mutations identified in ALS. E=NES: nuclear export 
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region. RGG: Arg-Gly-Gly repeat. RRM: RNA-recognition motif. ZnF: zinc 
finger motif. B. Schematic overview of the Drosophila melanogaster caz 
protein. 
Among the nuclear functions, FUS is also involved in recruiting 
the Drosha complex on the chromatin allowing efficient miRNA 
processing; 50% depletion of FUS levels is enough to reduce the 
biogenesis of miRNAs, with a role in neuronal function, 
differentiation and synaptogenesis [29].  
Baechtold and colleagues were the first to describe the 
involvement of FUS in DNA repair by promoting D-loop formation 
and homologous recombination during DNA double-strand break 
(DSB) repair [30]. FUS has a direct interaction with Poly-ADP-
ribose polymerase (PARP) and Histone deacetylase 1 (HDAC1) 
at the site of DNA damage; interestingly ALS-associated 
mutations in FUS show a reduced interaction with these two 
factors [31, 32]. 
Not only does FUS bind to numerous mRNAs, but it is involved 
in transporting RNA granules into dendritic spines [33, 34]. 
Moreover, FUS influences the formation of stress granules (SGs) 
and mutant FUS localizes to these structures [35]. It is 
hypothesized that the formation of SGs depends on liquid-liquid 
phase separation (LLPS). It was shown in vitro that the FUS low 
complexity domain mediates phase separation, what may result 
in the formation of insoluble fibrils [36, 37].  
 
Many missense/deletion mutations implicated in ALS cluster in 
the C-terminal domain of the protein, mainly affecting the nuclear 
localization signal (NLS) and leading to an increased cytoplasmic 
localization of FUS/TLS [18, 19] (Figure 2A). The protein loses 
its nuclear translocation ability which in turn may disrupt several 






reduction of nuclear FUS staining, consistent with the idea that 
defects in nuclear import of FUS contribute to FUS pathology 
[38]. Moreover, FUS/TLS is methylated in its C-terminal arginine 
residues, impairing Transportin (TRN)-dependent nuclear import 
of FUS [39]. 
Few ALS-causing mutations can be found within the prion-like 
QGSY-rich domain, they may increase FUS aggregation 
propensity and this can facilitate aggregation of FUS in stress 
granules [40] (Figure 3).  
 
Figure 3. Physiological roles of FUS/TLS (in green) in the nucleus and 
cytoplasmic compartment. The protein can shuttle between the nucleus and 
the cytoplasm. In the nucleus it is involved in transcription, miRNA processing, 
DNA repair, and pre-mRNA splicing. In the cytoplasm, among other functions 
it is involved in mRNA stability and transport and in translation. 
Even though progress in the knowledge of pathophysiological 
mechanisms, such as protein aggregation, mitochondrial 
dysfunction, oxidative stress, has been made over the years, it 
is still debated whether neurodegeneration is caused by the 
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protein in the cytoplasm or a combination of both. For this 
reason, it is fundamental to evaluate animal models exploiting 




The Drosophila homolog of human FUS is Cabeza (Caz), also 
known as SARFH (Sarcoma-associated RNA-binding Fly 
Homolog). Localized on the X chromosome at cytogenetic 
position 14B, it is the single fly orthologue of the three human 
FET family proteins and shares 45.2% sequence identity with 
FUS (LALIGN, https://www.ebi.ac.uk/). Described for the first 
time as a member of the glycine-rich protein family, Stolow and 
Haynes were able to detect with an UV-crosslinking assay the 
binding of the protein to RNA [41, 42]. Caz not only has a G-rich 
region, but it shares with FUS a similar domain architecture, 
including RGG motives, RRM and Zinc Finger domains, but it 
lacks the QGSY domain (Figure 2B). 
 
Enriched in the CNS and in several larval tissues, the Drosophila 
protein localizes to active transcription units on the polytene 
chromosomes in salivary gland nuclei in association with RNA 
pol II, indicating that it plays a role in the transcription of a number 
of genes [43]. Very little is known about the roles of caz. Multiple 
studies showed that caz and FUS are functionally homologous: 
in most cells, high-level caz expression leads to a reduction in 
the level of FUS and EWS [43]  and transgenic expression of 
FUS in Drosophila can rescue caz mutant phenotypes [44]. Caz 
has been previously involved in axonal transport, loss of caz 
affects both vesicle and mitochondrial transport [45] and it plays 






Drosophila as a model organism 
 
Over the years, Drosophila melanogaster has been a powerful 
tool for modeling and studying neurodegenerative diseases. The 
large number of offspring, short life cycle, the availability of a 
plethora of genetic tools to manipulate gene expression are 
some of the advantages of using Drosophila as a model 
organism. 
The fully sequenced Drosophila genome, encoding ∼13.600 
protein-coding genes located on four pairs of chromosomes, was 
published in 2000 [47, 48] and it has been estimated that 77% of 
human disease-associated genes, reported in the Online 
Mendelian Inheritance in Man (OMIM) database, have orthologs 
in the fly [49]. Moreover, Drosophila and humans share 
fundamental cellular processes, such as synapse formation, 
neuronal communication, membrane trafficking and cell death. 
The fly has a complex brain that makes the study of complex 
behavior interesting, yet the brain is simple enough to evaluate 
the structure and function of the neurons involved in such 
processes [50].  
 
Drosophila models for FUS-associated ALS 
 
Drosophila has been successfully used to model various human 
neurodegenerative disorders, including ALS, Parkinson’s 
disease, Alzheimer’s disease, and fragile X syndrome [51]. The 
ALS genetic risk factors have been studied 
in Drosophila disease models in order to understand the 
underlying pathophysiology and its effects on motor neurons. 
Drosophila models for FUS-associated ALS will be the focus of 
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Loss of function of caz was initially studied by Wang and 
colleagues. The majority of caz mutant individuals die with a few 
adult “escapers” showing a shortened lifespan and impaired 
locomotion. Interestingly, aged caz mutants did not present 
defects in their brain, suggesting that the Drosophila protein is 
not required for neuronal survival and function [44]. The 
aforementioned phenotypes could be rescued by 
overexpressing WT caz or WT human FUS, whereas ALS-
associated mutants could not rescue the adult lifespan and 
locomotion defects [44].  
To recapitulate ALS phenotypes and to evaluate the gain of 
toxicity of FUS mutations, several groups worked on 
overexpressing wild-type and mutant FUS in Drosophila. The 
overexpression of wild type Caz or FUS is sufficient to induce 
motor deficits, retinal degeneration and impaired synaptic 
transmission [46, 52, 53]. Xia et al. showed that overexpression 
of caz and null-mutant loss of function cause similar phenotypes, 
but the loss of caz in motor neurons did not cause apoptosis [53]. 
Moreover, both FUS and caz loss and gain of function affect 
axonal transport [45]. Fly models overexpressing ALS-
associated mutations in caz and FUS partially recapitulate the 
cytoplasmic mislocalization of FUS as observed in ALS patients 
[46, 52].  
All these studies suggest that both the loss and gain of function 
are implicated in ALS pathogenesis and it is important to 
generate accurate Drosophila models to distinguish the roles of 







Genetic tools to generate an accurate Drosophila model 
 
Different methods can be used to mutagenize Drosophila genes; 
besides the use of mutagenic chemicals or radiation, genetic 
approaches such as transposable P-elements, homologous 
recombination or CRISPR-Cas9 induced mutagenesis are used 
to generate knock-outs or introduce mutations [54-56].  
Taking advantage of the mobility of transposons, P-elements 
were used to disrupt gene function via random insertion or to 
generate a loss of function via imprecise excision from the 
genome. The P transposase, encoded by the P-element, 
recognizes the 31-bp terminal inverted repeats of the P-
element and mobilizes it from the original site. The mobilized P-
element can remove flanking DNA and create a deletion [57].  
An alternative approach utilizes homologous recombination (HR) 
to replace genomic DNA. The presence of the site-specific FLP 
recombinase and the I-SceI endonuclease, introduced into 
the Drosophila line, are enough to create double-strand breaks 
and mobilize a target locus flanked by FLP Recombinase Target 
sites (FRTs) and I-SceI recognition sites [58]. The frequency of 
“Ends-Out” targeting is rather low in Drosophila [59] but this 
problem can be overcome by the “Ends-In” targeting strategy. 
The combinatorial addition of attP sites in the gene of interest 
and the subsequent use of ΦC31 integrase allow genome editing 
to introduce any desired construct in the locus of interest [55, 60]. 
 
Another approach is to overexpress or knockdown human 
disease genes in a temporally and spatially regulated manner 
using the GAL4-UAS system. Discovered in yeast and 
introduced in Drosophila by Brand and Perrimon in 1993 [61], 
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GAL4, which can be expressed under the control of a specific 
gene promoter. The GAL4 driver line allows the expression of 
GAL4 in different tissues and at specific developmental stages. 
Not only lines with random insertion in the Drosophila genome 
are available, but also lines in which the GAL4 sequence was 
cloned downstream of specific regulatory elements to determine 
its expression pattern in certain tissues [62]. 
 
Figure 4. Genetic tools used in Drosophila. A. The binary GAL4-UAS system. 
Flies carrying the GAL4 driver are crossed with the UAS flies (gene of interest 
or RNAi), in the progeny the transgene will be expressed in a tissue-specific 
manner. B. The temperature sensitive GAL80 (GAL80ts) allows temporal 
control of a specific transgene. 
To activate a gene in a tissue- and stage-specific manner, GAL4-
expressing lines are then crossed to transgenic flies, carrying the 
cDNA of the specific gene downstream of the yeast upstream 
activator sequence (UAS) (Figure 4A). The same system is used 
to downregulate gene expression via UAS-driven RNA 






(dsRNAs) lead to the degradation of homologous RNAs [63] 
(Figure 4A). 
Another system that can be used to temporally control the GAL4-
UAS system is the temperature sensitive GAL80 (GAL80ts). At 
low/permissive temperature GAL80 binds to GAL4, inhibiting the 
expression of the UAS controlled transgene, whereas 
nonpermissive temperature leads to the instability of GAL80 and 
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Drosophila: understanding the development  
 
The role of muscles in ALS is still controversial, but a simple 
model organism such as Drosophila might be helpful in 
understanding basic processes. Although there are differences 
in the anatomy, at the developmental level it is obvious that there 
is similarity between Drosophila and the vertebrates. Embryonic 
development in Drosophila is very well characterized and 
studied, but in this paragraph, the focus will be on adult tissue 
development, that can serve as a comparison with the 
vertebrates.  
 
Vertebrate muscles can be divided into three categories: 
skeletal, cardiac and smooth, the counterparts in Drosophila are: 
the somatic (or body wall) muscles, the heart and visceral 
muscles [65]. The Drosophila somatic musculature, both in 
larvae and in adults, originates from the mesoderm as in 
vertebrates. During embryogenesis, myogenic progenitors 
undergo an asymmetric cell division resulting in the formation of 
either two embryonic founder cells (FCs), that through fusion with 
the fusion-competent myoblasts form the embryonic muscles or 
one FC and an adult muscle precursor (AMP); AMP cells 
maintain a high level of twist expression and do not differentiate 
until the end of the larval stages [66, 67]. All throughout larval 
life, these cells are associated with the nerves and keep 
proliferating; at the beginning of metamorphosis, when most of 
the larval muscles undergo histolysis, the myoblasts migrate 
along the nerves and reach their final position [68].  
AMPs associated with the wing imaginal disc will generate 
thoracic muscles, including direct and indirect flight muscles, 






of leg muscles; AMPs arranged in repeated pattern in the 
abdominal segments will form adult abdominal muscles [69]. 
The thorax consists of direct flight muscles (DFMs) and two types 
of indirect flight muscles (IFMs): dorsal longitudinal muscles 
(DLMs) and the dorsoventral muscles (DVMs) [70] (Figure 5).  
 
Figure 5. Schematic view of adult Drosophila muscle system. Indirect flight 
muscles are indicated in blue (DVM) and light blue (DLM), running in opposite 
directions. In violet the small group of direct flight muscles (DFM) is 
recognizable in the thorax. Abdominal muscles are organized in a specific 
repeated pattern, each segment presenting a group of dorsal muscles 
(yellow), a group of lateral muscles (orange) and a group of ventral muscles 
(brown). Adapted from [71]. 
A set of larval muscles in the mesothorax is not histolysed during 
metamorphosis and they serve as a template that is transformed 
into the DLMs by fusion of the myoblasts at 12−20 h after pupae 
formation (APF) [70]. The DVM indirect flight muscles and the 
direct flight muscles are generated by de novo myoblast fusion 
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muscles; a subset of FCs is selected and will fuse with fusion-
competent myoblasts (FCMs) (Figure 6). Adult founder selection 
is marked by the decline of twist and the expression 
of dumbfounded (duf) [72]. Interestingly, the selection of the 
adult muscle founders does not involve Notch-mediated lateral 
inhibition as in the embryos [73], but relies on fibroblast growth 
factor (FGF) signaling [74]. The selection is mediated by the FGF 
receptor Heartless (Htl) and involves the positive regulator 
Heartbroken/Stumps/Downstream of FGFR (Hbr/Dof), that 
becomes localized to the duf-expressing adult founders during 
puparium formation; the negative regulator Sprouty (Sty), 
expressed in all AMPs prior to pupariation, prevents the 
activation of the receptor.  
 
Figure 6. Representation showing the development of dorsal abdominal 
muscles (DAMs). By 16 hrs APF, all larval muscles are histolysed, myoblasts 






segments. 24 hrs APF, higher levels of duf are visible in FCs (green), while 
the FCMs (yellow) have a lower expression. Fusion of these two cell-types 
will follow to obtain the pattern of the adult muscles around 50 hrs APF. -
Adapted from [72]. 
 
The activation of Htl maintains the expression of Stumps by a 
positive feedback mechanism, regulating the expression of all 
genes involved in the specification of founders [74].  
The number of adult abdominal muscles is determined by the 
specified founder cells [72, 74]; in segments A2-A7, 17-22 
parallel dorsal abdominal muscles (DAMs) are formed, 20 
dorsoventral fibers compose the lateral group of muscles and 
one set of 5-8 muscles can be found on the ventral part of the 
abdomen [68] (Figure 5). 
 
The neuronal influence on muscle development still needs to be 
clarified. Interestingly, while muscles undergo a massive 
rearrangement, at the onset of metamorphosis, larval neurons 
are specified to function in the adult. The nerves that innervate 
larval muscles also disappear in the first 24 h APF, but a single 
nerve trunk per hemi-segment stays in contact with the epidermis 
and from this contact point a new nerve will grow [68]. Myoblasts 
not only associate with nerves, but they migrate to the final site 
using the growing nerve branches [68]. In a study published in 
1995, Currie and Bate showed that denervation occurring at the 
beginning of metamorphosis could cause a partial reduction in 
the number and in the size of dorsal abdominal muscles, but did 
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Scope and outline of the thesis 
 
In order to gain insight into the pathophysiological roles of human 
FUS in ALS, it is important to evaluate the functions of the protein 
and the molecular mechanisms it regulates. Drosophila as an 
animal model may help in understanding the physiological roles 
of the protein due to its simplicity and the availability of a great 
number of genetic tools. While the majority of the ALS studies 
using Drosophila focus on the overexpression of the human 
protein, this study aims to characterize the Drosophila protein in 
a loss of function scenario and to evaluate to which extent the 
loss of nuclear FUS contributes to ALS.    
 
In this introduction, starting from an explanation of Amyotrophic 
Lateral Sclerosis as a neurodegenerative disease, I gave an 
overview of the different roles of FUS and its Drosophila homolog 
Cabeza. I then focused my attention on Drosophila melanogaster 
to underline how powerful it is as an animal model.  
 
In Chapter 2, I will present a genetic approach to efficiently 
inactivate cabeza in a cell-type-specific manner; this approach 
permits the evaluation of a phenotype induced by the loss of 
function of a gene in a spatially and temporally regulated fashion, 
thereby avoiding the limitations of RNAi-mediated knock-down. 
Moreover, in this chapter caz null alleles are described and their 
phenotypes are characterized. 
 
The core of Chapter 3 is a genetic screen that leads to the 
identification of Xrp1 as a novel genetic interactor of cabeza. 
Xrp1 is up-regulated in caz mutant animals and interestingly, 






mutant phenotypes. Moreover, caz mutants exhibit gene 
expression dysregulation which is also mitigated by Xrp1 
heterozygosity. 
 
In Chapter 4, the role of caz in muscle development will be 
elucidated. The protein is involved in muscle specification during 
metamorphosis by regulating cellular Xrp1 levels. I will 
demonstrate in this chapter that defective FGF signaling 
underlies the caz mutant muscle phenotypes.  
 
Chapter 5 will focus on the discussion about the results 
presented in this thesis, together with the impact this study may 
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To expand the rich genetic toolkit of Drosophila melanogaster, 
we evaluated whether introducing FRT or LoxP sites in 
endogenous genes could allow for cell-type-specific gene 
inactivation in both dividing and postmitotic cells by GAL4-driven 
expression of FLP or Cre recombinase. For proof of principle, 
conditional alleles were generated for cabeza (caz), the 
Drosophila homolog of human FUS, a gene implicated in the 
neurodegenerative disorders amyotrophic lateral sclerosis 
(ALS) and frontotemporal dementia (FTD). 
Upon selective expression in neurons or muscle, both FLP and 
Cre mediated caz inactivation in all neurons or muscle cells, 
respectively. Neuron-selective caz inactivation resulted in failure 
of pharate adult flies to eclose from the pupal case, and adult 
escapers displayed motor performance defects and reduced life 
span. 
Due to Cre-toxicity, FLP/FRT is the preferred system for cell-
type-specific gene inactivation, and this strategy outperforms 
RNAi-mediated knock-down. Furthermore, the GAL80 target 
system allowed for temporal control over gene inactivation, as 
induction of FLP expression from the adult stage onwards still 
inactivated caz in >99% of neurons. Remarkably, selective caz 
inactivation in adult neurons did not affect motor performance 
and life span, indicating that neuronal caz is required during 












Drosophila melanogaster has been at the forefront of genetic 
research for over a century now [1] and a rich toolkit is available 
for genetic manipulation [2]. This toolkit includes the generation 
of mutant animals in which a gene of interest is inactivated, 
either in all body cells, or in homozygous mutant clones [3,4,5]. 
Such homozygous mutant clones are ideally suited to study the 
cell-autonomous effects of loss of gene function, but they can 
only be generated in dividing cells and typically constitute only a 
limited fraction of a cell population. The availability of a genome-
wide transgenic RNAi library allows for cell-type-specific knock-
down of gene expression [6], but knock-down efficiency is 
variable and never 100% and off-target effects may confound 
the interpretation of observed phenotypes. Recently, a strategy 
for conditional mutagenesis in Drosophila based on 
CRISPR/Cas9-induced gene disruption in somatic cells was 
reported [7]. It involves GAL4-driven Cas9 expression in flies 
that ubiquitously express one or more gRNAs targeting the gene 
of interest. Although the percentage of GAL4-expressing cells in 
which gene inactivation occurred was not evaluated, this 
strategy recapitulated known mutant phenotypes to variable 
degrees. Apart from the variable phenotypic outcomes and high 
interindividual variation, a downside of this approach is that the 
induced mutations are not molecularly defined and distinct 
mutations may occur in individual target cells, some of which 
may not represent (full) loss of function alleles. 
 
In an attempt to overcome the limitations of existing methods, 
we decided to evaluate whether flanking an endogenous gene 
with either FRT or LoxP recombination sites would allow for 




We anticipated that excision of a DNA segment bounded by 
direct FRT repeats may be an efficient way to 
inactivate Drosophila genes, as transgenes in which a promoter 
is separated from a coding sequence by a stop cassette flanked 
by FRT sites were previously used in so-called ‘FLP-out’ 
approaches for lineage tracing analysis [8] or cell-type-specific 
rescue strategies [9]. Furthermore, a strategy conceptually 
similar to our approach was previously reported [10], but only 
used for analysis of mutant clones and not for inactivation of a 
gene of interest in all cells of a defined cell population. For prove 
of concept, we selected the cabeza (caz) gene, which is 
the Drosophila homolog of human FUS. FUS is implicated in 
various human diseases, including the neurodegenerative 
disorders amyotrophic lateral sclerosis (ALS) and 
frontotemporal dementia (FTD) [11]. Although FUS shuttles 
between the nucleus and the cytoplasm, FUS displays a 
predominantly nuclear localization under physiological 
conditions. Most familial ALS-associated mutations cluster in the 
C-terminal nuclear localization signal of FUS, resulting in a shift 
from nuclear to a more cytoplasmic localization, formation of 
cytoplasmic FUS-containing protein aggregates and reduced 
nuclear FUS levels [12]. It is currently unclear whether ALS-FUS 
is caused by a “gain-of-toxic-function”, possibly mediated by 
cytoplasmic aggregates, or by a (partial) loss of nuclear function, 
or a combination of both mechanisms. 
As loss of FUS function may contribute to ALS pathogenesis, 
inactivation of the Drosophila FUS homolog caz may not only 
provide insight into the physiological function of caz, but may 
also help unraveling the molecular pathogenesis of ALS-
FUS. Caz mutant flies were reported previously, with only 14% 
of caz mutants surviving to adulthood and adult escaper flies 
2
49
Cell-type-specific gene inactivation reveals a key function for cabeza in neuron
 49 
exhibiting locomotion defects and shortened life span [13]. Here, 
we generated two independent caz null alleles, as well as 
conditional caz alleles. The conditional caz alleles were used to 
evaluate the efficiency of cell-type-specific gene inactivation 
in Drosophila, as well as the physiological consequences of 
neuron-selective caz inactivation. 
Results 
 
Generation of caz null and conditional alleles 
 
To generate caz “knock-out” (KO) and conditional KO alleles, 
the integrase-mediated approach for gene knock-out (IMAGO) 
[10] was used (Figure 1a). In the first step, in vivo homologous 
recombination [14] was used to replace exons 2 through 7 of 
the caz gene by a white eye color marker, flanked 
by AttP integrase sites (cazKO allele). In the second step, ΦC31 
integrase-mediated cassette exchange was used to reintroduce 
the wild type caz genomic sequences, either without or with 
flanking LoxP or FRT sites (cazAttR, cazlox and 
cazFRT alleles; Figure 1a). An independent caz null allele was 
generated by imprecise excision of a P-transposable element in 
the caz gene promoter. This yielded the caz2 allele, in which 
exons 1 through 3 of caz are deleted (Figure 1a). Quantitative 
real-time PCR (qPCR), Western blotting and immunostaining 
revealed that both the cazKO and the caz2 alleles are transcript 
and protein null (Figure 1b–l). Immunostaining further revealed 
that in third instar larval central nervous system (CNS), caz is 






Figure 1.  Generation and characterization of caz knock-out and 
conditional knock-out alleles. (a). The caz2 allele was generated by 
imprecise excision of the P-transposable element PMae-UAS.6.11 DP00882 in 
the caz gene promoter, which resulted in excision of exons 1 through 3.  
CazKO was generated by homologous recombination, replacing caz exons 2 
through 7 by a white marker gene flanked by AttP sites. ΦC31-mediated 
RMCE was subsequently used to reintroduce caz, flanked by either LoxP 
(cazlox) or FRT sites (cazFRT). (b). Quantitative real-time PCR revealed 
that caz2 and cazKO mutants are caz transcript null. The ‘revertant’ allele is 
generated by precise excision of PMae-UAS.6.11 DP00882 and serves as a 
control for caz2. N = 5. (c). No caz protein could be detected 
2
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in caz2 or cazKO mutants by Western blot. The full-length blot is shown 
in Supplementary Figure S5. (d–l). Immunostaining for caz and the neuronal 
nuclear marker elav revealed caz expression in all neuronal nuclei, as well 
as in non-neuronal cells in third instar larval ventral cord of control animals. 
In caz2 and cazKO mutants, no caz protein was detected. Scale bar: 20 μm. 
Loss of caz function results in motor defects 
 
As caz is on the X chromosome, hemizygous males were used 
to study caz null phenotypes. Loss of caz function resulted in 
developmental lethality, as no caz mutant adult flies emerged. 
At the third instar larval stage, caz mutant larvae were present 
at the expected Mendelian ratio (Figure 2a), but caz mutant 
animals took significantly more time than control animals to 
reach the pupal stage, indicative of a developmental delay 
(Figure 2b). Thus, loss of caz function results in developmental 
lethality during the pupal stage, with at least a fraction of animals 
developing to pharate adults. The latter fail to eclose from the 
pupal case, with only very few adult escapers (Figure 2c, Movie 
S1 and S2). When partially eclosed pharate adults were 
dissected out of their pupal case, these flies displayed severe 
motor coordination phenotypes (Movie S3) and died within a 
day. CazAttR flies, in which the cazKO allele was restored to wild 
type, did not show any pupal lethality or adult eclosion defects 
(Figure 2c), demonstrating that cazKO phenotypes are due to 
specific inactivation of the caz gene. Similar to previously 
reported results [13], caz null phenotypes could be rescued by 
selective reintroduction of wild type caz transgenic protein in 
neurons by elav-GAL4 (Figure 2c), demonstrating that loss 
of caz function in neurons is necessary to induce pupal lethality 






Figure 2. Caz2 and cazKO mutants display developmental delay and 
pupal lethality, which can be rescued by neuron-selective caz 
reintroduction. (a). At the third instar larval stage, caz2 and cazKO mutant 
animals are present at the expected Mendelian ratios. Results of three 
independent experiments were pooled, with 300–400 L3 larvae per 
experiment. (b). Caz mutants display an increased time to pupation, 
indicative of developmental delay. N = 80–110. (c). caz2 and cazKO mutant 
animals died during the pupal stage, with very few adult escapers. Pupal 
lethality could be rescued by selective expression of wild type caz in neurons 
(elav-GAL4). N = 92–393. 
 
Neuron-selective caz inactivation impairs motor performance 
and reduces life span 
 
To evaluate whether conditional gene inactivation in all or a large 
proportion of neurons is possible in Drosophila, the elav-GAL4 
driver was used to express either FLP or Cre recombinase 
panneuronally in cazFRT or cazlox animals, respectively. 
Remarkably, FLP/FRT-mediated recombination resulted in loss 
of caz protein in all neurons in the third instar larval CNS (Figure 
3a–f). This was confirmed by quantitative analysis 
of caz inactivation in an anatomically defined population of 
neurons in the ventral nerve cord (Figure 3m). Similarly, 
Cre/LoxP-mediated recombination also resulted in loss of caz 
protein in all CNS neurons (Figure 3g–m). Of note, consistent 
with previous reports [15], panneuronal Cre expression induced 
a mild rough eye phenotype (Supplementary Figure S1).  
2
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Selective inactivation of caz in all neurons resulted in pupal 
lethality attributable to the inability of adult flies to eclose from 
the pupal case (Movie S4, S5), with a variable fraction of adult 
escapers (Figure 3n, o). FLP/FRT-mediated 
neuronal caz inactivation resulted in only 7.5% of adult 
escapers, whereas Cre/LoxP-mediated recombination resulted 
in 56.7% of the expected frequency of adult offspring eclosing. 
We speculate that this discrepancy may be due to differences in 
timing of caz inactivation and/or genetic background.  
 
Nonetheless, independent of the recombinase system used, 
neuronal caz inactivation leads to motor defects and small 
differences in the degree of motor impairment may result in an 
apparently substantial difference in adult escaper frequencies. 
Overall, to a large extent, the neuronal caz KO phenocopies the 
full body KO, although the neuronal caz KO phenotype seemed 
somewhat less severe, suggesting that loss of caz function has 
deleterious effects in cell types other than neurons, which 
contribute to the caz mutant phenotypes. Evaluation 
of caz neuronal KO adult escaper flies in a negative geotaxis 
climbing assay revealed significant motor deficits (Figure 
3p, Movie S6) and the life span of these flies was significantly 











Cell-type-specific gene inactivation reveals a key function for cabeza in neuron
 55 
Figure 3. Neuron-selective caz inactivation induces pupal lethality, 
motor deficits and reduced life span. (a–l). Elav-GAL4 was used to drive 
panneuronal expression of FLP (a–f) or Cre (g–l), either in a wild type or 
conditional caz KO background. Immunostaining for caz and elav on third 
instar larval ventral nerve cord revealed caz inactivation in all neurons, but 
not in non-neuronal cells. Scale bar: 20 μm. (m). Quantification 
confirmed caz inactivation in 100% of neurons. N = 7–13. (n, o). Adult 
offspring frequencies of control genotypes versus neuron-selective caz KO 
mediated by FLP/FRT (n) or Cre/LoxP (o) revealed developmental lethality 
with a variable fraction of adult escapers. N = 514–665 (n) and 414–540 (o). 
(p). Neuronal caz KO adult escaper flies display significant motor 
performance deficits, as revealed by a negative geotaxis climbing assay. N = 
100. (q). Neuronal caz KO adult escaper flies display reduced life span. N = 
74–90. 
In contrast to panneuronal caz inactivation, 
panneuronal caz knock-down by two independent transgenic 
RNAi lines did not induce developmental lethality and did not or 
only slightly impair motor performance (Figure 4a, b). This can 
be explained by incomplete caz knock-down (Figure 4c), 
illustrating the advantage of cell-type specific gene inactivation 
over transgenic RNAi knock-down. 
 
 
Figure 4. Neuronal caz knock-down by transgenic RNAi does not induce 
developmental lethality and does not or only slightly impair motor 
performance. (a). Panneuronal expression of caz-RNAi with nsyb-GAL4 




control (w1118) are shown. N = 83–144. (b). Panneuronal caz knock-down 
by nsyb-GAL4 induced no or only slight motor performance defects in a 
negative geotaxis climbing assay. (c). caz transcript levels were quantified by 
qPCR in heads of adult flies ubiquitously expressing caz-RNAi from the adult 
stage onwards. Three distinct transgenic caz-RNAi lines were tested, either 
as a single transgene or in combinations of two transgenes. Significant caz 
knock-down of ≈ 50 to 80% was observed. caz-RNAi-1: VDRC100291; caz-
RNAi-2: HMS00790; caz-RNAi-3: HMS00156. 
Selective inactivation of caz in muscles 
 
To evaluate whether conditional gene inactivation also works in 
cell types other than neurons, selective gene inactivation in 
muscle cells was tested. We expected selective gene 
inactivation in muscle to be particularly challenging, as mature 
muscle fibers in Drosophila develop through fusion of myoblasts 
[16]. Therefore, target gene excision should occur in all nuclei, 
in order to have no residual gene expression in mature 
myocytes. Mef2-GAL4 was used to drive expression of either 
FLP or Cre in myoblasts of cazFRT or cazlox animals, 
respectively. Remarkably, in third instar larval body wall 
muscles, this approach resulted in loss of caz protein in all 
muscle cells (Figure 5a–p). Whereas FLP expression in muscles 
did not induce any obvious morphological changes, Cre 
expression resulted in a significantly reduced muscle width 
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Figure 5. Muscle-selective caz inactivation. (a–o). Mef2-GAL4 was used 
for muscle-selective expression of FLP or Cre, either in wild type or 
conditional caz KO background. GFP co-expression was used to visualize 
muscle cells and DAPI to label nuclei. Immunostaining for caz and GFP on 
third instar larval body wall musculature revealed caz inactivation in all 
muscle cells. Arrowheads in panels h and i indicate caz expression in a non-
muscle cell. Scale bar: 50 μm. (p). Quantification confirmed caz inactivation 
in 100% of muscle cells. Muscle 7 (indicated in panel a) in segments A1 and 
A2 was used for quantification. N = 7–10. (q, r). Defects in muscle 
morphology induced by Cre expression are documented by reduced width of 





The GAL80 TARGET system allows for temporal control over cell-
type-specific gene inactivation 
 
Finally, to determine if we could gain temporal control over cell-
type-specific gene inactivation, the GAL80 TARGET system 
[17] was used to repress elav-GAL4-driven FLP expression 
during development, and induce panneuronal FLP expression 
from the adult stage onwards. Two weeks after 
induction, caz was inactivated in more that 99% of neurons 
(average ± SEM: 99.38 ± 0.22%; Figure 6a–g). Thus, selective 
gene inactivation in neurons is feasible in Drosophila adults. 
This approach is particularly relevant for genes for which 
panneuronal inactivation during development results in lethality 
or developmental defects, precluding proper analysis of gene 
function in adult neurons. 
 
As ALS is an adult-onset disease, we reasoned that it would be 
particularly relevant to evaluate the effect of neuronal loss 
of caz function from the adult stage onwards on motor 
performance and life span. Surprisingly, loss of caz in adult 
neurons did not result in a climbing defect at four weeks of age 
(Figure 6h), and the life span of these flies was comparable to 
controls (Figure 6i). These data indicate that 















Figure 6. Temporal control over neuron-selective caz inactivation. 
Tubulin-GAL80ts>elav-GAL4 was used for induction of FLP expression 
in neurons of adult cazFRT flies. (a-f). Immunostaining for caz and elav on 
adult ventral cord revealed highly efficient caz inactivation in adult neurons 
(scale bar: 10 μm). (g). Quantification documented caz inactivation in >99% 




stage onwards does not affect motor performance at 4 weeks of age, as 
revealed by a negative geotaxis climbing assay. N = 90–100. (i). Loss of caz 
in adult neurons does not reduce life span in a biologically relevant manner. 
N = 100. 
Discussion 
 
The approach presented here allows for highly efficient 
inactivation of endogenous Drosophila genes in defined cell 
populations and analysis of resulting phenotypes. This method 
can be used in both dividing and non-dividing cells to address a 
broad range of biological questions and it allows for temporal 
control over gene inactivation.  
Consistent with previously described Cre toxicity in mice 
[18,19,20,21,22,23] and Drosophila [15], panneuronal Cre 
expression induced a mild rough eye phenotype and muscle 
expression resulted in severe muscle phenotypes. Moreover, 
the UAS-Cre transgenes used in this study displayed leaky 
expression (Supplementary Figure S3). Therefore, FLP/FRT is 
the preferred system for cell-type-specific gene inactivation 
in Drosophila. We believe that selective gene inactivation in a 
specific cell type complements experiments in which a mutant 
phenotype is rescued by cell-type-specific reintroduction of wild 
type protein. Indeed, the latter approach allows for evaluating 
whether loss of gene function in a certain cell type is necessary 
to induce (aspects of) the mutant phenotype, whereas cell-type-
specific gene inactivation evaluates whether loss of gene 
function in a certain cell type is sufficient to induce phenotypes. 
There are two caveats when using cell-type specific rescue 
approaches. Firstly, the UAS-transgene may be leaky, what may 
confound the interpretation of results. This also seems to be the 
case for the UAS-caz transgene used in this study, as the mere 
presence of the transgene results in a slight rescue of pupal 
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lethality (Supplementary Figure S4). Secondly, the levels of the 
rescue-transgene may not match the physiological protein levels 
in the cell type of interest. In the scenario where physiological 
protein levels would rescue the mutant phenotype, too low 
transgene expression levels may fail to do so, whereas 
transgene expression higher than physiological levels may 
induce overexpression phenotypes, which may again preclude 
rescue of mutant phenotypes. 
 
Compared to cell-type-specific knock-down by transgenic RNAi, 
cell-type-specific gene inactivation has the advantage that it 
results in complete loss of gene function in the targeted cells and 
that there is no risk for off-target effects. This is illustrated by the 
finding that panneuronal caz inactivation induced much stronger 
phenotypes than panneuronal caz knock-down (Figure 4). 
Compared to a recently reported strategy for conditional 
mutagenesis in Drosophila based on CRISPR/Cas9-induced 
gene disruption in somatic cells [7], our approach has the 
advantage that the cell-type-specific genetic mutations are 
molecularly defined, identical in all target cells and always 
resulting in complete loss of gene function. As a consequence, 
resulting phenotypes are less variable and more consistent 
between different individuals. 
 
For introduction of FRT or LoxP sites in the caz gene, we have 
used the IMAGO approach [10], which is labor-intensive and 
time-consuming. Recently however, several synthetic nuclease-
based methods have been reported for genome engineering 
in Drosophila, including zinc finger nucleases, TALENs and 
CRISPR/Cas9 [24,25]. These nuclease-based systems are 
highly efficient and allow for fast and easy genomic engineering. 




CRISPR/Cas9 technology allows for introduction of precise 
genomic changes within a time frame of one month 
[26,27,28,29]. Thus, this approach should allow for facile 
generation of conditional alleles. Therefore, cell-type specific 
gene inactivation in Drosophila can be expected to become a 
routine genetic manipulation strategy in the near future. 
 
Finally, as caz is the Drosophila homolog of human FUS, our 
findings may be relevant for ALS pathogenesis. Although ALS-
FUS is characterized by a dominant inheritance pattern, 
postmortem neuropathological analysis revealed cytoplasmic 
FUS-immunoreactive inclusions in neurons and glial cells, often 
accompanied by loss of FUS from its normal nuclear localization 
[30,31,32]. Furthermore, cell-biological studies have shown that 
most of the ALS mutations induce a shift in FUS subcellular 
localization from the nucleus to the cytoplasm and a positive 
correlation exists between the degree to which FUS nuclear 
import is impaired and the age of disease onset and the rate of 
disease progression [33,34,35,36,37]. Loss of nuclear FUS 
function may therefore be implicated in ALS-FUS pathogenesis. 
Both caz mutant lines described in this study die during the 
pupal stage of development, with at least a fraction of pharate 
adults trying to eclose from the pupal case, but failing to do so 
due to motor incapability. The caz mutant pupal eclosion defect 
could be rescued by selective reintroduction of wild type caz 
transgenic protein in neurons, demonstrating that loss of caz 
function in neurons is necessary to induce adult eclosion 
defects. Overall, these findings are in line with the phenotypes 
of a previously described caz mutant, which were interpreted as 
supporting the hypothesis that loss of FUS function may causally 
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We could further demonstrate that selective caz inactivation in 
all neurons during development (elav-GAL4C155 drives 
transgene expression from embryonic stage 12 onwards [38]) 
results in adult motor deficits and reduced life span. In contrast, 
selective neuronal caz inactivation from the adult stage onwards 
did not result in motor performance defects at four weeks of age 
and life span was not affected. The latter result may be 
particularly relevant in the context of ALS, which is an adult-
onset disease. Together, our findings indicate that neuronal caz 
is not required for maintenance of adult neuronal function. 
Rather, loss of neuronal caz function during development is 
necessary and sufficient to induce adult motor performance 
defects and shortened life span. Further studies are needed to 
evaluate whether loss of neuronal caz during development leads 
to neurodevelopmental defects or rather to degenerative 
changes during development. 
 
Although we are careful with extrapolating findings from 
Drosophila models to human ALS patients, our data suggest that 
(partial) loss of neuronal FUS function may not be sufficient to 
cause adult motor neuron degeneration in ALS-FUS patients. 
Rather, a gain of toxic function by cytoplasmic FUS 
mislocalization and/or aggregation may be necessary to cause 
motor neuron degeneration. An alternative possibility is that loss 
of FUS function in non-neuronal cells in addition to neuronal loss 
of FUS function is necessary to cause disease. Non-cell-
autonomous contributions to motor neuron degeneration have 
been clearly demonstrated in mutant SOD1 mouse models for 
ALS [39]. In any case, our data do not exclude the possibility that 
loss of nuclear FUS function could causally contribute to motor 
neuron degeneration in ALS-FUS patients. Loss of neuronal 




pathogenesis, albeit not sufficient to cause motor neuron 






All PCR primer sequences are listed in Supplementary Table 
S1. To introduce homology arms into pP{white-STAR} [10] for 
homologous recombination, 4590 bp of sequence upstream of 
base 21 in intron 1 of caz were PCR-amplified (Phusion 
polymerase, Thermo Scientific) and cloned into pP{white-STAR} 
using PCR primers 5′HR_FW and 5′HR_REV followed by 
restriction digestion of the PCR product with KpnI and XbaI. 
pP{white-STAR} was digested with KpnI and AvrII (compatible 
ends with XbaI) and ligated to the digested PCR product. To 
introduce the 3′ homology arm, 4990 bp of sequence, beginning 
10 bp downstream of the caz gene, were amplified using 
3′HR_FW and 3′HR_REV followed by digestion with NheI and 
AbsI. pP{white-STAR} containing the 5′ homology arm was then 
digested with SpeI and XhoI and ligated to the digested 3′HR 
PCR product (compatible ends). 
To facilitate cloning of cassette exchange constructs into pABC, 
an XbaI restriction site was introduced into pABC-ato [10] by 
site-directed mutagenesis using primers pABC_XbaI_FW and 
pABC_XbaI_REV (mutagenesis PCR with Pfu ultra, 
Stratagene). To reintroduce wild type caz (cazattR stock), the 
caz gene was amplified by PCR using primers XbaI_caz_FW 
and KpnI_caz_REV with P[acman] BAC CH322-28D08 
(BACPAC Resources) as a template (Phusion polymerase, 
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Thermo Scientific) and cloned into pABC-ato-XbaI with XbaI and 
KpnI, replacing ato by caz. 
To flank caz by FRT and loxP sites (cazlox and cazFRT stocks), 
the recombination sites were first cloned into pABC using 
synthetic oligonucleotides containing FRT or loxP sites and 
restriction sites (2xFRT FW and REV, 2xloxP FW and 
REV, Supplementary Table S1). BsiWI and HindIII were used to 
digest pABC-ato and the annealed oligonucleotides followed by 
a ligation. XbaI and KpnI were then used to clone caz between 
the loxP sites (caz PCR product using XbaI_caz_FW and 
KpnI_caz_REV). NcoI and KpnI were used to 
clone caz between FRT sites (caz PCR product using 
NcoI_caz_FW and KpnI_caz_REV). All inserts were fully 
sequenced before plasmid injections into embryos. 
 
Generation of fly lines 
 
To generate caz null flies by imprecise P-element excision, 
Ki1 pp P[ry Δ2-3]99B transposase (Bloomington stock 4368) was 
used to mobilize P{y[+ t7.7] = MaeUAS.6.11}DP00882 inserted 
upstream of the caz gene (Bloomington stock 21828), according 
to the protocol published by Hummel and Klämbt [40]. Excision 
events were identified using the yellow marker. Candidate 
excisions were balanced over FM7 and stocks that were not 
homozygous viable were screened for rescue of lethality with a 
genomic caz construct [13] and further characterized by PCR 
genotyping and sequencing. PCR and sequencing with primers 
caz -1500 FW and caz intron3 REV were used to molecularly 
characterize the caz2 imprecise excision allele, revealing that 
nucleotides 16288762 to 16289716 were deleted. 
For homologous recombination, the ends-out targeting vector 




arms was introduced into the fly genome using standard 
transposase-mediated random integration followed by selection 
of transgenic flies based on red eye color. All plasmid injections 
were performed by the Model Systems Genomics service at 
Duke University. The ends-out homologous recombination 
procedure was based on the protocol of Maggert et al. [41]. 
Virgins from stocks carrying the donor construct on chromosome 
2 were crossed to males carrying heat-inducible FLP and SceI 
(P{ry[+ t7.2] = 70FLP}23 P{v[+ t1.8] = 70I-SceI}4A/TM6, 
Bloomington stock 6935). Parents were transferred every 2-3 
days and larvae were heat-shocked in a water bath at 38°C for 
1 h one day after the parents had been transferred. All balancer-
negative virgins from these crosses were collected and 
testcrossed to males expressing FLP (P{ry[+ t7.2] = 70FLP}10, 
Bloomington stock 6938; in total approximately 1300 crosses 
with 1–2 virgins each were set up). Red-eyed virgins from these 
crosses were used to establish candidate stocks. Correct 
targeting events were identified by (i) identification of X-
chromosomal white insertions by crossing to FM7/Y males, (ii) 
screening for lethality of FM7-negative males in candidate 
stocks (known phenotype of caz mutants [13]), (iii) rescue of 
observed lethality using a genomic caz construct [13], (iv) PCR 
genotyping of caz and surrounding genomic regions using 
LongAmp Taq polymerase (NEB) and sequencing and (v) 
Southern Blotting. 
To replace the white marker gene in cazKO flies by recombinase-
mediated cassette exchange, cazKO embryos expressing ΦC31 
integrase in the germ line (M(vas-int.B)ZH-102D, Bloomington 
stock 23649) were injected with pABC-caz constructs. Selection 
of flies with a correct cassette exchange was based on loss of 
red eye color, followed by PCR genotyping using primers caz 
RMCE FW, caz RMCE REV1 and caz RMCE REV2 
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(Supplementary Table S1), which also revealed the direction of 
the inserted caz sequence. 
 
Cell-type-specific caz inactivation 
 
To induce cell-type-specific caz knock-
out, cazlox and cazFRT were recombined with elav-Gal4 (P{w[+ 
mW.hs] = GawB}elav[C155], Bloomington stock 458) or Mef2-
Gal4 (kindly provided by Frank Schnorrer). Homozygous 
recombinant females were subsequently crossed to UAS-Cre 
(UASt-Cre II.3 provided by Christian Lehner [15]) or UAS-FLP 
(P{w[+mC] = UAS-FLP1.D}JD1, Bloomington stock 4539) males 
and male offspring was used for experiments. P{w[+mC] = UAS-
GFP.nls}8 was used to express GFP in muscles (Bloomington 
stock 4776). 
To inactivate caz panneuronally from the adult stage onwards, 
tubulin-GAL80ts (Bloomington stock 7018) was used to express 
UAS-FLP in a temperature-dependent manner. cazFRT,elav-
GAL4; UAS-FLP; tubulin-GAL80ts flies and controls were raised 
at 18°C to suppress UAS-FLP expression and shifted to 29°C 2 
to 4 days after eclosion to excise caz in adult neurons. 
Uninduced controls were not shifted to 29°C but kept at 18°C. 
Two weeks later, all genotypes were kept at 18° for 6 more days 
prior to dissection. 
 
Immunostaining and microscopy 
 
Third instar larval CNS was fixed in 2% PFA for 30 min, followed 
by three 15 min washes in PBT (1% TritonX-100 in PBS) at RT 
and blocking with 10% goat serum in PBT for 1 h. Anti-elav 
(DSHB, 9F8A9, 1:200) and anti-caz (mouse monoclonal clone 




Dependent Recruitment of the Amyotrophic Lateral Sclerosis-
Associated Protein FUS/TLS to Sites of Oxidative DNA 
Damage], 1:30) were diluted in 10% goat serum in PBT and 
applied overnight at 4°C. After three 20 min washes in PBT, 
secondary goat anti-mouse antibodies (Alexa Fluor 568 and 
488, 1/500) were applied for 2 h at RT, followed by mounting on 
a microscopy slide in Vectashield medium. Quantification of 
efficiency of caz excision in L3 CNS was performed on 70 
neurons organized in central clusters in the ventral nerve cord 
(Figure 3a). Adult CNS was fixed in 2% PFA for 1 h followed by 
an immunostaining according to the protocol described for L3 
CNS. To quantify the efficiency of caz excision in adults, an area 
of 80 × 80 μm located laterally in between segment T1 and T2 
in the ventral nerve cord was used (in a randomly selected layer 
of a Z stack). 
To image larval body wall muscles, third instar larval filets were 
fixed in Bouin's solution for 3 min followed by three 10 min 
washes in PBT (0.2% TritonX-100 in PBS) at RT and blocking 
with 10% goat serum in PBT for 1 h. Anti-GFP (Invitrogen, 
A6455, 1/1000) and anti-caz (3F4, 1:30) were applied overnight 
at 4°C in 10% goat serum in PBT. After incubation with 
secondary goat anti-mouse antibodies (Alexa Fluor 568 and 
488, 1/500) for 2h and washing, filets were mounted in 
Vectashield medium with DAPI to stain muscle nuclei. 
Quantification of efficiency of caz excision in muscles was 
performed on nuclei of muscle 7 on both sides in segments A1 
and A2 (Figure 5a). All images were acquired using a Zeiss 










SDS-PAGE (10% gel) was used to separate third instar larval 
CNS protein extracts, followed by semi-dry transfer to a PVDF 
membrane following standard procedures. Primary antibodies 
against caz (3F4, 1:100) and β-tubulin (E7, DSHB, 1:700) were 
used, followed by secondary HRP-conjugated anti-mouse IgG 
(W402B, Promega, 1:2500). 
 
Drosophila adult offspring frequencies, life span and motor 
performance assays 
 
Flies for offspring quantifications, life span and motor 
performance assays were kept at 25°C in a 12h light/dark rhythm 
on standard Drosophila medium. To determine adult offspring 
frequencies, the F1 generation eclosing from crosses was 
counted for 9 days starting from the first day of eclosion. The 
ratio of FM7 negative males to FM7-positive males ( 
= caz mutant, caz conditional knock-out or control males versus 
balancer control males) was calculated and normalized to the 
ratio of one control genotype. Adult offspring frequencies are 
reported as percentage relative to the control genotype (set at 
100%). The UAS-caz line used for rescue experiments was the 
UAS-flag-caz line described by Wang et al [13]. 
For life span assays, 74–100 males per genotype were collected 
within 24 h of eclosion and grouped into batches of 10 flies per 
food vial. The number of dead flies was counted every day and 
flies were transferred to fresh food vials every 3 days. 
For motor performance assays, male flies were collected within 
48 h after eclosion and divided into groups of 10 individuals. 
Motor performance of 6- to 7-day old flies was evaluated. On the 




the test tubes without anesthesia and assayed within 10 minutes 
under standardized light conditions. 10 test tubes were loaded 
into a rack, which was mounted onto an apparatus that releases 
the rack from a fixed height upon pushing a button. The rack falls 
down, thereby shaking the flies to the bottom of the test tubes 
and inducing a negative geotaxis climbing response. The whole 
procedure was videotaped with a Nikon D3100 DSLR camera 
and repeated 2 more times. The resulting movies were then 
converted into 8-bit grayscale TIF image sequences with 10 
frames per second. Subsequently, the image sequence was 
imported in ImageJ/FIJI, background-subtracted, filtered and 
binarized to allow for tracking of flies using the MTrack3 plug-in. 
Average climbing speed (mm/s) was determined and compared 
between genotypes. 
 
Measurement of transcript levels 
 
The efficiency of caz knock-down by transgenic RNAi was 
examined by quantitative real-time PCR (qPCR). Flies 
expressing caz-RNAi transgenes (Bloomington stock numbers 
34839 and 32990 and VDRC stock 100291) under control of 
the tub-Gal80ts; tub-Gal4 target system were raised at 18°C to 
suppress transgene expression and shifted to 29°C for 48 h to 
induce transgene expression. Total RNA was extracted from 20 
heads per genotype by using the NucleoSpin® RNA kit 
(Macherey-Nagel). First-strand synthesis was performed on 1 
microgram total RNA using the QuantiTect Reverse 
Transcription Kit (Qiagen). qPCR primer and probe sets 
designed to amplify caz cDNA were obtained from Applied 
Biosystems. Measurements were normalized 
to EfTuM and Actin5C controls and data were analyzed using 
the comparative CT method. 
2
71




Offspring frequency results were analyzed by Chi Square test in 
Microsoft Excel. Results from climbing assays were analyzed by 
Mann Whitney U test comparing climbing speeds of individual 
flies per genotype and per run. Subsequently, Fisher's combined 
probability test was used to combine the three p values 
originating from three consecutive measurements per genotype. 
qPCR results were analyzed by ANOVA followed by Bonferroni 
correction. For life span analysis, Log Rank Test was used to 
test for statistical significance. Muscle size results were 
analyzed by Mann Whitney U test. If not stated otherwise, 
GraphPad Prism 5 was used to perform statistics and to 
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Figure S1. Rough eye phenotypes in elav-GAL4>UAS-Cre flies. Five-day old 





















Figure S2. Additional control genotypes for life span of neuronal caz KO adult 
escaper flies. (a). The mere presence of FRT or LoxP sites in the caz gene, 
or the additional presence of elav-GAL4, UAS-FLP or UAS-Cre does not 
influence life span in a biologically relevant manner. (b). Panneuronal FLP or 
Cre expression does not reduce life span. Following genotypes are also 
shown in Figure 2q: yw, cazFRT and cazlox.  
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Figure S3. Leaky Cre expression results in occasional caz inactivation in 
neurons and muscle cells. (a-f). Immunostaining for caz and the neuronal 
nuclear marker elav on third instar larval ventral nerve cord revealed 
occasional caz inactivation in neurons when UAS-Cre is present in the cazlox 
background (arrowheads), but not when UAS-FLP is present in the cazFRT 
background. (g-l). Immunostaining for caz on third instar larval body wall 
muscles along with DAPI staining of nuclei revealed occasional caz 
inactivation in muscles when UAS-Cre is present in the cazlox background 














Figure S4. Caz mutant pupal lethality is rescued by neuron-selective wild 
type caz expression. Note that the mere presence of UAS-caz also induces 
a slight but significant rescue of pupal lethality, probably attributable to leaky 
caz expression. Following genotypes are also shown in Figure 1e: WT, 
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Figure S5. Full-length Western blot of which a cropped version is shown in 
Figure 1c. The blot was probed with primary antibodies against caz and β-




















Supplementary movies can be found at the: 
https://doi.org/10.1038/srep09107 
 
SUPPLEMENTARY MOVIE LEGENDS 
 
SUPPLEMENTARY MOVIE S1. Pupal eclosion of wild type control flies. The 
movie is 10x sped up. 
SUPPLEMENTARY MOVIE S2. Pupal eclosion of caz2 flies. The movie is 
10x sped up. 
SUPPLEMENTARY MOVIE S3. Motor deficits displayed by caz2 pharate 
adult flies that were dissected out of their pupal case when partially eclosed. 
SUPPLEMENTARY MOVIE S4. Pupal eclosion of an elav-GAL4>UAS-FLP 
fly. 
SUPPLEMENTARY MOVIE S5. Pupal eclosion of a cazFRT, elav-
GAL4>UAS-FLP fly. The movie is 8x sped up. 
SUPPLEMENTARY MOVIE S6. Motor performance of elav-GAL4>UAS-Cre 
(two left tubes), cazlox; UAS-Cre (two middle tubes) and cazlox, elav-
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Cabeza (caz) is the single Drosophila melanogaster orthologue 
of the human FET proteins FUS, TAF15, and EWSR1, which 
have been implicated in amyotrophic lateral sclerosis (ALS) and 
frontotemporal dementia. In this study, we identified Xrp1, a 
nuclear chromatin-binding protein, as a key modifier of caz 
mutant phenotypes. Xrp1 expression was strongly up-regulated 
in caz mutants, and Xrp1 heterozygosity rescued their motor 
defects and life span. Interestingly, selective neuronal Xrp1 
knockdown was sufficient to rescue, and neuronal Xrp1 
overexpression phenocopied caz mutant phenotypes. 
The caz/Xrp1 genetic interaction depended on the functionality 
of the AT-hook DNA-binding domain in Xrp1, and the majority of 
Xrp1-interacting proteins are involved in gene expression 
regulation. Consistently, caz mutants displayed gene expression 
dysregulation, which was mitigated by Xrp1 heterozygosity. 
Finally, Xrp1 knockdown substantially rescued the motor deficits 
and life span of flies expressing ALS mutant FUS in motor 



















Amyotrophic lateral sclerosis (ALS) is an adult-onset 
neurodegenerative disorder characterized by motor neuron loss, 
leading to progressive muscle weakness and ultimately 
complete paralysis and death (Taylor et al., 2016). Mutations in 
several genes encoding RNA-binding proteins (RBPs) cause 
familial ALS (FALS), including TDP-43 (Gitcho et al., 2008; 
Kabashi et al., 2008; Sreedharan et al., 2008), FUS 
(Kwiatkowski et al., 2009; Vance et al., 2009), TAF15 (Couthouis 
et al., 2011), EWSR1 (Couthouis et al., 2012), hnRNPA1 and 
hnRNPA2B1 (Kim et al., 2013b), and matrin-3 (Johnson et al., 
2014). Furthermore, TDP-43–positive inclusions are found in 
most sporadic ALS patients (Neumann et al., 2006; Taylor et al., 
2016), and inclusions containing either TDP-43 or FUS are a 
pathological hallmark in ∼45% and ∼10% of patients with 
frontotemporal dementia (FTD), respectively (Ling et al., 2013). 
These findings implicated defects in RNA biogenesis in ALS and 
FTD pathogenesis.  
Of the ALS-associated RBPs, FUS, EWSR1, and TAF15 (FET) 
proteins are highly homologous proteins that constitute the FET 
family (Schwartz et al., 2015). The FET proteins are DNA-
binding proteins and RBPs involved in gene expression 
regulation, including transcription, mRNA splicing, and mRNA 
subcellular localization (Schwartz et al., 2015). Heterozygous 
mutations in FUS account for ∼5% of FALS (Ling et al., 2013), 
while mutations in TAF15 and EWSR1 are rare (Couthouis et al., 
2011, 2012). Most ALS-associated mutations cluster in the 
nuclear localization signal of FUS, resulting in a shift from a 
predominantly nuclear to a more cytoplasmic localization, 
formation of cytoplasmic aggregates, and reduced nuclear FUS 




nuclear FUS function may contribute to ALS pathogenesis, 
although evidence from ALS-FUS 
mouse models indicates that ALS-FUS mutations also result in 
a novel toxic function that triggers motor neuron degeneration 
(Scekic-Zahirovic et al., 2016, 2017; Sharma et al., 2016). 
Moreover, in FTD with FUS pathology (FTLD-FUS), the three 
FET proteins are found in pathogenic inclusions, with reduced 
levels or complete loss of nuclear FET proteins in inclusion-
bearing cells, indicating that loss of nuclear FET function may 
contribute to FTLD-FUS (Neumann et al., 2011; Davidson et al., 
2013). The Drosophila melanogaster gene cabeza (caz) 
encodes the single fly orthologue of the three human FET 
proteins. Accordingly, Caz is a predominantly nuclear RBP that 
contains the functional domains of the human FET proteins 
(Schwartz 
et al., 2015). When expressed in mammalian cells, Caz elicits 
down-regulation of FUS protein levels (Immanuel et al., 1995), 
while FUS expression in Drosophila rescues caz mutant 
phenotypes (Wang et al., 2011), indicating functional homology.  
We previously generated caz mutant animals, which exhibit 
pupal lethality because adult flies fail to eclose due to motor 
deficits (Frickenhaus et al., 2015). In this study, we performed a 
genetic screen to gain insight into the molecular mechanisms 
underlying caz mutant phenotypes. Exhaustive screening of 
∼80% of the Drosophila genome identified Xrp1 as the only gene 
for which heterozygosity could rescue caz mutant phenotypes. 
Xrp1 encodes a protein containing an AT-hook DNA-binding 
domain often found in proteins involved in chromatin remodeling, 
transcriptional regulation, and DNA repair (Reeves, 2010). Xrp1 
expression was increased in caz mutants, and neuron-selective 
knockdown of Xrp1 was sufficient to rescue caz mutant 
phenotypes. Importantly, the DNA-binding capacity of the AT-
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hook domain of Xrp1 was required to mediate caz mutant 
phenotypes, and caz mutants displayed substantial gene 
expression dysregulation, which was significantly mitigated by 
heterozygosity for Xrp1. Finally, Xrp1 knockdown in motor 
neurons rescued phenotypes induced by ALS mutant FUS 
expression, underscoring the potential relevance of our findings 
for human disease. Together, we propose that caz mutant 
phenotypes are mediated by up-regulation of Xrp1, leading to 




A genetic screen to identify suppressors of caz mutant 
phenotypes 
 
We previously generated two independent caz null alleles: (1) 
caz2, an imprecise excision allele, and (2) cazKO, generated by 
homologous recombination (Frickenhaus et al., 2015). Caz 
mutants die during the pupal stage due to motor incapability 
resulting in pharate adults failing to eclose from the pupal case. 
This phenotype was used to perform a dominant suppressor 
screen whereby males carrying chromosomal deficiencies were 
crossed to caz2 heterozygous females. Since caz is on the X 
chromosome, this approach allowed us to screen for genes on 
the second and third chromosomes for which hemizygosity 
would rescue the pupal lethality of caz2 males (Fig. 1 A).  This 
screen yielded only a single deficiency that rescued caz2 pupal 
lethality, Df(3R)ED2 (Fig. 1 B). Fine mapping using smaller 
overlapping deficiencies reduced the number of candidate 
genes to 11 (Fig. 1 C). As Df(3R)Exel6181 and Df(3R)Exel6182 
are neighbouring but nonoverlapping deficiencies that have a 




either of these deficiencies rescued caz2 pupal lethality 
suggested that heterozygous loss of Xrp1 may mediate the 
rescue (Fig. 1, B and C). 
 
Heterozygosity for Xrp1 rescues caz mutant pupal lethality 
 
Xrp1 is predicted to encode seven alternative transcripts (Fig. 
S1A), four of which can be translated into a 668-aa “long” 
isoform (Xrp1Long) and the remaining three into a 406-aa “short” 
isoform (Xrp1Short). We generated two Xrp1 deletion alleles: 
Df(3R)Xrp1Plus is a ∼25-kb deletion of Xrp1, Mpc1, and part of 
CG42613 (Fig. 1 D), whereas Xrp1Ex-long selectively deletes two 
thirds of Xrp1, expected to abolish expression of all Xrp1Long 
transcripts, but possibly leaving expression of a Xrp1Short 
transcript (Xrp1-RD) intact (Fig. 1 E). In addition, we used in vivo 
homologous recombination to generate the Xrp1KO allele, in 
which the entire Xrp1 coding region is precisely deleted (Figs. 1 
F and S1 C). All three Xrp1 mutant alleles were homozygous 
viable, and quantitative PCR (qPCR) using primers that 
selectively detect Xrp1Long revealed loss of Xrp1Long transcript in 
homozygous Df(3R)Xrp1Plus, Xrp1Ex-long, and Xrp1KO animals 
(Fig. 1 G). qPCR using primers detecting all Xrp1 isoforms 
revealed loss of Xrp1 transcript in Df(3R)Xrp1Plus and Xrp1KO 
flies, whereas in Xrp1Ex-long flies, some residual Xrp1 transcript 
could be detected (∼8% of WT levels), presumably reflecting 
expression of the short Xrp1-RD mRNA isoform (Fig. 1 H). 
Crossing males heterozygous for either Df(3R)Xrp1Plus, Xrp1Ex-
long, or Xrp1KO to caz2/FM7 or cazKO/FM7 females revealed that 
heterozygosity for Df(3R)Xrp1Plus or Xrp1KO rescued caz mutant 
pupal lethality to a similar extent as Xrp1 deficiencies and a 
genomic caz transgene, independent of the caz null allele used 
(Fig. 1, I and J).  
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Figure 1. Heterozygosity for Xrp1 rescues caz mutant pupal lethality. 




rescue caz2 pupal lethality. (B) Frequency of adult male offspring from the 
indicated cross that is heterozygous for a genomic caz transgene or the 
indicated deficiencies. n > 128 per genotype. ***, P < 0.0001; 
χ2 test. (C) Genomic region uncovered by Df(3R)ED2. Pink indicates genes 
in the plus orientation; white indicates genes in the minus orientation. The 
different smaller deficiencies within this region which were tested for rescue 
of caz2 pupal lethality are shown. Check marks indicate deficiencies that 
rescue; X marks indicate deficiencies that do not rescue. (D–
F) Xrp1 genomic locus showing the insertion sites of the transposable 
elements used to generate Xrp1 mutant alleles. In the Df(3R)Xrp1Plus allele 
(D), Xrp1, Mpc1, and the 5′ end of CG42613 are deleted. In the Xrp1Ex-
long allele (E), the 5′ half of Xrp1 is deleted, predicted to abolish expression of 
the Xrp1Long isoform. The Xrp1Short isoform, encoded by Xrp1-RD, may still be 
expressed. In the Xrp1KO allele (F), the Xrp1 coding region is precisely 
deleted. (G and H) Xrp1 transcript levels in Xrp1 mutant lines relative to WT 
controls (100%) determined by qPCR using primers either selectively 
detecting Xrp1Long transcripts (G) or detecting all Xrp1 transcripts (H). n = 10. 
***, P < 0.0001; one-way ANOVA. Mean ± SEM. (I and J) Frequency of adult 
male offspring from the indicated crosses that is heterozygous for the 
indicated Xrp1 allele. n > 87 per genotype. *, P < 0.05; ***, P < 0.0001; χ2 test. 
Furthermore, the mild rough eye phenotype previously reported 
in caz mutant adult escaper flies (Wang et al., 2011) was 
rescued by Xrp1 heterozygosity. While a genetic interaction was 
previously reported between caz and TBPH, the Drosophila 
homologue of TARDBP, encoding TDP-43 (Wang et al., 2011), 
Xrp1 heterozygosity could not rescue the adult eclosion defect 
of TBPH mutants (Fig. S 2). Thus, loss of 50% of Xrp1 gene 
dosage is sufficient to rescue pupal lethality induced by loss of 
caz but not TBPH function. 
Xrp1 heterozygosity rescues motor deficits and life span of caz 
mutant flies 
 
As caz mutant flies display motor defects (Wang et al., 2011; 
Frickenhaus et al., 2015), we evaluated motor performance of 
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caz mutant Xrp1 heterozygous flies using an automated 
negative geotaxis climbing assay (Niehues et al., 2015). While 
we failed to obtain caz mutant adult escapers, Xrp1 
heterozygous caz mutant flies managed to climb the wall of a 
test vial, although their climbing speed was still significantly 
reduced as compared with control animals (Fig. 2 A). Analysis 
of larval locomotion revealed that caz mutant third instar larvae 
display a significantly reduced crawling speed, which was fully 
rescued by heterozygosity for Xrp1 (Fig. S3 A). Evaluation of life 
span revealed that Xrp1 heterozygosity resulted in a substantial 
rescue of life span as compared with pupal lethality of caz2 and 
cazKO flies, although the life span of rescued caz mutants was 
still shorter than control flies (Fig. 2 B). Thus, heterozygosity for 
Xrp1 partially but substantially rescues caz mutant motor 
performance and life span. 
 
Selective knockdown of Xrp1 in neurons rescues caz mutant 
phenotypes 
 
Selective reintroduction of Caz in neurons was shown to 
rescue caz mutant phenotypes (Wang et al., 2011; Frickenhaus 
et al., 2015), while selective inactivation of caz in neurons 
resulted in severe motor deficits and reduced life span 
(Frickenhaus et al., 2015), indicating that loss of caz function in 
neurons is both necessary and sufficient to induce caz mutant 
phenotypes. We therefore evaluated whether selective 
knockdown of Xrp1 in neurons was sufficient to 
rescue caz mutant phenotypes despite the fact that the FlyAtlas 
and modENCODE databases report Xrp1 expression in all 
tissues throughout development and adult life. Two independent 
transgenic Xrp1-RNAi lines revealed that selective knockdown 




lethality (Fig. 2 C) and partially rescued caz mutant motor 
performance for cazKO even to a similar extent as neuronal Caz 
reintroduction (Fig. 2 D). 
 
 
Figure 2. Rescue of caz mutant phenotypes by Xrp1 heterozygosity or 
by selective knockdown of Xrp1 in neurons. (A) Average climbing speed 
in an automated negative geotaxis assay of 
heterozygous Df(3R)Xrp1Plus male flies (control) and caz mutant males 
rescued by genomic caz or heterozygosity for Xrp1. n > 100 per genotype. 
***, P < 0.0005; Mann-Whitney test. Mean ± SEM. (B) Life span of WT 
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(control), Df(3R)Xrp1Plus heterozygous, and caz mutant male flies rescued by 
genomic caz or heterozygosity for Xrp1. n = 78–127 per 
genotype. (C) Frequency of adult male offspring from the indicated cross that 
carries UAS-caz, UAS-Xrp1-RNAi, or no UAS transgene (control). n > 176 
per genotype. ***, P < 0.0001; χ2 test. (D) Average climbing speed of adult 
male control (driver-only) flies, flies with neuronal (elav-GAL4) Xrp1 
knockdown, and caz mutants rescued by neuronal Caz or neuronal Xrp1 
knockdown. n > 100 per genotype. *, P < 0.05; **, P < 0.01; Mann-Whitney 
test. Mean ± SEM. (E and F) Life span of male flies selectively expressing 
caz or Xrp1-RNAi in neurons either in a WT, caz2 (E), or cazKO (F) 
background. n = 76–164 per genotype. 
Importantly, selective knockdown of Xrp1 in motor neurons 
(D42-GAL4) was sufficient to fully rescue the reduced crawling 
speed of caz mutant larvae (Fig. S3 B), indicating that the larval 
locomotion deficit is attributable to dysfunction of motor neurons. 
Finally, the median life span of caz mutant flies with neuronal 
Xrp1 knockdown ranged from 30% to 50% of the life span of their 
respective controls (Fig. 2, E and F), comparable with the life 
span of Xrp1 heterozygous caz mutants. To evaluate the level 
of knockdown induced by the two Xrp1-RNAi lines, qPCR 
revealed residual Xrp1 transcript levels in the central nervous 
system (CNS) of actin5C-GAL4>UAS-Xrp1-RNAi third instar 
larvae of ∼7% and ∼11% of control levels for UAS-Xrp1-RNAi-1 
and UAS-Xrp1-RNAi-2, respectively (Fig. S1 B). Furthermore, 
selective Xrp1 knockdown in glial cells did not 
rescue caz mutant pupal lethality (Fig. S4 A). Together, these 
findings demonstrate that selective down-regulation of Xrp1 in 
neurons is sufficient to rescue caz mutant phenotypes. 
Increased Xrp1 expression mediates caz mutant phenotypes 
Our finding that reducing Xrp1 expression rescues caz mutant 
phenotypes raised the possibility that these phenotypes are 




deleterious effects in neurons. Consistent with this hypothesis, 
qPCR revealed that Xrp1 mRNA levels are increased three- to 
fourfold in both CNS and body wall of caz mutants (Figs. 3 A and 
S4, B and C). Remarkably, in caz mutant Xrp1 heterozygotes, 
Xrp1 transcript levels were not significantly different from 
controls (Fig. 3 A). Thus, phenotypic rescue of caz mutants 
by Xrp1 heterozygosity is associated with normalization of Xrp1 
expression levels. Vice versa, ubiquitous caz overexpression 
from the adult stage onwards did not reduce Xrp1 mRNA levels 
(Fig. 3 B). To evaluate whether Xrp1 gene dosage 
modifies caz expression levels, qPCR and Western blotting was 
performed on Xrp1 mutants and transgenic flies ubiquitously 
overexpressing Xrp1Long or Xrp1Short. These analyses revealed 
that Caz levels are not significantly changed in Xrp1 mutants 
(Fig. 3, C, E, and F) or upon Xrp1 overexpression (Fig. 3 D). 
Thus, loss of caz increases Xrp1 expression, but Caz 
overexpression does not down-regulate Xrp1, and alteration of 
Xrp1 levels has no effect on caz expression. To further test the 
hypothesis that increased Xrp1 expression in neurons is a key 
mediator of caz mutant phenotypes, we evaluated the effect of 
selective Xrp1 overexpression in neurons of otherwise WT flies. 
Neuronal overexpression of either Xrp1Long or Xrp1Short induced 
developmental lethality, with a fraction of adult escapers 
emerging (Figs. 3 G and S4 D). These adult escapers displayed 
substantial motor performance deficits (Figs. 3 H and S4 E) and 
a significantly shortened life span (Figs. 3 I and S4 F). Thus, 
neuronal Xrp1 overexpression phenocopies caz mutant 
phenotypes. Together with the findings that Xrp1 heterozygosity 
or Xrp1 neuronal knockdown rescue caz mutant phenotypes, 
these results indicate that increased neuronal Xrp1 levels 
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Figure 3. Xrp1 expression is up-regulated in caz mutants, and selective 
neuronal Xrp1 overexpression phenocopies caz mutant phenotypes. 




WT, caz mutant, Xrp1 heterozygous, and caz mutant Xrp1 heterozygous 
larvae. n = 10. (B) Xrp1 transcript levels in heads of adult male flies that 
ubiquitously (tub-GAL4) overexpress Caz, Xrp1Long, Xrp1Short, or no transgene 
(control) from the adult stage onwards. n = 10. (C) Caz transcript levels in 
larval CNS of WT and two Xrp1 mutants. n = 10. (D) Caz transcript levels in 
heads of adult male flies that ubiquitously overexpress caz, Xrp1Long, 
Xrp1Short, or no transgene (control) from the adult stage onwards. n = 10. ***, 
P < 0.0001; one-way ANOVA. (E) Representative Western blot to evaluate 
Caz protein levels in larval CNS from WT, caz mutants, and Xrp1 mutants. β-
tubulin was used as loading control. (F) Quantification of Caz protein levels 
relative to β-tubulin. n = 5. P = NS; one-way ANOVA. (G) Frequency of adult 
male offspring from the indicated cross. n > 111 per genotype. ***, P < 
0.0005; χ2 test. (H) Average climbing speed of adult male flies selectively 
overexpressing Xrp1Short in neurons (elav-GAL4) as compared with driver-
only controls. n > 100 per genotype. ***, P < 10−9; Mann-Whitney test. (I) Life 
span of male flies selectively overexpressing Xrp1Short in neurons (elav-
GAL4) as compared with driver-only controls. n = 77–102. All graphs display 
mean ± SEM. 
Xrp1 is a nuclear protein that binds chromatin 
The Xrp1 protein is predicted to contain two conserved DNA-
binding domains in its C terminus: (1) an AT-hook motif 
consisting of nine amino acids centered on the invariant 
tripeptide glycine-arginine-proline (Reeves, 2010) and (2) a 
basic-region leucine zipper (bZIP) motif found in the bZIP family 
of transcription factors, which typically consists of a basic region 
of ∼20 aa that mediates sequence-specific DNA binding along 
with a leucine zipper, a sequence of 40–60 hydrophobic amino 
acids in which leucine occurs every seventh residue, which 
mediates dimerization (Vinson et al., 2002). Despite the fact that 
Xrp1 was reported to heterodimerize with the bZIP protein 
Irbp18 (Francis et al., 2016), coimmunoprecipitation 
experiments on extracts of Drosophila S2 cells cotransfected 
with N-terminal HA-tagged and Flag-tagged variants of either 
Xrp1Long or Xrp1Short indicated that Xrp1 does not homodimerize 
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(Fig. S4, G and H). As Ensembl and NCBI Blastp searches failed 
to identify a human Xrp1 orthologue, we used HHpred 
(Zimmermann et al., 2018), the most sensitive homology 
detection tool, to identify human Xrp1 homologues. This yielded 
human homologues for the C-terminal ∼150 aa of Xrp1 that 
contain the conserved DNA-binding domains (Table S1).   
Although these human proteins all contain a bZIP domain, they 
do not appear to be Xrp1 orthologues, as reciprocal searches 
against Drosophila proteins using HHpred with the “best hits” 
from human, a reliable method to detect orthologues whose 
sequence homology is not apparent with pairwise searches 
(Szklarczyk et al., 2012), did not uncover Xrp1. Furthermore, 
none of the human Xrp1 homologues contained an AT-hook 
motif, and in fact, none of the bZIP proteins in the SMART 
database (Letunic and Bork, 2018) contained an AT-hook motif. 
Consistent with the presence of two putative DNA-binding 
domains and its reported roles in protection against genotoxic 
stress and DNA repair (Brodsky et al., 2004; Akdemir et al., 
2007; Francis et al., 2016), subcellular localization experiments 
revealed that Xrp1 is localized to the nucleus, where it 
colocalizes with Caz, both in Drosophila S2R+ cells and in motor 
neurons in vivo (Fig. 4, A–C). To evaluate whether Xrp1 binds 
chromatin, immunostaining for Xrp1 was performed on polytene 
chromosomes from larval salivary glands. Xrp1 was found to 
preferentially localize to euchromatic bands and to “puffs,” 
enlarged regions which indicate sites of active transcription (Fig. 
4 D), suggesting a possible involvement of Xrp1 in regulation of 
gene expression. Furthermore, Xrp1 also localized to 
centromeric β-heterochromatin (Fig. 4 D). Caz prominently 
localized to puffs on polytene chromosomes (Fig. 4 E), and 
overall, Caz and Xrp1 displayed a distinct binding pattern with 





Figure 4. Xrp1 is a nuclear protein that binds chromatin. 
(A) Immunostaining of Drosophila S2R+ cells expressing N-terminal HA-
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tagged Xrp1Short for lamin (labels the nuclear membrane), and the HA tag 
revealed Xrp1 localization to the nucleus (top). Immunostaining for Caz and 
HA::Xrp1 showed colocalization (bottom). (B) HA-tagged Xrp1 was 
selectively expressed in larval motor neurons (OK371-GAL4). 
Immunostaining for lamin and HA::Xrp1 revealed nuclear localization. Control 
animals are driver only. (C) HA-tagged Xrp1 was coexpressed with 
membrane-bound GFP in larval motor neurons. Immunolabeling for Caz and 
HA::Xrp1 showed colocalization of Caz and Xrp1. Control animals do not 
express HA::Xrp1. (D and E) Immunostaining of Xrp1 (D) or Caz (E) on 
polytene chromosomes. Chromatin was counterstained with DAPI. Xrp1 
prominently localizes to euchromatic bands (arrows indicate examples), to 
puffs (arrowheads), and to centromeric β-heterochromatin (asterisks). Caz 
prominently localizes to puffs. Overall, Caz and Xrp1 display a distinct binding 
pattern, although there is some overlap, e.g., the puff region indicated by an 
arrowheads in D and E. Bars: 10 µm (A); 20 µm (B–E). 
Xrp1-interacting proteins suggest a role in gene expression 
regulation 
 
To obtain a comprehensive overview of the molecular processes 
in which Xrp1 may be involved, we immunoprecipitated N-
terminal Flag-tagged Xrp1 (either short or long isoform) 
from Drosophila S2 cells and identified interacting proteins by 
mass spectrometry (MS; Fig. 5 A).  106 Xrp1long-interacting 
proteins and 40 Xrp1short-interacting proteins were identified 
(Tables S2 and S3). The substantially higher number of 
Xrp1long-interacting proteins is likely attributable to its 262 
additional N-terminal amino acids. Importantly, of the 40 
Xrp1short-interacting proteins, 33 were also identified as 
Xrp1long-interacting proteins (Fig. 5 B). In addition, consistent 
with heterodimer formation between Xrp1 and Irbp18 (Francis et 
al., 2016), Irbp18 was identified as an Xrp1-interacting protein 






Figure 5. Identification of Xrp1- and Caz-interacting proteins. 
(A) Approach used to identify Xrp1-interacting proteins. N-terminal Flag-
tagged Xrp1 was expressed in Drosophila S2 cells. Coimmunoprecipitation 
followed by quantitative MS was used to identify Xrp1-interacting proteins, 
defined as proteins significantly enriched in Flag::Xrp1-expressing cells as 
compared with control cells. (B) Venn diagrams illustrating the substantial 
overlap between Xrp1Long-, Xrp1Short-, and Caz-interacting proteins. (C) The 
majority (55.4%) of Xrp1-interacting proteins are involved in gene expression 
regulation or DNA/RNA metabolism, including regulation of transcription, 
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chromatin organization, DNA metabolism, DNA repair, RNA metabolism, and 
DNA- or RNA-binding proteins. 
Remarkably, out of a total of 112 Xrp1-interacting proteins, 62 
(55.4%) are involved in gene expression regulation or DNA/RNA 
metabolism, including regulation of transcription (15), chromatin 
organization (12), DNA metabolism (9), DNA repair (5), RNA 
metabolism (14), and DNA-binding proteins (3) and RBPs 
(4; Fig. 5 C). Following a similar experimental approach, we 
immunoprecipitated endogenous Caz from S2 cells and 
identified 88 Caz-interacting proteins (Table S4). Remarkably, 
58 of these proteins (65.9%) were also identified as Xrp1-
interacting proteins (Fig. 5 B), suggesting that Caz and Xrp1 are 
involved in similar molecular processes and/or commonly reside 
in protein complexes. The latter possibility is unlikely, as Caz did 
not coimmunoprecipitate with Xrp1 (Fig. S4 I).  
 
The caz-Xrp1 genetic interaction depends on the functionality of 
the AT-hook domain of Xrp1 
 
We next wanted to evaluate whether the rescue of caz mutant 
phenotypes by Xrp1 heterozygosity depends on the functionality 
of the AT-hook DNA-binding domain of Xrp1. We therefore 
evaluated whether a mild increase of Xrp1 levels in 
“rescued” Xrp1 heterozygous caz mutant flies would revert the 
rescue and result in pupal lethality, and if so, whether expression 
of Xrp1 with a subtle mutation in the AT-hook motif that 
precludes DNA binding would still revert the rescue. As neuron-
selective expression of Xrp1 from the standard pUAST 
transgenesis vector induces phenotypes by itself (Fig. 3, G–I; 
and Fig. S4, D–F), we used a modified pUAST vector with only 




levels (Fig. 6 A; Pfeiffer et al., 2010). The resulting 3×UAS-Xrp1 
lines did not induce developmental lethality when selectively 
expressed in neurons (elav-GAL4; Fig. 6 C). Neuronal Xrp1 
expression from 3×UAS transgenes was nevertheless able to 
revert the rescue of caz mutant pupal lethality 
by Xrp1 heterozygosity (Fig. 6, D and E). 
 
 
Figure 6. Functionality of the AT-hook DNA-binding domain of Xrp1 is 
required to mediate caz mutant phenotypes. (A) Schematic 
representation of the Xrp1 transgene in the pUAST transgenesis vector, with 
five UAS GAL4-binding sites, and the pJFRC4 vector, with three UAS 
sites. (B) The Xrp1 AT-hook motif consists of nine amino acids including the 
invariant GRP triplet (top). To inactivate the DNA-binding capacity of the AT-
hook motif, three amino acids essential for DNA binding (RGR) were 
mutagenized to alanine (bottom). (C) Panneuronal expression (elav-GAL4) 
of WT or AT-hook mutant (Mut) 3×UAS-Xrp1 transgenes (short isoform) does 
not induce developmental lethality. Adult offspring frequency relative to a 
driver-only control (100%) is shown. n > 376 per genotype. (D and E) Adult 
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offspring frequency of caz2, elav-GAL4/Y;; Df(3R)Xrp1Plus/+ (D) or cazKO, 
elav-GAL4/Y;; Df(3R)Xrp1Plus/+ (E) males expressing 3×UAS-Xrp1 
transgenes (WT or AT-hook mutant) or no transgene (control). n > 115 per 
genotype. ***, P < 0.0001; χ2 test. 
We therefore inactivated the Xrp1 AT-hook domain in the 
3×UAS constructs by mutagenizing the RGR triplet of the 
KRKRGRPAK motif to AAA, known to abolish AT-hook–
mediated DNA binding (Fig. 6 B; Metcalf and Wassarman, 
2006; Turlure et al., 2006; Baker et al., 2013). The subtle AT-
hook mutation altered the binding pattern of Xrp1 on polytene 
chromosomes (Fig. S3 C) but did not reduce the stability of the 
Xrp1 protein and in fact increased Xrp1 protein level (Fig. S1, D–
F). In spite of this, AT-hook–mutant UAS-Xrp1 transgenes were 
no longer able to revert the rescue of caz mutant pupal lethality 
by Xrp1 heterozygosity (Fig. 6, D and E). These data 
demonstrate that the genetic interaction 
between caz and Xrp1 is dependent on the functionality of the 
AT-hook DNA-binding motif in Xrp1. 
 
Gene expression dysregulation in caz mutants is rescued 
by Xrp1 heterozygosity 
 
FUS is known to be involved in transcriptional regulation and 
mRNA splicing (Schwartz et al., 2012, 2015; Tan et al., 
2012; Yang et al., 2014), and knockdown or knockout of Fus in 
the mouse brain results in gene expression dysregulation 
(Ishigaki et al., 2012; Lagier-Tourenne et al., 2012; Scekic-
Zahirovic et al., 2016). Furthermore, AT-hook proteins are often 
involved in gene expression regulation either as transcription 
factors or as chromatin architectural proteins (Reeves, 2010), 
and our results thus far indicate that Xrp1 is a nuclear chromatin-




therefore hypothesized that loss of caz function may result in 
gene expression dysregulation, which could possibly be 
mitigated by heterozygosity for Xrp1.  
To test this hypothesis, we used RNA sequencing (RNA-seq) to 
evaluate mRNA expression levels in third instar larval CNS 
of cazKO and cazKO Xrp1 heterozygous animals as well 
as Xrp1 heterozygous and WT animals as controls. Principal 
component analysis and clustering of the samples discriminated 
the four genotypes from each other, with a certain degree of 
overlap between Xrp1 heterozygous and WT samples (Fig. S5, 
A and B). Differential gene expression analysis between mRNA 
levels from WT and cazKO identified 1,641 up-regulated and 
1,605 down-regulated genes in caz mutants (FRD-adjusted P 
value <0.05; Fig. 7, A and D; and Table S5), indicating 
substantial gene expression dysregulation. Gene expression 
changes for caz and Xrp1 were consistent with the previously 
obtained qPCR data (Fig. S5 C). In contrast, comparison 
between WT and Xrp1 heterozygotes identified only 184 up-
regulated and 30 down-regulated genes (Fig. 7, B and D). Most 
interestingly, in caz mutant Xrp1 heterozygous CNS, 315 up-
regulated and 314 down-regulated genes were identified, with 
>90% of these displaying a less than twofold change (Fig. 7, C 
and D). Thus, heterozygosity for Xrp1 significantly mitigated 
gene expression dysregulation in caz mutant CNS. Principal 
component analysis confirmed the dramatic gene expression 
dysregulation in caz mutant CNS, which was significantly 
rescued in caz mutant Xrp1 heterozygous animals (Fig. S5 A). 
Up- or down-regulation of a panel of 19 genes was validated by 
qPCR (Fig. S5 E), and gene ontology (GO) analysis showed that 
transcripts whose expression was altered in caz mutant animals 
were enriched for genes involved in processes such as axon and 
dendrite guidance, peripheral nervous system development, 
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regulation of transcription and mRNA splicing, DNA repair, and 
mitotic spindle organization and assembly (Fig. 7 E). 
 
 
Figure 7. Heterozygosity for Xrp1 mitigates gene expression 
dysregulation in caz mutant CNS. (A–C) MA plots displaying gene 
expression changes in cazKO versus w1118 (genetic background control; 
A), Df(3R)Xrp1Plus/+ versus w1118 (B), and cazKO;; 
Df(3R)Xrp1Plus/+ versus w1118 (C). X axes represent the mean of the 
normalized read counts per gene across all samples included in each 
comparison. Y axes represent the log2 fold change per gene resulting from 
each comparison. Green dots correspond with differentially expressed genes, 
with P < 0.05 adjusted for multiple testing. (D) Venn diagram representing the 
overlap between differentially expressed genes across the three 
comparisons. Numbers in parenthesis indicate the total number of 
differentially expressed genes in each comparison. (E) Top 10 enriched GO 
terms (Biological Process ontology) in the cazKO versus w1118 comparison for 





GO analysis for molecular function revealed that transcripts with 
altered expression in caz mutants were enriched for mRNAs 
encoding DNA- and chromatin-binding proteins as well as 
mRBPs, along with transcription factor activity, among others 
(Fig. S5 D). Overall, this is in line with the known functions of 
Caz and its mammalian FET protein orthologues (Schwartz et 
al., 2015) and strikingly similar to results from RNA-seq 
experiments in Fus−/− mice (Scekic-Zahirovic et al., 2016). In 
conclusion, our transcriptome analysis revealed that gene 
expression dysregulation in caz mutant CNS is substantially 
mitigated by Xrp1 heterozygosity. 
 
Phenotypes induced by motor neuron–selective expression of 
ALS mutant FUS are substantially mitigated by Xrp1 knockdown 
 
To evaluate the potential relevance of our findings for human 
ALS, we used a Drosophila ALS-FUS model. Selective 
expression of R518K mutant human FUS in motor neurons 
(D42-GAL4) yielded adult flies that developed progressive motor 
deficits and displayed a substantially shortened life span (Fig. 8, 
A–D). We therefore evaluated the effect of Xrp1 knockdown on 
motor behavior and life span of these flies. Coexpression of 
Xrp1-RNAi more than tripled the median life span of both male 
and female D42-GAL4>UAS-FUS-R518K flies (Fig. 8, A and B). 
At 10 d of age, FUS-R518K flies displayed a mild climbing defect 
(reduction in speed by ∼12%), which was fully rescued by motor 
neuron–selective Xrp1 knockdown (Fig. 8 C). At 16 d of age, 
FUS-R518K flies displayed a severe climbing defect (reduction 
in speed by ∼45%), which was rescued by knockdown of Xrp1 
to a level that was not significantly different from D42-




Xrp1 genetically interacts with caz and mediates its toxicity
 109 
 
Figure 8. Motor neuron–selective Xrp1 knockdown mitigates motor 
deficits and shortened life span induced by ALS mutant FUS 
expression. (A and B) Life span of control (driver only) flies and flies with 




Xrp1-RNAi, or both transgenes. Data for male (A) and female (B) flies are 
shown. n > 75 per genotype. (C and D) Average climbing speed of adult 
female flies with motor neuron–selective (D42-GAL4) expression of human 
FUS-R518K, Xrp1-RNAi, or both transgenes versus driver-only controls. Flies 
were tested at 10 (C) and 16 (D) d of age. n > 100 per genotype. **, P < 0.01; 
***, P < 0.005; Mann-Whitney test. (E and F) Transcript levels of caz (E) and 
Xrp1 (F) in heads of adult female flies 3 d after induction of ubiquitous FUS-
R518K expression (tub-GAL4) versus driver-only controls. n = 9–11. ***, P < 
0.0005; two-tailed unpaired t test. (G and H) Caz (G) and Xrp1 (H) transcript 
levels in the CNS of third instar female larvae heterozygous 
for caz2 or cazKO versus WT controls. n = 11–13. ***, P < 0.001; one-way 
ANOVA. All graphs display mean ± SEM. 
Thus, reduction of Xrp1 levels in motor neurons substantially 
rescues the motor deficits and shortened life span of 
a Drosophila ALS-FUS model. To gain insight into the 
mechanism underlying this major phenotypic rescue, we 
evaluated the effect of FUS-R518K overexpression 
on caz and Xrp1 transcript levels. Ubiquitous overexpression of 
FUS-R518K in adult female flies moderately reduced caz 
transcript levels to ∼60% of control levels (Fig. 8 E). Strikingly, 
Xrp1 transcript levels were about threefold increased upon FUS-
R518K expression (Fig. 8 F). This substantial increase in Xrp1 
expression cannot be attributed to the moderate reduction in caz 
levels because Xrp1 transcript levels were not altered 
in caz heterozygous females in spite of a ∼50% reduction of caz 
transcript levels (Fig. 8, G and H). Thus, expression of ALS 
mutant FUS results in substantial up-regulation of Xrp1 
expression independent of caz levels. The fact that Xrp1 
knockdown substantially rescues phenotypes induced by ALS 
mutant human FUS indicates that these phenotypes are to a 










In this study, we identified Xrp1 as a genetic modifier 
of caz mutant phenotypes. Caz is the 
single Drosophila orthologue of the three human FET family 
proteins FUS, EWSR1, and TAF15 (Schwartz et al., 
2015). Xrp1 expression was up-regulated by three- to fourfold 
in caz mutant animals, and heterozygosity for Xrp1 fully rescued 
the caz mutant eclosion defect and partially but substantially 
rescued adult motor performance and life span. Exhaustive 
genetic screening of the second and third chromosome, which 
together constitute ∼80% of the fly genome, identified Xrp1 as 
the only gene for which reduction of gene dosage by 50% could 
rescue caz mutant pupal lethality, indicating that Xrp1 is a key 
modifier of caz mutant phenotypes. Interestingly, in spite of the 
previously reported ubiquitous expression of Xrp1 (Tsurui-
Nishimura et al., 2013) and the fact that Xrp1 expression was 
not only increased in the CNS but also in the body wall and 
presumably other tissues of caz mutants, neuron-selective 
knockdown of Xrp1 was sufficient to rescue caz mutant 
phenotypes, and selective neuronal overexpression of Xrp1 in 
otherwise WT animals phenocopied caz mutant phenotypes. 
This is consistent with the previously reported key function of 
Caz in neurons (Wang et al., 2011; Frickenhaus et al., 2015). 
Together, our data indicate that caz mutant phenotypes are 
largely mediated by increased Xrp1 expression, with particularly 










Figure 9. Xrp1 is a key mediator of caz mutant phenotypes. (A) In WT 
animals, Caz controls Xrp1 levels, resulting in normal gene expression 
regulation. (B) Loss of caz function results in substantial up-regulation 
of Xrp1 expression, leading to gene expression dysregulation and neuronal 
dysfunction. (C) In caz mutant Xrp1 heterozygous animals, Xrp1 levels are 
normalized, resulting in rescue of gene expression dysregulation and 
neuronal dysfunction. (D) Expression of ALS mutant human FUS results in 
substantial up-regulation of Xrp1 expression, and motor neuron–selective 
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expression induces neuronal dysfunction and reduced life 
span. (E) Simultaneous knockdown of Xrp1 in motor neurons expressing 
FUS-R518K rescues neuronal dysfunction and reduced life span. 
Xrp1 has previously been implicated in protection against 
genotoxic stress and DNA damage repair (Brodsky et al., 
2004; Akdemir et al., 2007; Francis et al., 2016). Consistently, a 
number of Xrp1-interacting proteins are involved in DNA repair 
(Fig. 5 C), and GO analysis of our RNA-seq data revealed 
enrichment for genes involved in DNA repair among genes up-
regulated in caz mutant CNS (Fig. 7 E). This study revealed a 
novel role for Xrp1 in gene expression regulation as a substantial 
number of Xrp1-interacting proteins are involved in regulation of 
transcription, chromatin organization, and RNA metabolism (Fig. 
5 C). Interestingly, neuronal overexpression of the long Xrp1 
isoform induced significantly stronger phenotypes as compared 
with the short isoform (Fig. 3, G–I; and Fig. S4, D–F), despite 
insertion of the transgenes in the same genomic site and similar 
expression levels (Fig. 3 B). This is likely attributable to the 
additional N-terminal 262 aa of the long isoform, allowing the 
binding of substantially more interacting proteins (Fig. 5 B and 
Table S2), which may result in more pronounced gene 
expression dysregulation and stronger phenotypes.  
Consistent with a key role of Xrp1 in gene expression regulation, 
significant gene expression dysregulation was found 
in caz mutant CNS, which was substantially mitigated by 
normalizing Xrp1 levels in caz mutants (Fig. 7). Importantly, of 
the 3,246 differentially expressed genes in caz mutants, only 
489 are still significantly up- or down-
regulated caz mutant Xrp1 heterozygotes (Fig. 7 D). The 2,757 
genes that are significantly changed in caz mutants but not 
in caz mutant Xrp1 heterozygotes are likely direct or indirect 




in caz mutants may contribute to neuronal dysfunction. The 
novel function of Xrp1 in gene expression regulation is likely 
dependent on the capacity of Xrp1 to bind DNA, presumably 
mediated by two predicted DNA-binding domains in its C 
terminus: an AT-hook motif and a bZIP motif. Whereas the 
functionality of the predicted bZIP motif remains to be 
investigated, the AT-hook motif of Xrp1 conforms with the 
consensus sequence, consisting of nine amino acids centered 
on the invariant tripeptide glycine-arginine-proline (Reeves, 
2010). The DNA-binding capacity of the Xrp1 AT-hook motif is 
likely required to mediate gene expression regulation and 
dysregulation, as the introduction of a subtle mutation in this 
motif demonstrated that its functionality is essential to 
mediate caz mutant phenotypes. Based on our findings, we 
propose a working model in which caz mutant phenotypes are 
mediated by increased Xrp1 expression, leading to gene 
expression dysregulation and neuronal dysfunction (Fig. 9).  
Extensive bioinformatic searches did not reveal a clear one-to-
one Xrp1 orthologue in mammals. However, we believe that it is 
highly likely that Xrp1 has functional homologues in mammals. 
Candidate functional homologues include 27 human genes 
encoding proteins predicted to contain at least one AT-hook 
motif (Table S6), including the Rett syndrome 
gene MECP2 (Amir et al., 1999). Interestingly, DNA binding 
mediated by the MeCp2 AT-hook domains has been implicated 
in the pathogenesis of Rett syndrome (Baker et al., 2013), and 
FUS was reported to bind the MECP2 promotor and positively 
regulate MECP2 transcription (Tan et al., 2012). In addition, FUS 
also binds MECP2 mRNA (Lagier-Tourenne et al., 2012), 
indicating that MECP2 is both a transcriptional and mRNA target 
of FUS. Furthermore, brains from Fus−/− mice or transgenic mice 
overexpressing ALS mutant FUS display up-regulation 
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of Cbx2, Dot1l, Elf3, Prr12, and KMT2B (Scekic-Zahirovic et al., 
2016; Shiihashi et al., 2016), and 17 of the 27 AT-hook genes 
are reported FUS RNA targets (Table S6). En route toward 
identification of human functional homologues of Xrp1, it will be 
particularly important to gain detailed molecular insight into how 
Xrp1 regulates gene expression. A first step could be the 
identification of the genomic binding sites of Xrp1 and its putative 
target genes. Furthermore, since Xrp1 does not have other 
predicted functional domains apart from the AT-hook and bZIP 
domains, it is tempting to speculate that Xrp1 regulates gene 
expression by recruiting other proteins that contain functional 
domains such as transactivation or histone-modifying domains 
to specific genomic sites. Several of the Xrp1-interacting 
proteins identified in this study contain such functional domains 
and have human orthologues (e.g., TAF9, ZMYM2, NFX1, 
HCFC1/2, VRK1, RSF1, and BPTF). Interestingly, gene 
expression dysregulation was previously implicated in ALS and 
FTD pathogenesis. For instance, a significant enrichment in de 
novo mutations in the chromatin regulatory pathway in sporadic 
ALS patients was reported (Chesi et al., 2013). Furthermore, 
involvement of the three FET proteins in regulation of 
transcription and mRNA splicing is well established (Schwartz et 
al., 2015), and in fact, several other RBPs that have been 
implicated in ALS and FTD pathogenesis are also known to play 
important roles in gene expression regulation (Ling et al., 2013). 
These include TDP-43, involved in regulation of transcription 
and mRNA splicing (Buratti and Baralle, 2010), which 
mislocalizes to cytoplasmic inclusions with nuclear clearance in 
>95% of ALS and ∼45% of FTD patients (Ling et al., 2013). 
Furthermore, the ALS-causing expanded hexanucleotide repeat 
in C9orf72 may sequester RBPs, thus inducing gene expression 




potential relevance of our findings for ALS-FUS pathogenesis is 
further indicated by the fact that knockdown 
of Xrp1 substantially rescues the motor deficits and shortened 
life span of flies that selectively express ALS mutant human FUS 
in motor neurons (Figs. 8 and 9). This may be explained by a 
substantial increase in Xrp1 expression induced by mutant FUS, 
which is not attributable to the moderate (∼40%) downregulation 
of caz expression. Finally, our findings may also be relevant for 
FTLD-FUS pathogenesis as this disease is characterized by 
pathological inclusions containing not only FUS but also TAF15 
and EWS, with reduced levels or complete loss of nuclear FET 
proteins in inclusion-bearing neurons and glial cells (Neumann 
et al., 2011; Davidson et al., 2013). Thus, loss of FET protein 
function and consequent gene expression dysregulation may 
contribute to FTLD-FUS pathogenesis. Consistently, FUS 
knockout or knockdown in the hippocampus of mice induces 
behavioral aberrations related to FTD symptoms (Kino et al., 
2015; Udagawa et al., 2015). In conclusion, our findings provide 
important novel insights into the molecular mechanisms by 
which loss of Caz, the Drosophila orthologue of human FET 
proteins, induces motor deficits and reduced life span, and they 
suggest that gene expression dysregulation may be involved in 
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Materials and methods  
 
Drosophila genetics 
Flies were housed in a temperature-controlled incubator with 
12:12 h on/off light cycle at 25°C, and for some experiments, at 
23°C (5×UAS-Xrp1 overexpression), in vials containing standard 
cornmeal medium. X chromosome–inserted elav-GAL4 (458; 
Bloomington Drosophila Stock Center [BDSC]) was used for 
panneuronal expression of UAS transgenes, OK371-
GAL4 and D42-GAL4 were used for targeted expression in 
motor neurons, and tub-GAL4 was used for ubiquitous 
expression of UAS transgenes. For the dominant suppressor 
screen, deficiencies covering the second and the third 
chromosome from the Bloomington Deficiency Kit were used as 
this kit provides maximal coverage (euchromatic coverage ≥ 
97.5%) with a minimal number of deletions (Cook et al., 2012). 
Df/Balancer males were crossed to caz2/FM7 females to screen 
for the emergence of caz2/Y; Df/+ males in the offspring, which 
would indicate suppression of pupal lethality of caz2 males by 
hemizygosity for the deficiency. To narrow down the genomic 
region that is uncovered by Df(3R)ED2, the deficiency that 
mediated rescue of caz mutant pupal lethality, molecularly 
mapped smaller deficiency lines in this region were ordered from 
the BDSC. PCR genotyping of caz mutant males was used to 
exclude X chromosome nondisjunction in all experiments. The 
UAS-Xrp1-RNAi lines used in this study were 
P[TRiP.HMS00053]attP2 (34521; BDSC; UAS-Xrp1-RNAi-1) 
and P[GD9476]v33010 obtained from the Vienna Drosophila 
Resource Center (UAS-Xrp1-RNAi-2). The UAS-FUS-R518K 





Generation of Xrp1 mutant lines 
 
For generation of Xrp1 deletion 
lines, P[XP]d11439, P[XP]Xrp1d04790, PBac[WH]f07598, 
and PBac[WH]f05721 were obtained from the Drosophila 
Genetic Resource Center at the Kyoto Institute of Technology 
and used to isolate Xrp1 chromosomal deletions (Fig. 1, D and 
E) following the basic schemes outlined by Parks et al. (2004). 
The chromosomal deletions generated were verified by PCR 
with primers flanking the transposable element insertions (Table 
S7), followed by sequencing of the PCR fragments. For 
generation of a clean Xrp1-null allele, in vivo homologous 
recombination was used to target the Xrp1 gene. Following a 
previously published strategy (Vilain et al., 2014), the presence 
of a Mi{MIC} transposon in the Xrp1 gene (Mi{MIC}Xrp1MI07118) 
was exploited for site-specific insertion of a targeting construct 
(Figs. 1 and S1 C). For the construction of a targeting vector, a 
fosmid (FlyFos clone number FF017187) containing the 
extended Xrp1 genomic region was used to PCR amplify left and 
right homology arms using the primers Xrp1_LHA_FW, 
Xrp1_LHA_REV, Xrp1_RHA_FW, and Xrp1_RHA_REV (Table 
S7). To minimize the chance of introducing mutations during 
PCR amplification, Phusion high-fidelity DNA polymerase (New 
England Biolabs) was used with only 20 cycles of PCR 
amplification. The obtained PCR products were subcloned in a 
Zero Blunt TOPO PCR cloning vector (Invitrogen) and sequence 
verified. The presence of a HindIII site in primer Xrp1_LHA_FW 
and an EcoRI site in primer Xrp1_LHA_REV was subsequently 
used to clone the left homology arm into pABC (Choi et al., 
2009). Next, the presence of an EcoRI site in Xrp1_RHA_FW 
and a KpnI site in Xrp1_RHA_REV was used to clone the right 
homology arm into the pABC vector that already contained the 
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left homology arm. The obtained targeting vector was sequence 
verified and injected into Mi{MIC}Xrp1MI07118 embryos for site-
specific integration of the targeting construct into the Mi{MIC} 
transposable element in the Xrp1 gene. Transgenic lines in 
which the transgenic construct was integrated into 
Mi{MIC}Xrp1MI07118 in the correct orientation were identified. 
These lines were subsequently crossed to a transgenic line that 
expresses I-SceI under the control of a heat-inducible promoter. 
Given the presence of an I-SceI restriction site in primer 
Xrp1_LHA_FW, this will induce a double-strand break adjacent 
to the left homology arm of the targeting construct, allowing for 
precise removal of the Xrp1 and Mi{MIC} sequences left of the 
targeting construct through homologous recombination (Fig. S1 
C). Lines with successful homologous recombination were 
identified by PCR and sequencing of the obtained PCR 
fragments. Next, these lines were crossed to a transgenic line 
that expresses I-CreI under the control of a heat-inducible 
promotor. Given the presence of an I-CreI restriction site in 
primer Xrp1_RHA_REV, this will induce a double-strand break 
adjacent to the right homology arm of the targeting construct, 
allowing for precise removal of the Xrp1 and Mi{MIC} sequences 
right of the targeting construct through homologous 
recombination. Lines with successful homologous 
recombination were identified by PCR and sequencing of the 
obtained PCR fragments. 
Generation of UAS-Xrp1 transgenic lines 
 
For generation of UAS-Xrp1Long transgenic lines, RNA was 
extracted from WT flies and converted into cDNA, which was 
used as a template for PCR (primer sequences in Table S7) to 




clone FI10013 containing the Xrp1Short cDNA was obtained from 
Kyoto Stock Center. Xrp1Long and Xrp1Short cDNAs were 
subsequently cloned into pUAST-attB using either NotI or EagI 
as well as XhoI restriction sites (Table S7). Site-directed PCR 
mutagenesis was used to generate AT-hook mutant versions of 
the long and short Xrp1 isoforms (mutagenesis primers are 
included in Table S7). WT and AT-hook mutant Xrp1 cDNAs 
were subsequently amplified by PCR using Phusion high-fidelity 
DNA polymerase (New England Biolabs) and primers containing 
XhoI and XbaI restriction sites (Table S7). The obtained PCR 
products were subcloned in a Zero Blunt TOPO PCR cloning 
vector (Invitrogen), and XhoI and XbaI were used to transfer the 
Xrp1 cDNAs to the pJFRC4 vector, which contains three UAS 
sites (Pfeiffer et al., 2010). UAS constructs were embryo injected 
following standard procedures. For each of the constructs, VK31 
(on III) and VK37 (on II) genomic landing sites were used to 
avoid any influence of neighboring genomic sequences on 
transgene expression. As neuronal expression of 5×UAS-Xrp1 
transgenes (elav-GAL4) in many cases resulted in 
developmental lethality with no adult escapers when raised at 
25°C, experiments in which elav-GAL4 was used to drive 
expression of 5×UAS-Xrp1 transgenes were performed at 23°C. 
 
Motor performance assay 
 
For assaying mobility, flies were collected within 24 h after 
eclosion and divided into groups of 10 individuals. Motor 
performance of 3-, 10-, or 16-d-old flies was evaluated as 
described earlier (Frickenhaus et al., 2015; Niehues et al., 
2015), and average climbing speed (mm/s) was determined and 
compared between genotypes. As female D42-GAL4>FUS-
R518K flies lived longer than males, we studied the effect of 
3
121
Xrp1 genetically interacts with caz and mediates its toxicity
 121 
Xrp1 knockdown on age-dependent motor deficits in female 
flies. Larval locomotion was analyzed using the frustrated total 
internal reflection–based imaging method FIM (Risse et al., 
2013, 2014, 2017). Batches of 15 third instar larvae were 
allowed to freely move for 3 min on a recording platform at RT. 
Tracking data were obtained using FIMTrack (http://fim.uni-
muenster.de), and output files were analyzed with MatLab 
(MathWorks). In Fig. S3 B, larvae were sorted in a Petri dish with 
water for ∼5 min, and only male larvae were recorded. 
 
Adult offspring frequency and life span analysis 
 
For determination of adult offspring frequencies, appropriate 
crosses were set up, and the number of adult flies eclosing was 
counted for each genotype. For life span analysis, newly eclosed 
flies were collected and housed at a density of 10 flies per vial. 
At least 75–100 flies were tested for each genotype. The number 
of dead flies was counted every day, and the flies were 




Total RNA was extracted from 15–20 third instar larval brains or 
from four adult male flies per biological replicate using 
NucleoSpin RNA (Macherey-Nagel) according to the 
manufacturer’s instructions. Reverse transcription was 
performed on 1 µg RNA treated with gDNA Wipeout Buffer using 
the Quantitect Reverse Transcription kit (QIAGEN). Resulting 
cDNA samples were used as templates for real-time PCR 
assays performed on an ABI 7300 system (Applied Biosystems) 
with iTaq Universal SYBR Green supermix (Bio-Rad 




transcript levels are listed in Table S7. Measurements were 
normalized to EifTuM and rp49 controls. Data were analyzed 
using the ΔΔCt calculation method. Experiments included no–
reverse transcriptase controls for each template and no-




For Western blots, protein extracts were made by homogenizing 
third instar larval CNS in extraction buffer (50 mM Tris/HCl, pH 
7.4, 150 mM KCl, 0.25 M sucrose, 5 mM MgCl2, and 0.5% Triton 
X-100). Lysates of Drosophila S2 cells transfected with plasmids 
encoding actin5C-GAL4 alone or cotransfected with plasmids 
encoding N-terminal HA-tagged Xrp1Short or Xrp1Long were 
prepared in cell lysis buffer (20 mM Tris, 200 mM NaCl, 1 mM 
EDTA, and 0.5% NP-40 containing 1 U complete mini protease 
inhibitor cocktail [Roche]). Samples separated on 10% SDS-
PAGE were electrotransferred onto polyvinylidene difluoride 
(EMD Millipore) for 45 min at 15 V. Blotted membranes were 
incubated overnight at 4°C with primary antibodies against Caz 
(mouse monoclonal 3F4; 1:30; Immanuel et al., 1995), HA 
epitope tag (mouse monoclonal HA.11; 1:1,000; Covance), and 
β-tubulin (mouse monoclonal E7; 1:700; Developmental Studies 
Hybridoma Bank). Immunoreactive proteins were visualized 
after incubation with anti-mouse IgG coupled to horseradish 
peroxidase (W402B; 1:2,500; Promega) for 1 h at RT. Blots were 
developed with enhanced chemiluminescence (GE Healthcare), 
and x-ray film images of chemiluminescence were developed 
and scanned. Densitometric quantification of images was 
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Coimmunoprecipitation 
For detection of potential homodimers of Xrp1Short and 
Xrp1Long, Drosophila S2 cells were either transfected with a 
plasmid encoding actin5C-GAL4 alone or cotransfected with 
plasmids encoding N-terminal HA- or Flag-tagged Xrp1Short or 
Xrp1Long constructs, all under UAS control. 48 h after 
transfection, protein lysates of cells expressing HA- or Flag-
tagged Xrp1 were either directly used or combined in a 1:1 ratio. 
5% of protein extracts were used for Western blotting, while the 
remaining 95% were added to anti-HA agarose beads for 24 h 
at 4°C. Immunoprecipitation of HA-tagged proteins was 
performed using an Anti-HA Immunoprecipitation Kit (Sigma-
Aldrich), according to the manufacturer’s protocol. To evaluate 
whether Caz and Xrp1 physically associate with each other, S2 
cells expressing the actin5C-GAL4 plasmid alone (control) or in 
conjunction with the N-terminal HA-tagged Xrp1Short or 
Xrp1Long constructs were seeded at a density of 106 cells/ml in 1 
ml Shields and Sang medium (Sigma-Aldrich) in 12-well plates 
1 d before transfection. Transfection was performed using 
Fugene HD Transfection Reagent (Promega) according to 
manufacturer’s instructions. Cell lysates were prepared, cellular 
debris was pelleted by centrifugation at 12,000 g for 15 min and 
washed, and the protein-containing supernatant was incubated 
overnight at 4°C with 100 µl of either anti-Flag (10 µg; clone M2; 
F1804; Sigma-Aldrich) or anti-Caz (10 µg; 3F4; Immanuel et al., 
1995) conjugated SureBeads Protein G Magnetic Beads (Bio-
Rad Laboratories) according to the manufacturer’s instructions. 
Bound proteins were eluted by heating to 70°C for 10 min with 
40 µl of 1× Laemmli buffer (Bio-Rad Laboratories). Inputs, 
precipitates, and binding proteins were analyzed by SDS-PAGE 




using the following primary antibodies: anti-Flag (clone M2; 
F1804; 1:1,500; Sigma-Aldrich) and anti-HA (Mono HA.11; 
1:1,000; Covance). 
Liquid chromatography (LC)–tandem MS analysis 
 
S2 cells were seeded at a density of 106 cells/ml in 3 ml Shields 
and Sang medium (Sigma-Aldrich) in six-well plates 1 d before 
transfection. Flag-tagged Xrp1Short or Xrp1Long plasmids were 
transfected, along with the actin5C-GAL4 construct. Three 
replicates were processed for each condition. After incubating 
the cells for 2 d with the transfection mixes, cells were collected 
and lysed in cell lysis buffer (described above). Cellular debris 
was cleared by centrifugation at 12,000 g for 15 min. To pull 
down Xrp1-interacting proteins, the protein-containing 
supernatant was applied to 100 µl anti-Flag (clone M2; F1804; 
Sigma Aldrich)–conjugated SureBeads Protein G Magnetic 
Beads (Bio-Rad Laboratories) according to the manufacturer’s 
instructions. Cell lysates were incubated with the antibody beads 
overnight at 4°C. Washed beads were resuspended in 4% SDS 
and 50 mM Tris, pH 7.5, and bound proteins were eluted by 
heating to 95°C for 10 min and then precipitated with a fourfold 
excess (vol/vol) of ice-cold acetone overnight to remove 
detergent and salts. Precipitated protein pellets were washed 
twice with 90% acetone, air dried, and then resuspended in 8 M 
urea and 50 mM Tris-HCl, pH 8.5, before in-solution digestion, 
first with endopeptidase LysC (1 µg/immunoprecipitation) for 3 h 
at 37°C, and then with trypsin overnight at 37°C (1.5 
µg/immunoprecipitation). After acidification of the digest by 
addition of 1% formic acid (final concentration), peptides were 
desalted using Empore-C18 StageTips (Rappsilber et al., 2003) 
and stored at 4°C until further use. Prior to LC–tandem MS, 
peptides were eluted using 2 × 20 µl of 80% acetonitrile and 
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0.1% formic acid, and then they were dried in an Eppendorf 
concentrator to a volume of ∼2 µl and resuspended in 10 µl 
buffer A (0.1% acetic acid). 6 µl of this peptide solution was then 
analyzed by nanoscale reverse-phase chromatography using an 
EASY nLC 1200 (Thermo Fisher Scientific) as a high-
performance LC pump and a Picofrit column (25 cm × 75 µm ID; 
New Objective) filled with C18 reverse-phase material (Reprosil 
pur C18-AQ; 1.9 µm; Dr. Maisch GmbH) that was online coupled 
via a Nanospray Flex electrospray ionization source (Thermo 
Fisher Scientific) to a QExactive HF mass spectrometer (Thermo 
Fisher Scientific). Peptides were separated at a flow rate of 300 
nl/min using a gradient running from 3–35% B (80% acetonitrile 
and 0.1% formic acid) in 90 min, which was ramped up to 100% 
B in 5 min, where it was maintained for additional 10 min before 
reequilibration at starting conditions. Column temperature was 
maintained at 45°C with the help of a column oven (PRSO-V1; 
Sonation). The mass spectrometer was operated in data-
dependent mode, acquiring full-scan spectra in profile mode at 
a resolution of 60,000 and an automatic gain control target value 
of 3 × 10−6 (scan range 300–1,650 m/z). Spray voltage was set 
to 2.1 kV. The 17 most intense ions were chosen for higher 
energy collisional dissociation with a resolution of 15,000 at m/z 
200 and a target value of 10−5. The isolation window was set to 
1.6 m/z, and the normalized collision energy to a value of 28. 
Dynamic exclusion was allowed and set to 20 s. Uncharged as 
well as singly charged compounds were excluded from the 
analysis as well as peptides with a charge state >6. Data were 







MS data analysis 
 
Raw MS files were processed using the MaxQuant 
computational platform (version 1.5.3.8; Cox and Mann, 2008). 
The Andromeda search engine integrated into MaxQuant was 
used for the identification of peptides and proteins by querying a 
concatenated forward and reverse UniProt Drosophila database 
(UP000000803_7227.fasta; release 2015-12), including 
common laboratory contaminants. The search for precursor and 
fragment ions was performed allowing an initial mass deviation 
of 20 ppm and 0.5 D, respectively. Trypsin with full enzyme 
specificity was selected, and only peptides with a minimum 
length of seven amino acids were allowed. A maximum of two 
missed cleavages was allowed. Carbamidomethylation (Cys) 
was set as fixed modification, while oxidation (Met) and N-
acetylation were defined as variable modifications. For protein 
and peptide identification, a minimum false discovery rate of 1% 
was required. Label-free quantification (LFQ) was based on the 
measurements of three independent biological replicates for 
each strain analyzed by the MaxQuant LFQ algorithm with the 
“match between runs” option turned on (Cox et al., 2014). 
Further data processing was performed using the bioinformatics 
module Perseus (version 1.5.6.0; Cox et al., 2011). Following 
initial filtering and grouping (actin; caz; XRP1-L; XRP1-s), LFQ 
values were log2 transformed, and only proteins were included 
in the analysis that were identified with at least three valid values 
in at least one of the four groups. Still-missing values (NaN) were 
replaced by imputation, simulating signals of low abundant 
proteins within the distribution of measured values. A width of 
0.3 SD and a downshift of 1.8 SD were used for this purpose. To 
identify proteins that displayed significant differences between 
the groups, ANOVA testing was performed (P = 0.05).  
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Fold enrichment was calculated based on LFQ intensity values. 
The MS proteomics data have been deposited to the public 
PRIDE repository (Vizcaíno et al., 2013) via the 
ProteomeXchange platform 
(http://proteomecentral.proteomexchange.org) with the dataset 
identifier PXD008417. 
 
Immunocytochemistry and histochemistry 
Drosophila S2R+ cells were seeded in a density of 4 × 
105 cells/ml on Concanavalin A (Sigma-Aldrich)–treated circular 
microscope cover glasses (12 mm; VWR) in a 24-well cell 
culture dish. After 24 h at 25°C, cells were transfected with a mix 
containing the Fugene HD transfection reagent (Promega) 
and actin5C-GAL4 and UAS-HA::Xrp1Short plasmids. 48 h later, 
cells were fixed in 4% PFA for 15 min followed by two 5-min 
washes in DPBS (1×; Gibco) at RT. After permeabilization with 
DPBS (1×) and 0.5% Triton X-100, cells were washed twice with 
DPBS. Cells were blocked for 1 h in 2% BSA and 10% goat 
serum in DPBS, followed by overnight incubation at 4°C with 
primary antibodies against Caz (mouse monoclonal clone 3F4; 
1:30; Immanuel et al., 1995), lamin (mouse monoclonal 
ADL67.10; 1:100; Developmental Studies Hybridoma Bank), 
and HA (rabbit polyclonal; 1:50; Santa Cruz Biotechnology) 
diluted in 2% BSA and 10% goat serum in DPBS. After two 
washes in DPBS, secondary goat anti-mouse and anti-rabbit 
antibodies (Alexa Fluor 488 and 568; 1:500) were applied for 2 
h at RT, followed by three washes in DPBS and mounting on 
microscopy slide with Aqua-Poly/Mount (Polysciences, Inc.). For 
subcellular localization of Xrp1 in motor neurons, brains/CNS 
from wandering third instar larvae expressing OK371-




UAS-Xrp1Short were dissected in PBS and fixed in 4% PFA for 30 
min. Tissues were washed 3 × 10 min in PBS/0.2% Triton X-100 
and blocked for 1 h at RT in 10% goat serum in PBS. Tissues 
were incubated with primary antibodies against Caz (mouse 
monoclonal clone 3F4; 1:30; Immanuel et al., 1995), lamin 
(mouse monoclonal ADL67.10; 1:100; Developmental Studies 
Hybridoma Bank), or HA (rabbit polyclonal; 1:50; Santa Cruz 
Biotechnology) overnight at 4°C with gentle agitation. 
Appropriate secondary antibodies conjugated either with Alexa 
Fluor 405, Alexa Fluor 488, or Alexa Fluor 568 (Molecular 
Probes) were used to detect the given primary antibody. All 
images were acquired using ZEN 2010 software on a Zeiss 
LSM700 laser scanning confocal microscope using an EC Plan 
neofluar 1.3 NA 40× oil-immersion objective. 
Squash preparation of polytene chromosomes from larval 
salivary glands 
For preparing polytene chromosome squashes, salivary glands 
of WT third instar larvae were dissected in PBS (1×) and 
transferred to 1% Triton X-100 for 30 s. Fixation was in 4% PFA 
(1 min) and in 45% acetic acid/4% PFA (2 min). The glands were 
then incubated in 45% acetic acid (1 min) and subsequently 
squashed in the same solution under a coverslip to get polytene 
spreads. After freezing the slides in liquid nitrogen, coverslips 
were flipped off with a sharp blade, and slides were stored in 
90% ethanol. For immunostaining, squash preparations were 
rehydrated twice for 5 min in PBS (1×). Immunostaining was 
performed following the Dangli and Bautz (1983) procedure 
using rabbit polyclonal anti-Xrp1 (1:50; Francis et al., 2016) 
followed by an Alexa Fluor 568–conjugated secondary antibody 
(1:500; Molecular Probes). The preparation was counterstained 
with DAPI and mounted in Vectashield antifade mounting 
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medium (Vector Laboratories) for confocal microscopy. All 
images were acquired using ZEN 2010 software on a Zeiss 
LSM700 laser scanning confocal microscope using an EC Plan 
neofluar 1.3 NA 40× oil immersion objective. 
RNA-seq and data analysis 
For RNA-seq, total RNA was extracted from 15–20 brains 
dissected from wandering third instar male larvae using 
NucleoSpin RNA (Macherey-Nagel) according to the 
manufacturer’s instructions. After performing quality control 
checks, the RNA was sent to the Max Planck Genome Center, 
where cDNA libraries were prepared using the NEBNext Ultra 
Directional RNA Library Prep Kit for Illumina (New England 
Biolabs) using standard procedures. The libraries were 
sequenced on an Illumina HiSeq 2500 instrument as 100-bp 
paired-end reads each according to the manufacturer’s standard 
protocols. Three biological replicates per genotype were 
sequenced, with an average of 8.6 million nonredundant read 
pairs uniquely mapped to the Drosophila genome. 
Preprocessing filtering of the reads before alignment, e.g., 
quality- or adapter-trimming, was not necessary. 
The Drosophila reference genome was downloaded from 
Flybase. Revision 6.04 of the genome assembly and gene 
annotation was used for all analyses. We aligned reads to the 
reference transcriptome using the TopHat pipeline (version 
2.0.14; Kim et al., 2013a) with Bowtie2 (version 
2.2.5; Langmead and Salzberg, 2012) and the flags b2-very-
sensitive and library-type = fr-firststrand. The mapped reads 
were assigned to genes using the HTseq-count script from the 
HTseq package (Anders et al., 2015). We used the intersection-
nonempty mode to exclude ambiguous gene assignments. 




rRNA genes were removed from the gene list for further 
analysis. Differential gene expression analysis was performed 
using DeSeq2 (version 1.11; Love et al., 2014). All comparisons 
were performed in a pairwise manner, comparing samples of 
each genotype separately against the WT. We chose to disable 
filtering genes based on Cook’s distance for the whole analysis 
because we observed that the high biological variability 
of Xrp1 heterozygous animals lead to the exclusion of a large 
number of genes. Genes were called differentially expressed if 
the log2 fold change differed significantly from 0 with a false 
discovery rate–adjusted P value of <0.05. Expression levels for 
each annotated protein-coding gene were determined by the 
number of mapped reads per kilobase of exon per million 
mapped reads (RPKM). Principal component analysis and 
hierarchical clustering of the global expression profile was 
performed on a variance-stabilized transformation of the read 
counts per gene using methods provided by the DeSeq2 R-
package. For clustering, the distances between samples were 
calculated using the Manhattan distance metric. Based on the 
distance matrix, hierarchical clustering by complete linkage was 
performed using standard R functions. GO-term enrichment 
analysis was done using the topGO package for R (version 
2.22; Alexa et al., 2006). We extracted the sets of up- and down-
regulated genes for each comparison from the DeSeq2 analysis 
and used the “weight01” algorithm in topGO in combination with 
Fisher’s exact test to check for enrichment of specific GO terms 
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Statistical analysis 
χ2 statistics were used to analyze offspring frequency data. For 
life span analysis, the log-rank test was used to test for statistical 
significance. Motor performance was analyzed using the Mann-
Whitney U test to compare climbing speed of individual flies per 
genotype and per run. As all flies were tested in three 
independent runs, three P values were generated per genotype. 
These P values were combined using the Fisher’s combined 
probability test. To analyze larval locomotion data, Mann-
Whitney rank-sum tests were performed with MatLab. One-way 
ANOVA with Bonferroni correction was used to analyze Caz and 
Xrp1 mRNA and protein levels as data displayed normal 
distribution and equal variance. All images were assembled in 
figure panels using the Adobe Illustrator CS5 software. 
 
Online supplemental material 
Fig. S1 shows generation and characterization of Xrp1 mutant 
and transgenic lines. Fig. S2 shows that heterozygosity 
for Xrp1 does not rescue the adult eclosion defect 
of TBPH mutant flies. Fig. S3 shows larval locomotion 
phenotypes and binding of WT or AT-hook mutant Xrp1 to 
polytene chromosomes. Figs. S4 shows characterization of 
the caz-Xrp1 genetic interaction. Fig. S5 shows that 
heterozygosity for Xrp1 mitigates gene expression 
dysregulation in caz mutant CNS. Table S1 lists human 
homologues of Xrp1. Tables S2, S3, and S4 list Xrp1long, Xrp1Short, 
and Caz-interacting proteins, respectively. Table S5 lists RNA-
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Figure 10.  Generation and characterization of Xrp1 mutant and 
transgenic lines. (A) Schematic representation of the Xrp1 genomic locus 
and the seven predicted Xrp1 transcripts (Xrp1-RA to Xrp1-RG) encoding 
either the short or long Xrp1 isoform. ORFs are colored orange; 5′ and 3′ 
UTRs are colored gray. (B) Efficiency of Xrp1 knockdown by transgenic RNAi 
expression. Real-time qPCR was used to quantify total Xrp1 transcript levels 
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in the CNS of third instar larvae. Control animals (driver only) were compared 
with animals ubiquitously (actin5C-GAL4) expressing either of the two UAS-
Xrp1-RNAi transgenes used in this study. Expression levels relative to control 
(100%) are shown. n = 8 (control), 5 (Xrp1-RNAi-1), and 7 (Xrp1-RNAi-2). **, 
P < 0.01; one-way ANOVA. Mean ± SEM. (C) Strategy used for generation 
of the Xrp1KO allele: (1) Xrp1 genomic region with the insertion site of the 
Mi{MIC}07118 transposable element indicated. The sequences used as left 
and right homology arms (LHAs and RHAs, respectively) are underlined. (2) 
Magnification of the Mi{MIC} element with flanking Xrp1 sequences. The 
targeting vector used for recombination-mediated cassette exchange 
(RMCE) contains the left homology arm, preceded by an I-SceI restriction 
site, and the right homology arm, followed by an I-CreI restriction site, and 
flanked by attB recombination sites. (3) PhiC31 recombinase mediates 
recombination between the attP sites in the Mi{MIC} element and the attB 
sites in the targeting vector, resulting in exchange of the Mi{MIC} cassette by 
the targeting cassette. (4) Crossing with an I-SceI transgenic line results in a 
DNA double-strand break at the I-SceI site, and (5) in vivo homologous 
recombination between left homology arm sequences results in precise 
deletion of the Xrp1 coding region left of the Mi{MIC} element. (6) Crossing 
with an I-CreI transgenic line results in a DNA double-strand break at the I-
CreI site, and (7) in vivo homologous recombination between right homology 
arm sequences results in precise deletion of the Xrp1 coding region right of 
the Mi{MIC} element. (D–F) The RGR-to-AAA mutation in the AT-hook motif 
does not reduce, but rather increases, the stability of the Xrp1 protein. (D) 
Drosophila S2 cells were cotransfected with a plasmid encoding actin5C-
GAL4 and plasmids encoding N-terminal HA-tagged Xrp1 (short isoform), 
either WT or AT-hook mutant (Mut). Cells transfected with the actin5C-GAL4 
plasmid alone were used as controls. Western blotting on protein extracts 
with antibodies against the HA-tag and β-tubulin (loading control) is shown. 
(E) WT or AT-hook mutant HA::Xrp1Short was selectively expressed in motor 
neurons (OK371-GAL4) from UAS transgenes inserted in the same genomic 
landing site (VK31). Protein extracts from third instar larval CNS were used 
for Western blotting, using the same antibodies as in D. Driver-only animals 
were used as controls. (F) Quantification of HA::Xrp1Short protein levels 
relative to β-tubulin in Western blots shown in E. Data are shown as 






Figure S2. Heterozygosity for Xrp1 does not rescue the adult eclosion 
defect of TBPH mutant flies. (A) Bar graph showing the relative frequency 
of adult F1 offspring for the indicated cross, using the TBPHΔ23 and 
TBPHΔ142 alleles. The offspring frequency of crosses between +/CyO males 
and females is shown as control. Since homozygous CyO flies die during 
development, the theoretically expected offspring frequency is 66.6% 
TBPHΔ/CyO and 33.3% TBPHΔ/TBPHΔ. The adult offspring frequency of 
TBPHΔ23/TBPHΔ142 flies is significantly reduced. (B) Relative frequency of 
adult non-CyO F1 offspring for the indicated cross. The theoretically expected 
offspring frequency is 50% TM6B/+ and 50% Df(3R)Xrp1Plus/+. In control 
crosses, females carry a WT chromosome instead of Df(3R)Xrp1Plus. Thus, 
heterozygosity for Xrp1 does not rescue TBPH mutant developmental 
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Figure S3. Caz mutant larval motor defects are rescued by Xrp1 
heterozygosity or selective Xrp1 knockdown in motor neurons, and a 
subtle mutation in the Xrp1 AT-hook motif affects Xrp1 chromatin 
binding. (A) Reduced crawling speed of caz mutant larvae is rescued by 
heterozygosity for Xrp1 or a genomic caz transgene. n = 30–90. ***, P < 
0.0005; one-way ANOVA. (B) Selective knockdown of Xrp1 in motor neurons 
(D42-GAL4) is sufficient to rescue the caz mutant locomotion defect. n = 90. 
***, P < 5 × 10−7; one-way ANOVA. (C) A subtle mutation in the AT-hook 
motif alters the binding pattern of Xrp1 to polytene chromosomes. WT 
(middle) or AT-hook mutant (bottom) Xrp1Short with N-terminal HA-tag was 
transgenically expressed in larval salivary glands. Anti-HA immunostaining 
revealed Xrp1 binding to polytene chromosomes, and DAPI was used to 
visualize banding patterns. Driver-only control (top) confirms specificity of the 









Figure S4. Characterization of the caz-Xrp1 genetic interaction. (A) 
Selective knockdown of Xrp1 in glial cells does not rescue caz mutant pupal 
lethality. Relative frequency of adult male F1 offspring from the indicated 
cross is shown for two independent UAS-Xrp1-RNAi lines. No adult caz2 
males were detected, even in the presence of the repo-GAL4 driver to knock 
down Xrp1 selectively in glial cells. Note that a similar frequency of 
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hemizygous FM7 males with or without panglial Xrp1 knockdown was found, 
showing that Xrp1 knockdown in glial cells does not induce developmental 
lethality. n > 81 per genotype. (B and C) Xrp1 expression is up-regulated in 
both CNS and body wall of caz mutant animals. Real-time qPCR was used 
to quantify total Xrp1 transcript levels in the CNS (B) and body wall (C) of 
third instar larvae, either WT or caz2. Expression levels relative to WT (100%) 
are shown. n = 8. ***, P < 0.001; two-tailed unpaired t test. Mean ± SEM. (D–
F) Selective neuronal Xrp1 overexpression phenocopies caz mutant 
phenotypes. (D) Relative frequency of adult female F1 offspring from the 
indicated cross that is heterozygous for either the balancer or UAS 
transgenes expressing the short or long Xrp1 isoforms. Neuron-selective 
(elav-GAL4) Xrp1Long overexpression induces developmental lethality. n > 
144 per genotype. (E) Average climbing speed of adult female flies selectively 
overexpressing Xrp1Short in neurons (elav-GAL4) as compared with control 
(driver only) flies. n > 100 per genotype. ***, P < 10−9; Mann-Whitney test. 
(F) Life span of female flies selectively overexpressing short or long Xrp1 
isoforms in neurons (elav-GAL4) as compared with control (driver only) flies. 
n = 26–189 per genotype. (G and H) Coimmunoprecipitation experiments 
indicate that Xrp1 does not form homodimers. Drosophila S2 cells were 
transfected with a plasmid encoding actin5C-GAL4 and different 
combinations of plasmids encoding N-terminal HA- or Flag-tagged Xrp1. 
Protein extracts were either directly used for Western blotting (WB) with anti-
HA or anti-Flag antibodies (input [I] lanes) or immunoprecipitated with anti-
HA antibody followed by Western blotting (immunoprecipitation [IP] lanes). 
Similar experiments were performed for the short (G) and long (H) Xrp1 
isoforms. In both cases, immunoprecipitation of HA-tagged Xrp1 did not result 
in coimmunoprecipitation of Flag-tagged Xrp1. (I) Caz does not 
coimmunoprecipitate with Xrp1. Drosophila S2 cells were cotransfected with 
a plasmid encoding actin5C-GAL4 and plasmids encoding N-terminal HA-
tagged Xrp1, either the short or the long isoform. Cells transfected with the 
actin5C-GAL4 plasmid alone were used as control. Protein extracts were 
prepared and used for immunoprecipitation with anti-HA antibodies. Western 
blotting of immunoprecipitates and 5% of original extracts (input) was 








Figure S5. Heterozygosity for Xrp1 mitigates gene expression 
dysregulation in caz mutant CNS. (A) Principal component analysis plot for 
all samples included in the RNA-seq analysis (red dots, cazKO; purple dots, 
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Df(3R)Xrp1Plus/+; green dots, cazKO;;Df(3R)Xrp1/+; blue dots, w1118). The 
principal component analysis procedure performs an orthogonal 
transformation on the data to convert the observed gene expression values 
in each sample into a set of values of variables linearly uncorrelated known 
as principal components (PCs). This transformation is defined so that the first 
principal component explains the largest possible variance. The plot displays 
the distribution of the samples according to the first two principal components, 
which overall explain 58% of the variance found in the data. The percentage 
of variance explained by the rest of principal components is displayed as a 
cumulative bar plot underneath the principal component analysis plot. (B) 
Unsupervised hierarchical clustering of all RNA-seq samples. Entries in the 
matrix are color-coded according to the Manhattan distance between 
samples. The dendrograms in the margins represent linkage distance 
between clusters. (C) Distribution of RPKM values for caz (left) and Xpr1 
(right) across all samples. RPKM values for each replicate are represented 
as solid dots. Horizontal lines indicate the mean value for each condition. (D) 
Top 10 enriched GO terms (Molecular Function ontology) in the cazKO versus 
w1118 comparison for the set of up-regulated (red) and down-regulated genes 
(blue). (E) Correlation analysis of the log2 fold change values obtained from 
the RNA-seq analysis and qPCR-derived ΔΔCt values for a panel of 19 
genes. Each plot displays the regression line (solid blue), 95% confidence 
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Table S1. Human homologs of Xrp1. Human homologs of Xrp1 (E-value < 
0.001) ranked according to E-value. Homology detection was done with 
HHpred against the human proteome, using the default settings (three 
multiple-sequence alignment iterations with HHblits). Protein isoforms from 
the same gene were removed. All homologs are against the C-terminal, bZIP 

























Supplementary movies can be found at the: 
doi: 10.1083/jcb.201802151. 
 
Table S2 is a separate Excel file showing Xrp1Long-interacting 
proteins ranked according to fold enrichment.  
Table S3 is a separate Excel file showing Xrp1Short-interacting 
proteins ranked according to fold enrichment.  
Table S4 is a separate Excel file showing Caz-interacting 
proteins ranked according to fold enrichment.  
Table S5 is a separate Excel file showing a list of RNA-seq 
results for each gene from the DESeq2 analysis.  
Table S6 is a separate PDF showing human genes encoding 
AT-hook proteins, including gene name, Ensemble Gene ID, 
Ensemble Protein ID, and chromosomal location.  
Table S7 is a separate PDF showing name, sequence, and 
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The number of adult myofibers in Drosophila is determined by 
the number of founder myoblasts selected from a myoblast pool, 
a process governed by fibroblast growth factor (FGF) signaling. 
Here, we show that loss of cabeza (caz) function results in a 
reduced number of adult founder myoblasts, leading to a 
reduced number and misorientation of adult dorsal abdominal 
muscles. Genetic experiments revealed that loss of caz function 
in both adult myoblasts and neurons contributes to caz mutant 
muscle phenotypes. Selective overexpression of the FGF 
receptor Htl or the FGF receptor-specific signaling molecule 
Stumps in adult myoblasts partially rescued caz mutant muscle 
phenotypes, and Stumps levels were reduced in caz mutant 
founder myoblasts, indicating FGF pathway deregulation. In 
both adult myoblasts and neurons, caz mutant muscle 
phenotypes were mediated by increased expression levels of 
Xrp1, a DNA-binding protein involved in gene expression 
regulation. Xrp1-induced phenotypes were dependent on the 
DNA-binding capacity of its AT-hook motif, and increased Xrp1 
levels in founder myoblasts reduced Stumps expression. Thus, 
control of Xrp1 expression by Caz is required for regulation of 
Stumps expression in founder myoblasts, resulting in correct 
















Skeletal muscles mediate movement, and therefore, proper 
structure and function of skeletal muscles is required for 
respiration, locomotion, and posture. Adult muscles arise from 
fusion of muscle precursor cells during development. In the fruit 
fly Drosophila melanogaster, muscle precursor cells come in two 
flavors: founder cells and fusion-competent cells. The number of 
founder cells selected during development corresponds to the 
number of adult muscles formed. Here, we report that 
inactivation of the Drosophila caz gene results in muscle 
developmental defects. Loss of caz function in both muscle 
precursor cells and the nerve cells that innervate muscles 
contributes to the muscle developmental defect. At the 
molecular level, loss of caz function leads to increased levels of 
Xrp1. Xrp1 regulates the expression of many other genes, 
including genes that produce components of the FGF signaling 
pathway, which is known to be involved in founder cell selection. 
In all, we uncovered a novel molecular mechanism that 












In Drosophila, two phases of somatic muscle development can 
be distinguished: during embryonic development, a set of 
muscles is generated that will mediate larval movement, while 
during metamorphosis, adult muscles are generated that allow 
for adult movement, including eclosion from the pupal case, 
locomotion and flight. In the first 24 h after puparium formation 
(APF), nearly all larval muscles are histolysed and removed by 
phagocytosis [1]. Larval motor neurons persist through 
metamorphosis, but their processes are substantially remodeled 
to innervate the adult muscles [2]. The latter are formed from 
undifferentiated myoblasts originating from mesodermal 
precursor cells that were set aside during embryonic 
development. These cells continue to express Twist in the late 
embryo and proliferate during larval life [3]. During early pupal 
stages, proliferation continues and myoblasts spread out by 
migrating along the peripheral nerves [1]. Around 24 h APF, a 
subset of adult myoblasts is selected to become founder 
myoblasts, while the remaining cells become fusion-competent 
myoblasts which later fuse with founder myoblasts to form the 
characteristic multinucleate adult myotubes [4].  
 
Founder cell selection is accompanied by a decline in Twist 
expression and induction of dumbfounded (duf, also known 
as kirre) expression [4]. Intriguingly, while the selection of 
founder myoblasts during embryonic development involves 
Notch-mediated lateral inhibition [5], adult founder myoblast 
selection is mediated by FGF signaling and independent of 
Notch signaling [4, 6]. Indeed, manipulation of the expression 
level of the FGF receptor Heartless (Htl) in adult myoblasts 
modulates the number of adult founder myoblasts selected [6]. 
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While Htl is expressed in both founder and fusion-competent 
myoblasts, Stumps (also known as Dof or Hbr), an FGF 
receptor-specific signaling molecule downstream of Htl, is 
selectively expressed in founder myoblasts from 24 h APF 
onwards [6]. Thus, restriction of Stumps expression to founder 
myoblasts may be a key event in founder myoblast selection. 
The molecular mechanism that mediates restricted Stumps 
expression in founder myoblasts is currently elusive. 
 
Here, we identify a novel role for cabeza (caz) in adult muscle 
development. Caz is the single Drosophila orthologue of FUS, 
EWSR1 and TAF15, three highly homologous proteins that 
constitute the FET protein family in humans [7]. The FET 
proteins are DNA- and RNA-binding proteins involved in gene 
expression regulation, including transcription, mRNA splicing 
and mRNA subcellular localization [7]. Each of the three FET 
proteins has been implicated in the pathogenesis of the motor 
neurodegenerative disorder amyotrophic lateral sclerosis (ALS) 
and frontotemporal dementia (FTD) [8]. We previously reported 
that loss of caz function results in failure of pharate adult flies to 
eclose from the pupal case due to motor weakness. This is at 
least in part mediated by loss of neuronal caz function, as 
selective reintroduction of Caz in neurons was sufficient to 
rescue the caz mutant eclosion defect. Moreover, selective 
inactivation of caz in neurons was sufficient to induce an adult 
eclosion defect, albeit with a fraction of adult escaper flies that 
display dramatic motor performance deficits and reduced life 
span [9]. The fact that selective caz inactivation in neurons 
induces an adult eclosion defect that is not as severe 
as cazKO animals suggests that loss of caz function in other cell 




considered the adult abdominal muscles (Fig 1A) as a likely 
candidate, given their known role in mediating adult eclosion. 
 
We therefore investigated the role of caz function in adult 
abdominal muscle development. Loss of caz function resulted in 
a significant reduction of the number of adult founder myoblasts 
and dorsal abdominal muscles (DAMs), as well as DAM 
misorientation. Interestingly, loss of caz function in both adult 
myoblasts and neurons contributed to the deranged 
development of adult abdominal muscles. Increased expression 
of Htl or Stumps in adult myoblasts significantly 
rescued caz mutant muscle phenotypes, indicating that 
impaired FGF signaling contributes to these phenotypes. 
Consistently, Stumps levels were significantly reduced 
in caz mutant founder myoblasts. It was previously reported that 
neuronal dysfunction in caz mutants is mediated by increased 
expression of Xrp1, a DNA-binding protein involved in gene 
expression regulation [10]. Here, we could show that also the 
newly-discovered caz mutant muscle phenotypes are caused by 
increased Xrp1 expression levels in both adult myoblasts and 
neurons. Muscle phenotypes induced by increased Xrp1 
expression were dependent on the DNA-binding capacity of its 
AT-hook motif, and Xrp1 overexpression suppressed Stumps 
expression in adult founder myoblasts. In summary, we 
uncovered a novel mechanism for regulation of Stumps 
expression in adult founder myoblasts: Caz controls Xrp1 
expression, thus permitting increased Stumps levels in founder 











Loss of caz function deranges adult abdominal muscle 
development 
 
As proper abdominal muscle function is required for eclosion of 
adult Drosophila from the pupal case, we decided to investigate 
adult abdominal muscle development in two 
independent caz loss-of-function lines (caz2 and cazKO) [9].  
We generated caz mutants in which the Myosin heavy 
chain (Mhc) gene is GFP-tagged to label muscle fibers [11–
13]. In vivo confocal imaging of dorsal abdominal muscles 
(DAMs) 96 h APF revealed a reduced number of DAMs in 
both caz2 and cazKO (Fig 1B). Quantification of DAM number in 
abdominal hemisegments 3 and 4 revealed a significant 
reduction by ~30–40% in both body segments of the 
two caz mutant lines (Fig 1C and 1D). In addition, DAMs were 
frequently misoriented in caz mutant animals (arrowheads in Fig 
1B; quantification in Fig 1E and 1F).  
These abdominal muscle defects are independent of Mhc-
GFP expression, as immunostaining of late pupal filets for actin 
confirmed the profound muscle developmental defects, with 
both reduced number and misorientation of DAMs 
in caz mutants that did not carry additional transgenes (Fig 2A 
and 2B; S1A Fig). Furthermore, caz mutant muscle defects 
cannot be attributed to a delay in pupal development, as muscle 
defects were observed both in age-matched (100 h APF) and 
stage-matched pupae (based on outer appearance [14], S1A 
and S1B Fig). Importantly, muscle defects were not confined to 
DAMs, but also observed in other abdominal muscle groups, 




the larval muscle pattern and number was not affected by loss 
of caz function (S2 Fig), indicating that caz mutant muscle 
defects were confined to adult muscle development, while 
embryonic muscle development occurred normally. 
Figure 1. Loss of caz function deranges adult abdominal muscle 
development. (A) Schematic of adult abdominal muscle architecture 
4
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in Drosophila. Dorsal, lateral and ventral abdominal muscles are 
indicated. (B) A transgenic line, in which Myosin heavy chain is GFP-tagged 
(Mhc-GFP), allowed visualization of dorsal abdominal muscles (DAMs) at 96 
h APF in wild type (WT), cazKO, and caz2 animals. Red arrowheads indicate 
misoriented DAMs. Scale bar: 50μm. (C,D) Quantification of DAM number in 
abdominal segments 3 (A3) and 4 (A4) of cazKO (C) and caz2 (D) pupae at 96 
h APF, as compared to WT. Mann Whitney test (C), t-test with Welch 
correction (D); ***p<0.0005; n = 10 WT versus 14 cazKO (A3), 11 WT versus 
12 cazKO (A4), 13 WT versus 15 caz2 (A3), 8 WT versus 10 caz2 (A4). 
Average ± SEM. (E,F) Percentage of misoriented DAMs per animal in 
segments A3 and A4 of cazKO (E) and caz2 (F) pupae at 96 h APF, as 
compared to WT. One sample Wilcoxon signed rank test; *p<0.05, **p<0.005; 
n = 10 WT versus 14 cazKO (A3), 11 WT versus 12 cazKO (A4), 13 WT versus 
15 caz2 (A3), 8 WT versus 10 caz2 (A4). Average ± SEM. 
These muscle morphological defects did not appear secondary 
to defective innervation by motor neurons, as the number of 
motor neurons in the third instar larval ventral cord was not 
altered in caz2 animals (Fig 2I and 2J). The fact that caz mutant 
larvae enter metamorphosis with a normal number of motor 
neurons is relevant for pupal development, as the larval motor 
neurons persist to adulthood, in contrast to the majority of larval 
muscles, which degenerate during metamorphosis [1, 2]. 
Furthermore, staining of abdominal filets of late pupae (100 h 
APF) for horseradish peroxidase (HRP), Discs large 1 (Dlg1) 
and actin revealed normal innervation of both dorsal and ventral 
abdominal muscles in caz knock-out animals (Fig 2A–2H and 
2K–2R). This was confirmed by quantitative analysis of NMJ 
morphology on DAMs of WT and cazKO pupae 96 h APF, which 
revealed that both NMJ area and bouton number were not 
altered in cazKO (Fig 2S and 2T). Thus, loss of caz function 
induces muscle developmental defects, which are not 






Figure 2. Motor neuron number and muscle innervation are not affected 
by loss of caz function. (A-H) Immunostaining for actin (A,B), Caz (C,D), 
4
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and HRP (E,F) on abdominal filets of WT (A,C,E,G) and caz2 (B,D,F,H) 
pupae at 100 h APF showing DAM morphology and innervation. The merge 
of actin and HRP is shown in panels G,H. Scale bar: 50μm. (I) Central motor 
neuron clusters in segments A2 to A7 in the ventral nerve cord of a third instar 
larva are delineated by a dashed red rectangle. (J) Quantification of motor 
neuron number in segments A2 to A7 in WT versus caz2 third instar ventral 
nerve cord. Unpaired t-test; n = 17 WT versus 22 caz2. Average ± SEM. (K-
R) Immunostaining for HRP (K,O), Dlg1 (L,P) and actin on abdominal filets of 
WT (K-N) and cazKO (O-R) pupae at 100 h APF showing ventral abdominal 
muscle morphology and innervation. Merges between HRP and Dlg1 (M,Q) 
and between HRP, Dlg1 and actin (N,R) are shown. Scale bar: 
10μm. (S) NMJ area relative to DAM area (shown as % of WT) in segments 
A3 and A4 of WT versus cazKO pupae at 96 h APF. Unpaired t-test; n = 18 
WT versus 18 cazKO. Average ± SEM. (T) Bouton number per DAM in 
segments A3 and A4 of WT versus cazKO pupae at 96 h APF. Unpaired t-test; 
n = 18 WT versus 19 cazKO. Average ± SEM. 
Reduced number of founder myoblasts in caz mutant animals 
 
As the number of adult muscles, including DAMs, is dependent 
on the number of founder myoblasts that are selected during 
early pupal stages (~24 h APF), we investigated whether caz is 
expressed in founder myoblasts, and whether the number of 
founder myoblasts in the dorsal abdomen was reduced 
in caz mutants. To identify founder myoblasts, a duf-
lacZ transgenic line was used in which β-galactosidase is 
selectively expressed in founder myoblasts under the control of 
the duf/kirre promoter [4]. Double immunostaining for Caz and 
β-galactosidase revealed that Caz is expressed in founder 
myoblasts (Fig 3A), as well as other cells, likely including fusion-
competent myoblasts, consistent with the previously reported 
broad expression pattern of caz [9]. Importantly, the number of 
founder myoblasts was significantly reduced in caz mutant 
pupae as compared to wild type (WT) control (Fig 3B and 3C). 




at least in part attributable to a reduced number of founder 
myoblasts 24 h APF. 
Loss of caz function in adult myoblasts contributes 
to caz mutant muscle defects 
 
Our findings suggested that the caz mutant muscle defects may 
be caused by loss of caz function in founder myoblasts. In line 
with this possibility, selective expression of Caz in adult 
myoblasts (1151-GAL4) of caz mutants rescued their reduced 
number of founder myoblasts to a level that was not statistically 
different from control genotypes (Fig 3D). Consistently, selective 
Caz expression in adult myoblasts also substantially rescued the 
reduced DAM number and DAM misorientation of cazKO pupae 
96 h APF (Fig 3E and 3F).   
We further examined the effect of selective inactivation of caz in 
adult myoblasts by crossing animals that selectively express 
FLP recombinase in these cells (1151-GAL4>UAS-FLP) to 
conditional caz knock-out animals in which the caz gene is 
flanked by FRT sites (cazFRT) [9]. Adult myoblast-
selective caz inactivation resulted in a significantly reduced 
number of founder myoblasts at 24 h APF (Fig 3G) and a 
reduced DAM number and DAM misorientation at 96 h APF (Fig 
3H and 3I; representative images in S3A Fig), albeit these 
muscle developmental defects appeared slightly less 
pronounced than in full-body caz knock-out animals.  
Together, these data show that Caz has a cell-autonomous 
function in adult myoblasts to promote founder myoblast 
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Figure 3.  Reduced founder myoblast number in caz mutants and 
rescue of caz mutant muscle phenotypes by adult myoblast-
selective caz expression. (A) Immunostaining of duf-lacZ/Y transgenic 
pupal filets 24 h APF for β-galactosidase and Caz revealed Caz expression 




myoblasts in a dorsal abdominal segment (A3 or A4) of 24 h APF duf-
lacZ pupal filets, either WT (duf-lacZ/Y) or cazKO (cazKO,duf-lacZ/Y), for β-
galactosidase (green) and Futsch (red). Scale bar: 20μm. (C) Quantification 
of the number of founder myoblasts in a dorsal abdominal segment (A3 or 
A4) of WT (duf-lacZ/Y) and cazKO (cazKO,duf-lacZ/Y) pupae at 24 h APF. 
Unpaired t-test; ***p<0.001; n = 8 WT versus 15 cazKO. Average ± 
SEM. (D) Quantification of the number of founder myoblasts in a dorsal 
abdominal segment (A3 or A4) of 24 h APF cazKO pupae in which caz is 
selectively expressed in adult myoblasts (cazKO,duf-lacZ,1151-GAL4/Y;; 
UAS-caz/+) as compared to the relevant control genotypes (duf-lacZ,1151-
GAL4/Y // duf-lacZ,1151-GAL4/Y;; UAS-caz/+ // cazKO,duf-lacZ,1151-
GAL4/Y). Two-way ANOVA with Tukey’s multiple comparisons test; 
**p<0.001, ***p<0.001; n = 13 per genotype. Average ± 
SEM. (E,F) Quantification of DAM number (E) and percentage of misoriented 
DAMs per animal (F) in segment A4 of 96 h APF cazKO pupae in which caz is 
selectively expressed in adult myoblasts (cazKO,1151-GAL4/Y; Mhc-GFP,his-
RFP/+; UAS-caz/+) as compared to the relevant control genotypes (1151-
GAL4/Y; Mhc-GFP,his-RFP/+ // 1151-GAL4/Y; Mhc-GFP,his-RFP/+; UAS-
caz/+ // cazKO,1151-GAL4/Y; Mhc-GFP,his-RFP/+). Statistics (E): Brown-
Forsythe and Welch ANOVA with Dunnett’s post test; **p<0.01, ***p<0.001; 
n = 8 per genotype. Average ± SEM. Statistics (F): One sample Wilcoxon 
signed rank test to compare all genotypes to control (set to 0), t-test with 
Welch’s correction to compare cazKO to cazKO;; UAS-caz/+; *p<0.05, 
**p<0.005, ***p<0.0001; n = 9 control, 8 UAS-caz, 10 cazKO, 18 cazKO; UAS-
caz. (G) Quantification of the number of founder myoblasts in a dorsal 
abdominal segment (A3 or A4) of 24 h APF pupae in which caz is selectively 
inactivated in myoblasts (cazFRT,duf-lacZ,1151-GAL4/Y; UAS-FLP/+) as 
compared to the relevant control genotype (cazFRT,duf-lacZ,1151-GAL4/Y). 
Unpaired t-test; ***p<0.0001; n = 18 cazFRT, 25 cazFRT; UAS-FLP. Average ± 
SEM. (H,I) Quantification of DAM number (H) and percentage of misoriented 
DAMs per animal (I) in segment A4 of 96 h APF pupae in which caz is 
selectively inactivated in myoblasts (cazFRT,1151-GAL4/Y; Mhc-GFP,his-
RFP/UAS-FLP) as compared to the relevant control genotype (cazFRT,1151-
GAL4/Y; Mhc-GFP,his-RFP/+). Statistics (H): Mann Whitney test; 
***p<0.0001; n = 23 cazFRT, 22 cazFRT; UAS-FLP. Average ± SEM. Statistics 
(I): One sample Wilcoxon test; *p<0.05; n = 23 cazFRT, 22 cazFRT; UAS-FLP. 
Average ± SEM. 
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Neuron-selective loss of caz function causes muscle defects 
 
The fact that (i) muscle phenotypes induced by adult myoblast-
selective caz inactivation were not as severe as in full-
body caz mutants, and (ii) adult myoblast-selective Caz 
reintroduction substantially but not fully rescued caz mutant 
muscle phenotypes, suggested that cell types other than muscle 
also contribute to the caz mutant muscle phenotypes. 
As caz function is known to be particularly important in neurons 
[9, 15], we evaluated whether loss of caz function in neurons 
could contribute to caz mutant muscle phenotypes. 
Consistent with this possibility, selective caz inactivation in 
neurons resulted in a significantly reduced number of founder 
myoblasts at 24 h APF (Fig 4A), and in a reduced DAM number 
and DAM misorientation at 96 h APF (Fig 4B and 4C; 
representative images in S3B Fig). 
We further evaluated the effect of neuron-selective Caz 
expression on caz mutant muscle phenotypes. Remarkably, 
even in a wild type genetic background, neuron-selective Caz 
overexpression significantly increased the number of DAMs at 
96 h APF (Fig 4D). In cazKO pupae, neuron-selective Caz 
expression partially rescued the reduced DAM number (Fig 4D). 
Two-way ANOVA statistical analysis indicated that the DAM 
number was increased to a similar extent in the control 
and cazKO genetic background (the ‘interaction’ 
between caz genotype and Caz overexpression was not 
statistically significant, p = 0.086). DAM misorientation 
in cazKO pupae was substantially rescued by neuron-selective 
Caz expression (Fig 4E). In all, our data show that loss 
of caz function in both neurons and adult myoblasts contributes 






Figure 4. Neuron-selective loss of caz function causes muscle defects. 
(A) Quantification of the number of founder myoblasts in a dorsal abdominal 
segment (A3 or A4) of 24 h APF pupae in which caz is selectively inactivated 
in neurons (cazFRT,duf-lacZ,elav-GAL4/Y; UAS-FLP/+) as compared to the 
relevant control (cazFRT,duf-lacZ,elav-GAL4/Y). Unpaired t-test; **p<0.001, n 
= 14 cazFRT versus n = 18 cazFRT; UAS-FLP. Average ± 
SEM. (B,C) Quantification of DAM number (B) and percentage of misoriented 
DAMs per animal (C) in segment A4 of 96 h APF pupae in which caz is 
selectively inactivated in neurons (cazFRT,elav-GAL4/Y; Mhc-GFP,his-
RFP/UAS-FLP) as compared to the relevant control genotypes (cazFRT,elav-
4
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GAL4/Y; Mhc-GFP,his-RFP/+ // cazFRT/Y; Mhc-GFP,his-RFP/UAS-FLP 
// elav-GAL4/Y; Mhc-GFP,his-RFP/UAS-FLP). Statistics (B): Kruskal-Wallis 
test with Dunn’s multiple comparisons test; *p<0.05, **p<0.005, ***p<0.0001. 
Statistics (C): one sample Wilcoxon signed rank test; **p<0.01; n = 
14 cazFRT, elav-GAL4, 14 cazFRT; UAS-FLP, 14 elav-GAL4>UAS-FLP, 
15 cazFRT, elav-GAL4>UAS-FLP. Average ± SEM. (D,E) Quantification of 
DAM number (D) and percentage of misoriented DAMs per animal (E) in 
segment A4 of 96 h APF cazKO pupae in which caz is selectively expressed 
in neurons (cazKO,elav-GAL4/Y; Mhc-GFP,his-RFP/+; UAS-caz/+) as 
compared to the relevant control genotypes (elav-GAL4/Y; Mhc-GFP,his-
RFP/+ // elav-GAL4/Y; Mhc-GFP,his-RFP/+; UAS-caz/+ // cazKO,elav-
GAL4/Y; Mhc-GFP,his-RFP/+). Statistics (D): two-way ANOVA with Tukey’s 
multiple comparisons test; ***p<0.0001; n = 21 per genotype. Statistics (E): 
one sample Wilcoxon signed rank test to compare all genotypes to control, 
Mann-Whitney test to compare cazKO to cazKO; UAS-caz; **p<0.01, 
***p<0.0001; n = 21 control, 23 UAS-caz, 21 cazKO, 25 cazKO; UAS-caz. 
Average ± SEM. 
Defective FGF signaling contributes to caz mutant muscle 
phenotypes 
 
As the FGF signaling pathway has previously been implicated in 
adult founder myoblast selection [6], we evaluated whether 
defective FGF signaling might contribute to caz mutant muscle 
phenotypes. Interestingly, overexpression of the FGF receptor 
Heartless (Htl) in adult myoblasts (1151-GAL4) partially but 
significantly rescued the reduced DAM number and DAM 
misorientation in caz mutants (Fig 5A and 5B). Htl 
overexpression in an otherwise wild type background tended to 
increase DAM number, but this difference did not reach 
statistical significance. Importantly, two-way ANOVA revealed 
that the rescue of caz mutant muscle phenotypes by myoblast-
selective Htl overexpression represents a genuine genetic 
interaction between caz and Htl, and is not merely an additive 




To confirm the role of the FGF pathway in caz mutant muscle 
phenotypes, we selectively overexpressed Stumps, the FGF 
receptor-specific signal transduction molecule downstream of 
Htl, in adult myoblasts. This also significantly rescued the 
reduced DAM number and DAM misorientation (Fig 5C and 5D) 
in caz mutants. Together these data indicate that caz mutant 
muscle phenotypes are at least in part attributable to defective 
FGF signaling. These findings raised the hypothesis that Caz 
may, directly or indirectly, regulate the expression level of FGF 
pathway components. As Stumps expression becomes 
restricted to founder myoblasts 24 h APF [6], suggesting a key 
role in founder myoblast selection, we evaluated Stumps 
expression levels in adult founder myoblasts by immunostaining, 
using a previously described specific anti-Stumps antibody [16]. 
This experiment revealed significantly reduced Stumps protein 
levels in cazKO founder myoblasts (Fig 5E and 5F). Thus, loss 
of caz function leads to reduced Stumps expression, which may 
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Figure 5. Defective FGF signaling contributes to caz mutant muscle 
phenotypes. (A,B) Quantification of DAM number (A) and percentage of 




APF cazKO pupae in which Htl is selectively expressed in adult myoblasts 
(cazKO,1151-GAL4/Y; Mhc-GFP,his-RFP/+; UAS-htl/+) as compared to the 
relevant control genotypes (1151-GAL4/Y; Mhc-GFP,his-RFP/+ // 1151-
GAL4/Y; Mhc-GFP,his-RFP/+; UAS-htl/+ // cazKO,1151-GAL4/Y; Mhc-
GFP,his-RFP/+). Statistics (A): two-way ANOVA with Tukey’s multiple 
comparisons test; ***p<0.0001; n = 19 per genotype. Average ± SEM. 
Statistics (B): one sample Wilcoxon signed rank test to compare all genotypes 
to control, Mann-Whitney test to compare cazKO to cazKO; UAS-htl; *p<0.05, 
**p<0.01, ***p<0.001; n = 32 control, 37 UAS-htl, 33 cazKO, 19 cazKO; UAS-
htl. Average ± SEM. (C,D) Quantification of DAM number (C) and percentage 
of misoriented DAMs per animal (D) in segments A3 and A4 of 96 h 
APF cazKO pupae in which Stumps is selectively expressed in adult 
myoblasts (cazKO,1151-GAL4/Y; Mhc-GFP,his-RFP/UAS-stumps) as 
compared to the relevant control genotypes (1151-GAL4/Y; Mhc-GFP,his-
RFP/+ // 1151-GAL4/Y; Mhc-GFP,his-RFP/+; UAS-stumps/+ // cazKO,1151-
GAL4/Y; Mhc-GFP,his-RFP/+). Statistics (C): two-way ANOVA with Tukey’s 
multiple comparisons test; ***p<0.0001; n = 16 per genotype. Average ± 
SEM. Statistics (D): one sample Wilcoxon signed rank test to compare all 
genotypes to control, Mann-Whitney test to compare cazKO to cazKO; UAS-
stumps for A3, t-test with Welch’s correction for A4; **p<0.005, ***p<0.001; n 
= 16 per genotype. Average ± SEM. (E) Immunostaining of founder 
myoblasts in a dorsal abdominal segment (A3 or A4) of 24 h APF duf-
lacZ pupal filets, either WT (duf-lacZ/Y) or cazKO (cazKO,duf-lacZ/Y), for β-
galactosidase (green) and Stumps (red). Scale bar: 50μm. (F) Quantification 
of Stumps staining intensity (% of WT) in founder myoblasts 
of cazKO (cazKO,duf-lacZ/Y) 24 h APF pupae relative to WT (duf-lacZ/Y). 
Unpaired t-test; *p<0.05; n = 9 WT, 10 cazKO. Average ± SEM. 
Increased Xrp1 levels mediate caz mutant muscle phenotypes 
 
We have previously reported that neuronal dysfunction 
in caz mutants is mediated by increased levels of Xrp1, a DNA-
binding protein involved in gene expression regulation [10]. 
Upregulation of Xrp1 by ~3-fold was not only found 
in caz mutant nervous system but also in larval body wall, which 
predominantly consists of muscles [10].  
4
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We therefore evaluated whether the newly 
discovered caz mutant muscle phenotypes are also mediated by 
increased Xrp1 levels. Consistent with increased Xrp1 
expression as the key mediator of caz mutant phenotypes, 
heterozygosity for Xrp1 almost fully rescued the reduced DAM 
number (Fig 6A) and fully rescued DAM misorientation (S4A Fig) 
in caz mutant animals. Importantly, selective overexpression of 
Xrp1 in adult myoblasts (1151-GAL4) was sufficient to induce a 
significant reduction of DAM number (Fig 6B), as well as DAM 
misorientation (S4B Fig), and a substantial reduction in the 
number of founder myoblasts (Fig 6C). 
Thus, adult myoblast-selective Xrp1 overexpression 
phenocopied caz mutant muscle phenotypes. This was 
dependent on the DNA-binding capacity of Xrp1, as adult 
myoblast-selective overexpression of Xrp1 with a subtle 
mutation in its AT-hook DNA-binding domain did not induce 
muscle phenotypes (Fig 6B, S4B Fig). These data suggest that 
gene expression dysregulation induced by increased Xrp1 
expression in adult myoblasts mediates caz mutant muscle 
phenotypes. Based on our finding that Stumps expression is 
reduced in caz mutant founder myoblasts (Fig 5E and 5F), we 
hypothesized that increased Xrp1 expression may suppress 
Stumps expression in adult founder myoblasts. Immunostaining 
for Stumps confirmed that Xrp1 overexpression in adult 
myoblasts of otherwise wild type animals was sufficient to 
significantly reduce Stumps levels in founder myoblasts (Fig 6D 
and 6E).  
In addition to increased Xrp1 expression in adult myoblasts, 
increased Xrp1 levels in neurons may also contribute 
to caz mutant muscle phenotypes. Indeed, selective knock-
down of Xrp1 in neurons (elav-GAL4) induced a partial but 




number and misorientation (Fig 6F and 6G). Thus, increased 
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Figure 6. Increased Xrp1 levels mediate caz mutant muscle phenotypes. 
(A) Quantification of DAM number in segments A3 and A4 of 96 h 
APF cazKO pupae that are heterozygous for Xrp1KO (cazKO/Y; Mhc-GFP,his-
RFP/+; Xrp1KO/+) as compared to the relevant control genotypes (+/Y; Mhc-
GFP,his-RFP/+ // +/Y; Mhc-GFP,his-RFP/+; Xrp1KO/+ // cazKO/Y; Mhc-
GFP,his-RFP/+). Two-way ANOVA with Tukey’s multiple comparisons test; 
**p<0.01, ***p<0.0001; n = 15 per genotype. Average ± 
SEM. (B) Quantification of DAM number in segments A3 and A4 of 96 h APF 
male pupae in which Xrp1 is selectively overexpressed in adult myoblasts 
(1151-GAL4), either as WT protein or with a subtle mutation that disrupts the 
DNA-binding capacity of the AT-hook motif (Mut), as compared to driver-only 
control. Brown-Forsythe and Welch ANOVA with Dunnett’s post test; 
***p<0.001; n = 8 control, 23 UAS-Xrp1 WT, 20 UAS-Xrp1 Mut. Average ± 
SEM. (C) Quantification of the number of founder myoblasts in 24 h APF male 
pupae in which Xrp1 is overexpressed in adult myoblasts (1151-GAL4). Mann 
Whitney test; ***p<0.001; n = 15 WT versus 19 UAS-Xrp1 WT. Average ± 
SEM. (D) Immunostaining of founder myoblasts in a dorsal abdominal 
segment (A3 or A4) of 24 h APF duf-lacZ pupal filets, either WT (1151-
GAL4,duf-lacZ/Y) or 1151-GAL4,duf-lacZ/Y;;UAS-Xrp1 WT/+, for β-
galactosidase (green) and Stumps (red). Scale bar: 20μm. (E) Quantification 
of Stumps staining intensity (% of WT) in founder myoblasts of 1151-
GAL4,duf-lacZ/Y;; UAS-Xrp1 WT/+ 24 h APF pupae relative to WT (1151-
GAL4,duf-lacZ/Y). Unpaired t-test; *p<0.05; n = 7 WT versus 8 UAS-Xrp1 
WT. Average ± SEM. (F,G) Quantification of DAM number (F) and 
percentage of misoriented DAMs per animal (G) in segments A3 and A4 of 
96 h APF cazKO pupae in which Xrp1 is selectively knocked-down in neurons 
(cazKO,elav-GAL4/Y; Mhc-GFP,his-RFP/+; UAS-Xrp1-RNAi/+) as compared 
to the relevant control genotypes (elav-GAL4/Y; Mhc-GFP,his-RFP/+ // elav-
GAL4/Y; Mhc-GFP,his-RFP/+; UAS-Xrp1-RNAi/+ // cazKO,elav-
GAL4/Y; Mhc-GFP,his-RFP/+). Statistics (F): two-way ANOVA with Tukey’s 
multiple comparisons test; *p<0.05, **p<0.005, ***p<0.0001; n = 10 per 
genotype. Statistics (G): one sample Wilcoxon signed rank test to compare 
all genotypes to control, and cazKO to cazKO; UAS-Xrp1-RNAi, **p<0.005; n = 
13 control, 15 UAS-Xrp1-RNAi, 10 cazKO, 16 cazKO; UAS-Xrp1-RNAi. 








Cabeza (caz) is the single Drosophila orthologue of the human 
FET protein family, which consists of FUS, EWSR1 and TAF15 
[7]. Caz was previously reported to have a particularly important 
function in neurons. Indeed, similar to full-body caz loss-of-
function (LOF) mutants, selective caz inactivation in neurons 
induced motor deficits resulting in failure of the majority of adult 
flies to eclose from the pupal case, and adult escaper flies 
displayed dramatic climbing deficits and reduced life span [9]. 
Furthermore, neuron-selective expression of Caz or human FUS 
was sufficient to rescue the adult eclosion and motor 
performance defects of caz LOF mutants [9, 15]. Here, we show 
for the first time that caz mutants display adult abdominal 
muscle defects, including a reduced number and occasional 
misorientation of dorsal abdominal muscles (DAMs). The 
reduced DAM number correlated with a reduced number of adult 
founder myoblasts, and our data indicate that caz mutant adult 
muscle developmental defects are to an important extent 
attributable to loss of caz function in adult myoblasts. Indeed, 
similar to full-body caz LOF mutants, adult myoblast-selective 
inactivation of caz resulted in a reduced number of adult founder 
myoblasts and DAMs, as well as DAM misorientation. In 
addition, myoblast-selective Caz expression in a caz mutant 
background substantially rescued adult muscle developmental 
defects. Thus, caz function in adult muscle precursor cells is 
required for normal muscle development. 
 
The normal muscle morphology and number in caz mutant third 
instar larvae indicated a selective defect in adult muscle 
development, with the reduced number of adult founder 
myoblasts as the earliest observable defect. While embryonic 
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founder myoblast selection involves Notch-mediated lateral 
inhibition [5], FGF signaling through the FGF receptor Heartless 
(Htl) and its downstream signal transduction molecule 
Stumps/Dof/Hbr has been shown to mediate adult founder 
myoblast selection [6]. We therefore investigated the potential 
contribution of defective FGF signaling to caz mutant muscle 
phenotypes. We found that selective expression of Htl or Stumps 
in adult myoblasts significantly rescued the reduced DAM 
number and DAM misorientation in caz mutants. Consistent with 
this genetic evidence for a role of FGF signaling in caz mutant 
muscle phenotypes, immunostaining revealed that Stumps 
levels are significantly reduced in caz mutant founder 
myoblasts. Together, these data indicate that defective FGF 
signaling contributes to caz mutant muscle phenotypes. 
 
Mallik et al. recently reported that neuronal dysfunction 
in caz loss-of-function mutants is mediated by increased 
expression of Xrp1 [10], a DNA-binding protein involved in 
protection against genotoxic stress [17], DNA damage repair 
[18], cell competition [19, 20] and intra- and inter-organ growth 
coordination [21]. Increased Xrp1 expression in caz mutant 
central nervous system led to gene expression dysregulation 
and neuronal dysfunction [10]. In this study, we show that 
increased Xrp1 levels also mediate the newly-
discovered caz mutant muscle phenotypes, as heterozygosity 
for Xrp1 almost completely rescued caz mutant muscle 
phenotypes. Interestingly, selective overexpression of Xrp1 in 
adult myoblasts of otherwise WT animals was sufficient to 
induce a substantial reduction in the number of founder 
myoblasts and DAMs, and DAM misorientation. A subtle 
mutation in the Xrp1 AT-hook motif that abolishes its DNA-




phenotypes upon selective overexpression in adult myoblasts. 
This indicates that gene expression dysregulation as a 
consequence of increased Xrp1 levels mediates caz mutant 
muscle phenotypes. Intriguingly, in adult founder myoblasts, 
Stumps is a downstream target of Xrp1, as selective 
overexpression of Xrp1 in adult myoblasts of otherwise WT 
animals significantly decreased Stumps expression in founder 
myoblasts, as is the case in caz mutants. As Stumps expression 
becomes restricted to adult founder myoblasts at the time of 
founder myoblast selection (24 h APF) [6], suppression of 
Stumps by Xrp1 is likely a key molecular mechanism underlying 
the reduced adult founder myoblast number in caz mutants. 
Altogether, our data indicate that in adult founder myoblasts, 
loss of caz function leads to increased Xrp1 expression levels, 
which in turn suppresses Stumps expression, leading to a 
reduced number of founder myoblasts and consequently to a 
reduced DAM number. 
 
Although our data indicate a role of caz in founder myoblast 
selection by controlling Xrp1 expression, which in turn regulates 
Stumps expression (and possibly other FGF pathway 
components), additional mechanisms may contribute 
to caz mutant muscle phenotypes. It is unlikely that defective 
myoblast fusion contributes to caz mutant muscle phenotypes, 
as the number of nuclei per DAM was not substantially changed 
in caz mutants at 96 h APF (S5 Fig). However, other processes 
that occur later during adult muscle development may be 
defective in caz mutants, including myoblast migration, 
attachment to tendons, or muscle degeneration may occur. Such 
mechanisms may underlie the frequent misorientation of DAMs 
that we observed in caz mutants, the mechanism of which 
remains to be elucidated.  
4
185
Caz promotes founder myoblast selection by Xrp1-dependent regulation of FGF signaling 
 185 
 
Consistent with the previously recognized importance 
of caz function in neurons [9, 15], loss of caz function in neurons 
also contributed to caz mutant muscle phenotypes, despite the 
fact that the number of motor neuron cell bodies was not altered 
and that the remaining muscles in caz mutant animals were 
normally innervated. Indeed, neuron-selective inactivation 
of caz in an otherwise WT genetic background was sufficient to 
induce a reduced founder myoblast and DAM number, as well 
as DAM misorientation. Furthermore, neuron-selective 
reintroduction of Caz in a caz mutant background partially 
rescued the reduced DAM number and DAM misorientation. The 
neuronal contribution to caz mutant muscle phenotypes is also 
mediated by increased Xrp1 expression, as neuron-selective 
knock-down of Xrp1 partially rescued caz mutant muscle 
phenotypes. Thus, gene expression dysregulation in caz mutant 
neurons likely explains the non-cell-autonomous contribution to 
muscle phenotypes. Future studies are needed to identify the 
Xrp1 target genes in neurons that are responsible for caz mutant 
muscle defects. In line with the neuronal contribution 
to caz mutant muscle phenotypes, the development of adult 
muscles is known to be intricately linked to the development of 
adult innervation. Early during metamorphosis, adult myoblasts 
migrate along motor nerves [1] and denervation of adult 
abdominal hemisegments at the onset of metamorphosis results 
in thinner and less numerous DAMs [22]. Furthermore, 
innervation is absolutely required for the formation of the male 
specific muscles [22, 23]. 
 
As mutations in FUS cause aggressive familial forms of the 
motor neurodegenerative disease ALS [8, 24], our findings may 




contribution of the skeletal muscle to ALS pathogenesis has 
been suggested, but is controversial. On the one hand, selective 
expression of ALS-mutant SOD1 in skeletal muscle of mice 
resulted in progressive muscle atrophy, reduced muscle 
strength, alteration in the contractile apparatus, mitochondrial 
dysfunction, paresis and motor defects [25, 26]. On the other 
hand, selective reduction of mutant SOD1 expression in skeletal 
muscle of mutant SOD1 transgenic mice did not affect their 
disease course, neither did increasing muscle fiber number and 
diameter by follistatin expression [27, 28]. Intriguingly, a recent 
study reported that ALS-mutant FUS is intrinsically toxic to both 
motor neurons and muscle cells, and toxicity in muscle may be 
attributable to defective FUS-mediated transcriptional regulation 
of acetylcholine receptor subunit genes [29]. While this and other 
studies in FUS-ALS mouse models indicate that a gain-of-toxic-
function of ALS-mutant FUS is required to cause motor neuron 
degeneration [30–32], a possible contribution of loss of nuclear 
FUS function to FUS-ALS pathogenesis cannot be excluded. 
Despite the fact that caz mutant muscle defects are 
developmental, our findings are consistent with a cell-
autonomous function of the Drosophila FUS orthologue in 
muscle, and a possible role of the skeletal muscle in FUS-ALS 
pathogenesis.   
 
Interestingly, FGF signaling has previously been implicated in 
ALS pathogenesis, through retrograde FGF signaling from 
muscle to motor neuron [33]. Beyond ALS, FGF signaling has 
also been implicated in spinal muscular atrophy (SMA) [34], a 
related motor neurodegenerative disease caused by loss 
of SMN1 function [35]. FUS also directly binds to SMN and 
associates with SMN complexes [36–39], and FUS knock-out or 
cytoplasmic mislocalization of ALS-mutant FUS induces 
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cytoplasmic SMN mislocalization and a reduced number of 
nuclear SMN-containing Gems [31, 36, 38, 39]. Thus, our 
finding that defective FGF signaling contributes to caz mutant 
muscle phenotypes is consistent with dysregulation of the FGF 
pathway as a contributing factor to both FUS-ALS and SMA, 
further indicating that common molecular pathways may 
































Flies were kept in a temperature-controlled incubator with 12 h 
on/off light cycle at 25°C. The X chromosome-inserted elav-
GAL4 (Bloomington Drosophila Stock center (BDSC) stock 
number 458) was used for pan-neuronal expression of UAS 
transgenes. 1151-GAL4 was used for targeted expression in 
adult myoblast precursors [40] (kindly provided by K. 
VijayRaghavan). For motor neuron quantification, OK371-
GAL4 was used to drive UAS-RedStinger. For in 
vivo imaging, elav-GAL4 and 1151-GAL4 drivers were 
recombined with cazKO, and recombinant females were crossed 
to Mhc-GFP, his-RFP/CyO [11–13] in order to generate an 
introgressed stock. To induce cell-type-
specific caz inactivation, cazFRT [9] was recombined with elav-
GAL4 and 1151-GAL4; homozygous females were crossed to 
UAS-FLP (BDSC stock 4539) males and male offspring was 
used for the experiments. In order to evaluate the number of 
founder myoblasts at 24 h APF, 1151-
GAL4 // cazKO // cazKO,1151-GAL4 // cazFRT,1151-
GAL4 // cazFRT,elav-GAL4 were recombined with duf-lacZ [41]. 
The UAS-caz line used for rescue experiments was the UAS-
flag-caz line described in [15]. The htl line used in this study was 
UAS-htl.ORF.3xHA (F000798; FlyORF). The UAS-stumps 
transgenic line was provided by M. Leptin [16]. 
The caz2 and cazKO lines [9], as well as Xrp1KO and 5xUAS-
Xrp1 lines were described [10] and the UAS-Xrp1-RNAi line 
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In vivo imaging of dorsal abdominal muscles 
 
To image dorsal abdominal muscles, appropriate crosses were 
set up, male larvae were selected and placed in a new vial 
containing standard Drosophila food supplemented with yeast 
paste. White prepupae were collected on wet Whatman filter 
paper in petri dishes and kept at 25°C for 96 h. After 96 h, 
pharate adults were dissected out from the pupal case and 
placed in an approximately 2 mm furrow of a plastic slide with a 
drop of 60% glycerol. Images of serial optical sections were 
acquired using a Zeiss LSM700 or a Leica SP8 laser scanning 
confocal microscope. For quantification, DAMs were manually 
counted using ImageJ/Fiji [42] by inspecting the acquired Z-
stacks. Histone-RFP (his-RFP) expression was used to quantify 
the number of nuclei that are present in the DAMs in abdominal 
segments A3 and A4. 
Motor neuron quantification 
 
The number of motor neuron cell bodies were quantified in third 
instar larval ventral nerve cords (VNC) of caz2 and WT controls. 
Motor neuron cell bodies were visualized by OK371-GAL4-
driven UAS-RedStinger and the number of motor neuron cell 
bodies was counted in the central clusters in segments A2-A7 of 
the 3rd instar larval VNC. 
Immunostainings 
Immunostaining of pharate adults (96 h APF) 
Open book preparations of pupal abdomens were fixed in 4% 
PFA in PBS for 30 minutes. Tissues were washed 3 x 10 min 
with PBS/0.2% Triton X-100 and blocked for 1 h at RT with 10% 




with primary antibodies against Caz (mouse monoclonal clone 
3F4; 1:30; [43]) or Dlg1 (mouse monoclonal clone 4F3; 1:200; 
Developmental Studies Hybridoma Bank). Secondary 
antibodies conjugated either with Alexa Fluor 488 or Alexa Fluor 
568 (1:500; Molecular Probes), anti-HRP-549 (1:1000; Jackson 
ImmunoResearch) and Phalloidin-647 (1:20; Cell Signaling) 
were applied for 3 h at RT. 
For quantification of neuromuscular endplate area we used 
ImageJ/Fiji in order to measure the endplate and muscle area in 
DAMs of abdominal segment A3 and A4, from maximum 
intensity projections of acquired confocal z-stacks. In case of 
multiple branches, the sum of the areas of individual branches 
was used as total endplate area. The endplate areas were then 
normalized to the respective muscle area. 
Immunostaining of 24 h APF pupae 
Open book preparations of abdomens were fixed in 4% PFA in 
PBS for 60 minutes. Tissues were washed 3 x 10 min with 
PBS/0.2% Triton X-100 and blocked for 1 h at RT in 10% goat 
serum in PBS.  
For quantification of founder myoblasts and Caz 
immunostaining, tissues were incubated overnight at 4°C with 
the first primary antibody against β-galactosidase (mouse 
monoclonal 40-1a; 1:50; Developmental Studies Hybridoma 
Bank). Anti-mouse secondary antibody conjugated with Alexa 
Fluor 488 (1:500; Molecular Probes) was applied at RT for 1 h. 
Tissues were then washed 3 x 10 min in PBS/0.2% Triton X-100 
and incubated overnight at 4°C with the second primary antibody 
against Caz or Futsch (mouse monoclonal clone 22C10; 1:100; 
Developmental Studies Hybridoma Bank). Anti-mouse 
secondary antibody conjugated with Alexa Fluor 568 (1:250; 
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Molecular Probes) was applied at RT for 30 min. For imaging a 
Zeiss LSM700 or a Leica SP8 laser scanning confocal 
microscope was used. 
For quantification of Stumps level, tissues were incubated 
overnight at 4°C with primary antibodies against β-galactosidase 
(mouse monoclonal 40-1a; 1:50; Developmental Studies 
Hybridoma Bank) and Stumps, a gift from M. Leptin (rabbit; 
1:1000) [16]. Secondary antibodies conjugated either with Alexa 
Fluor 488 or Alexa Fluor 568 (1:500; Molecular Probes) were 
applied at RT for 1 h. As internal control, TetraSpeck 
Microspheres 4.0 μm (ThermoFisher) were applied on the slides 
while mounting the tissues. Images were acquired using a Leica 
SP8 laser scanning confocal microscope with a 40x/1.3 NA oil 
objective with the exact same settings for all the samples. 
Maximum intensity projections of acquired z-stacks were 
generated with ImageJ/Fiji. The mean cytoplasmic intensity was 
measured in these projections using a custom-made ImageJ/Fiji 
macro, upon thresholding and removing all background pixels’ 
intensities. Same approach was used for the quantification of 
beads’ intensity. For both Stumps staining and internal control, 
the mean intensity per pupa was calculated and the cytoplasmic 
Stumps staining intensity was normalized to the beads intensity. 
Larval muscle quantification 
 
To visualize larval muscles, elav-GAL4; Mhc-
GFP and cazKO; Mhc-GFP larvae were dissected and briefly 
fixed in Bouin’s solution for 3 min, followed by 3 x 15-min washes 
with PBS/0.2% Triton X-100 and three 15-min washes in PBS, 
and mounted in Vectashield (Vector Laboratories). Samples 




microscope. For quantification, larval muscles in A3 and A4 were 
counted using ImageJ/Fiji. 
Statistical analysis 
 
All results from analysis are presented as mean ± standard error 
of the mean (SEM) and differences were considered significant 
when p <0.05. Before analysis, a Robust regression and Outlier 
removal method (ROUT) was performed to detect all outliers. 
This nonlinear regression method fits a curve that is not 
influenced by outliers. Residuals of this fit were then analyzed 
by a test adapted from the False Discovery Rate approach, to 
identify any outliers. This analysis did not identify outliers, and 
therefore no data points were removed. Normality and 
homoscedasticity of all data was analyzed by a Shapiro–Wilk 
and Brown–Forsythe (F-test for t-tests) test, respectively. 
Subsequent statistical tests were only performed if all 
assumptions were met, except mild heteroscedasticity that was 
observed between experimental groups in 
Figs 3F, 5A, 5B, 6A, S3A and S3B(A3).  
For comparison of normally distributed data of two groups, two-
tailed unpaired Student’s t-test was used in combination with 
an F-test to confirm that the variances between groups were not 
significantly different. Non-parametric Mann–Whitney tests were 
performed if data were not normally distributed. An unpaired t-
test with Welch’s correction was performed for data with 
heteroscedasticity. 
Comparisons of data consisting of more than two groups, 
varying in a single factor, were performed using Kruskal–Wallis 
for not-normally distributed data with homogeneous variance, 
and using Brown-Forsythe with Welch’s correction for normally 
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distributed data with heterogeneous variance, both using Dunn’s 
or Dunnett’s multiple comparisons post hoc test.  
Comparisons of data consisting of more than two groups, 
varying in two factors, was performed using two-way ANOVA 
and subsequent Tukey’s multiple comparisons test for normally 
distributed data with homogeneous variance.  
To analyze muscle misorientation, one sample two-tailed 
Wilcoxon signed rank test using the Pratt method was used to 
evaluate differences as compared to the control genotype (with 
a set value of 0). 
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S1 Fig. Reduced DAM number in both age-matched and stage-
matched cazKO pupae. (A,B) Quantification of DAM number in segments A3 
and A4 of either age-matched (100 h APF, A) or stage-matched (P15: 
twitching legs, B) cazKO versus WT male pupal filets immunostained for actin. 
Unpaired t-test (A, B-A3) and t-test with Welch’s correction (B-A4); **p<0.01, 
***p<0.001; n(A) = 4 WT versus 5 cazKO (A3), 5 WT versus 4 cazKO (A4); n(B) 
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S2 Fig. Loss of caz function does not affect larval muscle morphology. 
(A) A transgenic line in which the Myosin heavy chain gene is GFP-tagged 
(Mhc-GFP) allowed for visualization of muscles in abdominal segments A3 
and A4 of WT (+/Y; Mhc-GFP,his-RFP/+) and cazKO (cazKO/Y; Mhc-GFP,his-
RFP/+) third instar larvae. Scale bar: 100μm. (B) Quantification of larval 
muscle number in segments A3 and A4. Mann-Whitney test; n = 6 per 








S3 Fig. DAM phenotypes induced by selective caz inactivation in adult 
myoblasts or neurons. (A) Representative images of DAMs in abdominal 
segments A3 and A4 of 96 h APF pupae in which caz was selectively 
inactivated in adult myoblasts (cazFRT,1151-GAL4/Y; Mhc-GFP/UAS-FLP, 
right panel) as compared to the relevant control (cazFRT,1151-GAL4/Y; Mhc-
GFP/+, left panel). Scale bar: 100μm. (B) Representative images of DAMs in 
abdominal segments A3 and A4 of 96 h APF pupae in which caz was 
selectively inactivated in neurons (cazFRT,elav-GAL4/Y; Mhc-GFP/UAS-FLP, 
right panel) as compared to the relevant control (cazFRT,elav-GAL4/Y; Mhc-
GFP/+, left panel). Scale bar: 100μm. 
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S4 Fig. Increased Xrp1 levels mediate caz mutant DAM misorientation. 
(A) Percentage of misoriented DAMs per animal in segments A3 and A4 of 
96 h APF cazKO pupae that are heterozygous for Xrp1 (cazKO/Y; Mhc-
GFP,his-RFP/+; Xrp1KO/+) as compared to the relevant control genotypes 
(+/Y; Mhc-GFP,his-RFP/+ // +/Y; Mhc-GFP,his-RFP/+; Xrp1KO/+ 
// cazKO/Y; Mhc-GFP,his-RFP/+). One sample Wilcoxon signed rank test to 
compare all genotypes to control, and cazKO to cazKO; Xrp1KO/+; ***p<0.0005; 
n = 15 per genotype. Average ± SEM. (B) Percentage of misoriented DAMs 
per animal in segments A3 and A4 of 96 h APF male pupae that selectively 
overexpress Xrp1 in adult myoblasts (1151-GAL4), either as WT protein or 
with a subtle mutation that disrupts the DNA-binding capacity of the AT-hook 
motif (Mut), as compared to driver-only control. One sample Wilcoxon signed 
rank test to compare all genotypes to control and UAS-Xrp1 WT to UAS-Xrp1 
Mut; **p<0.01, ***p<0.0001; n = 8 control, 23 UAS-Xrp1 WT, 20 UAS-Xrp1 











S5 Fig. Loss of caz function does not preclude myoblast fusion. The 
average number of nuclei per DAM was determined in abdominal segments 
A3 and A4 of 96 h APF WT, caz2, and cazKO pupae that carried Mhc-
GFP and his-RFP transgenes to visualize muscles and nuclei, respectively. 
Ordinary one-way ANOVA with Dunnett’s post test; *p<0.05; n = 7 per 
































































Amyotrophic lateral sclerosis is a fatal neurodegenerative 
disease. Despite the fact that more than 20 genes have been 
linked to the familial form and the increasing knowledge on their 
pathways, to date, the etiology is still unexplained and treatment 
options are quite limited.  
In order to characterize and better understand the pathways 
involved, in the lab we used the knock-out approach in a simple 
model organism such as Drosophila.  
In this thesis, the knock-out model was characterized (Chapters 
2 & 3), I then introduced a powerful tool for cell-type-specific 
inactivation that contributed to the analysis of phenotypes 
observed in a null mutant (Chapter 2). I also identified the 
nuclear chromatin-binding protein Xrp1 as a genetic interactor of 
caz (Chapter 3). Moreover, I identified a novel role for caz in 
adult muscle development and found that the mutant 
phenotypes are mediated by Xrp1 (Chapter 4).  
In this chapter, results and novel findings described in Chapters 
2-4 will be discussed. 
 
Generation of knock-out and characterization  
 
In the study presented in Chapter 2, two mutant alleles cazKO 
and caz2 were generated. cazKO was generated by the 
integrase-mediated approach for gene knock-out (IMAGO) [1] 
and caz2 by imprecise excision of a P-transposable element in 
the caz gene promoter. These mutants are null alleles at the 
RNA and protein level. Both caz mutants exhibit lethality during 
the pupal stage, indicating that the protein might play a role 





independent study published by Wang and colleagues, which 
reported that caz1 mutant animals show a similar phenotype, 
with few escapers that are characterized by impaired motor 
behavior and a short lifespan [2].  
Interestingly, larval development is not affected by the absence 
of the protein, but caz mutant male larvae metamorphose with a 
delay of 1-2 days. The putative role of caz in regulating 
ecdysone signaling is out of the scope of this thesis, but this 
delay might be attributable to a novel role of the protein in 
triggering metamorphosis through the polyhydroxylated steroid. 
Ecdysone, synthetized in the prothoracic gland (PG), binds the 
heterodimer formed by two nuclear receptors: Ecdysone 
receptor (EcR) and ultraspiracle (USP) [3], thus regulating the 
expression of genes involved in cell proliferation, differentiation 
and apoptosis during Drosophila development. Recently, it has 
been shown that Egfr signaling in the PG endocrine cells 
regulates the ecdysone pulse, triggering puparium formation [4]. 
Interestingly, a genetic link between caz and Egfr signaling 
pathway has been described in Drosophila [5]. It may be 
interesting to evaluate whether Cabeza regulates Egfr signaling 
in a similar manner as I showed in Chapter 4 for FGF signaling. 
One might selectively inactivate caz in PG cells and evaluate 
whether the ecdysone pulse is affected by the absence of the 
protein.   
The pupal lethality observed in cazKO and caz2 mutants could be 
partially rescued by selective reintroduction of wildtype Caz in 
neurons with the elav-GAL4 driver; a similar result was obtained 
by Wang and colleagues with caz1 mutants [2], reconfirming the 
validity of our model. Taken together, these results indicate that 
loss of caz function in neurons is necessary to induce the pupal 
lethality, but the protein may play a role in a different tissue as 




Cell-type-specific gene inactivation 
 
To overcome problems arising from using a rescue approach, in 
which a UAS-transgene is expressed in a specific cell type, FRT 
or LoxP sites were introduced in the caz gene using the IMAGO 
approach. The method presented in Chapter 2 permits the 
specific inactivation of an endogenous Drosophila gene in a 
designated cell population (Figure 1A). Expression of UAS-FLP 
or UAS-Cre in CNS results in the loss of the protein in all neurons 
of third instar larvae; but, as previously reported [6], panneuronal 
expression of UAS-Cre induces toxic effects in the Drosophila 
eyes. Thus, FLP/FRT appears to be the most useful system for 
cell-type-specific gene inactivation in Drosophila.  
This method permits to evaluate whether a complete loss of 
function in a specific cell type is sufficient to induce a phenotype, 
without the added risk of off-target effects and incomplete knock-
down associated with using RNAi transgenic lines.  
In Chapter 2, it was shown that neuron-selective inactivation of 
caz results in pupal lethality, with few escapers showing an 
impaired motor behavior. This phenotype is less severe than that 
seen in the cazKO, suggesting, as previously discussed, a 
diverse role for the protein in different cell types. Knock-down of 
the protein with a panneuronal driver did not induce any 
phenotype due to incomplete efficiency of the RNAi lines, 







Figure 1. Schematic representation of the FRT/FLP system. A. When flies 
carrying the GAL4 driver and the gene of interest are mated with UAS-FLP 
flies, in the progeny the FLP will excise the gene of interest. B. Schematic 
depicting temperature sensitive control of the system. 
Even though this targeting procedure can be more time-




conditional mutagenesis (CMCM) method developed by Xue 
and colleagues [7], the efficiency of the FLP/FRT method turned 
out to be more precise in all the targeted cells. As the authors 
report, the efficiency of the CMCM method depends upon the 
expression of the gRNA promoter, the number of gRNAs or the 
temperature [7]. The FLP/FRT method can also be temporally 
activated, using the temperature-sensitive GAL4 inhibitor 
GAL80ts (Figure 1B); this approach finds its major application 
with essential genes that play a crucial role in development.  
Indeed, selective inactivation of caz in adult neurons does not 
induce a motor phenotype and does not affect the lifespan of 
those flies, indicating that Caz is not required for the 
maintenance of adult neurons rather it plays a critical role during 
their development. 
 
Xrp1: a genetic modifier of caz mutant phenotypes 
 
A screening of the second and third chromosomes led to the 
identification of Xrp1 as a genetic modifier of caz mutant 
phenotypes; 50% reduction of Xrp1 gene dosage is sufficient to 
partially rescue adult motor performance and life span. 
Consistent with the role of cabeza in neurons reported in 
Chapter 2, not only is selective knockdown of Xrp1 with the elav-
GAL4 driver sufficient to rescue the mutant phenotypes but also 
overexpression of the protein in neurons phenocopies caz 
mutant phenotypes.   
Xrp1 encodes a protein containing a predicted Basic Leucine 
Zipper domain (bZIP) and an AT-hook domain; it was known as 
a p53-target that is also implicated in P-element transposition [8-
10] and more recently it has been implicated in coordination of 





In the study presented in Chapter 3, we confirm the previously 
described role for Xrp1 and show an involvement in gene 
expression regulation. Xrp1-interacting proteins were identified 
by mass spectrometry and the majority are involved in regulation 
of transcription, chromatin organization, RNA-DNA metabolism 
and DNA repair. Moreover, GO analysis of the RNA-seq data 
demonstrated that genes involved in DNA repair were enriched 
in caz mutant CNS, and that gene expression dysregulation was 
diminished by 50% reduction in Xrp1 dosage in the mutants. 
Xrp1 is involved in gene expression regulation through the DNA-
binding capacity of the AT-hook motif. Indeed, experiments 
conducted with a UAS-Xrp1 transgene carrying an AT-hook 
domain mutation show that it is not able to block the rescue of 
the mutant lethality by Xrp1 heterozygosity.  
It was not possible to find a clear Xrp1 orthologue in mammals; 
in Chapter 3 it was indicated that the Rett syndrome 
gene MECP2 could be a functional homologue. More recently, 
Blanco et al. suggested that the DNA Damage Induced 
Transcript 3 (DDIT3) encodes a protein that shares some 
properties with Xrp1 [12]. Xrp1 was isolated in a genetic screen 
with the aim of revealing defects in cell competition [13], and it 
heterodimerizes with Irbp18, the Drosophila homolog of the 
mammalian C/EBP protein family [9, 10]. Blanco and colleagues 
identified Xrp1 orthologs in other Dipteran insects, they all share 
the AT-hook and bZIP domains and a N-terminal Xrp1-homology 
domain (Figure 2A). They then evaluated the human bZIP 
proteins interacting in vitro with C/EBPγ; this approach led to the 
identification of DDIT3, also indicated in Table S1, Chapter 3, as 
a functional homologue of Xrp1. 
Interestingly, DDIT3, also known as CHOP, lacks an ortholog 
in Drosophila; moreover, it plays a role in DNA damage and 




hDDIT3 with the eye-specific driver GMR-GAL4 reduces the eye 
size like Xrp1 and that this phenotype is rescued by 
coexpression of a RNAi transgene against Irbp18 or Xrp1 
(Figure 2B). It would be interesting to evaluate whether neuronal 
expression of hDDIT3 can phenocopy the caz pupal lethality and 
muscle phenotypes described in Chapter 4. Unfortunately, RNA-
seq data, used to evaluate RNA expression levels in brains 
of Fus ΔNLS/ΔNLS and Fus − /− mice do not show an upregulation of 
the mouse homolog Ddit3 [14].   
Rapid evolutionary divergence is a common phenomenon that, 
through gene duplication, might have led to different functional 
homologs in humans; in order to identify proper functional 
homologs of Xrp1, it will be necessary to gain insight into the 
molecular pathway/s in which Xrp1 is involved and to analyze 






Figure 2. Modified from Blanco et al. A. Xrp1 gene conservation, % amino-
acid identity to Xrp1 from Drosophila melanogaster. B. Expression of the 
hDDIT3 with the GMR-GAL4 reduces eye size, rescued by down-regulation 
of Irbp18 or Xrp1 using RNAi transgenes. 
Novel role for cabeza 
 
During the study for the characterization of caz mutants, a small 
fraction of pharate adults could reach the end of metamorphosis 
and start to eclose from the pupal case, although typically dying 
during this process (Movie S1 and S2, Chapter 2).  
Eclosion depends upon characteristic peristaltic movement of 
dorsal abdominal muscles (DAMs) to enable a pharate adult to 
escape from the pupal case. Therefore, the few escapers that 
failed to eclose from the pupal case suggested the presence of 
a muscle defect.  
In Chapter 4 I show that caz mutant animals present an 
abdominal muscle defect, with a reduced number of muscles 
and misorientation of DAMs. Interestingly this deficiency 
correlates with an early pupal phenotype; as introduced in 
Chapter 1 the number of DAMs is specified by the founder cells 
and indeed the reduced number of muscles in caz mutants 
correlates with a reduced number of founders. 
This developmental role for cabeza is confirmed by selective 
inactivation of the protein in adult myoblasts with the 1151-GAL4 
driver, that resulted in similar phenotypes as the cazKO animals. 
Moreover, the selective reintroduction of Caz in myoblasts, in an 
otherwise mutant background, strongly rescued the number of 
founders and therefore, the number of adult muscles.  
 
As previously mentioned, larvae are not affected by the absence 
of the protein, as third instar larvae have a normal muscle 
morphology (Figure S2, Chapter 4). It might be tempting to 




an absence of maternal mRNA or protein in the eggs [15]. The 
above phenotype could be explained on the basis that the 
protein plays a different role during metamorphosis. During 
Drosophila development, Cabeza has two forms, type 1 and type 
2, corresponding to two mRNA isoforms, caz-RD and caz-RB, 
respectively wherein caz-RD lacks exon 2 which encodes 44 
amino acids in the Glycine-rich domain [15]. During embryonic 
stages both forms of the protein are present, whereas only the 
type 2 form of the protein is available later in development. The 
presence of Glycine-rich domain in type 2 form might be related 
to the specific role of the protein during metamorphosis. 
Muscle-selective inactivation of caz with MHC-GAL4 was 
sufficient to induce pupal lethality (Figure 3A), with few escapers 
showing a shorter lifespan and a strong motor performance 
deficit (Figure 3B and 3C), as well as a reduced number of DAMs 
and DAM misorientation at 96 h APF (Figure 3D and 3E).  
MHC-GAL4 is a muscle driver active in the latest phases of 
metamorphosis [16]. Taken together, these data not only confirm 
a role of the protein during metamorphosis but point to a role in 
the stability of the adult muscles stability, indicating that loss of 
caz function leads to muscle degeneration.  
The selection of adult founders involves FGF signaling, through 
Htl and the downstream molecule Stumps [17], while embryonic 
founders are selected via Notch-mediated lateral inhibition [18]. 
In the study presented in Chapter 4, I evaluated whether Cabeza 
plays a role in FGF signaling. Interestingly, muscle phenotypes 
could be partially rescued by overexpression of Htl or Stumps in 
the adult myoblasts, and immunostaining of cazKO animals at 24 
h APF revealed a reduced level of Stumps in founder myoblasts. 
Taken together these results indicate that Cabeza plays a major 







Figure 3. Muscle selective loss of caz function causes muscle defect. A. 
Adult offspring frequencies of control genotypes versus muscle-selective 
inactivation of caz. B. Adult escapers flies display motor deficits. C. Adult 
escapers display a reduced lifespan. D, E. Quantification of DAM number (D) 
and percentage of misoriented DAMs in segments A3 and A4 of 96h APF 
pupae. 
Not well understood in such selection process is why among the 
entire pool of adult myoblasts certain cells are more sensitive to 
the FGF signal and have a higher expression of duf. This 




Pyramus (Pyr) and Thisbe (Ths) [19], but so far, the presence of 
the two ligands has never been shown in adult abdomen. Knock 
down of the two ligands singularly with the panneuronal driver 
elav-GAL4 did not lead to muscle phenotypes, indicating that 
they function in a redundant way and a mutation in both the 
















Figure 4. Quantification of DAM number in segment A3 of 96 h APF pupae 
in which either Pyramus or Thisbe was down-regulated in all neurons with the 
elav-GAL4 driver. 
Cabeza might regulate the expression levels of the two ligands. 
Interestingly, selective inactivation of the protein in the CNS with 
a panneuronal driver induces a reduced number of founder 
myoblasts and consequently a lower number of muscles. RNA-
seq data of larval CNS do not show any effect on Pyramus and 
Thisbe mRNA levels at that stage. However, it would be helpful 





evaluate whether the expression levels of the ligands are 
affected.  
To evaluate the role of the ligands, the potential function of the 
surrounding tissues should be taken into consideration; it was 
shown in Drosophila legs that Wg signal from the epithelium 
regulates the expression of ladybird early, which is maintained 
in the adult myoblasts and controls the expression of duf [20]; 
abdominal epithelium might play a similar role on a pool of 
myoblasts that stays in closer contact controlling the activation 
of FGF signaling.  
 
Xrp1 mediates caz muscle phenotypes 
 
Muscle phenotypes observed in caz mutants are mediated by 
increased levels of Xrp1, as the reduced number of muscles is 
completely rescued by heterozygosity for Xrp1. Moreover, 
myoblast specific overexpression of Xrp1 in a wildtype 
background is sufficient to induce a muscle phenotype. 
Interestingly, overexpression of AT-hook mutant Xrp1 does not 
induce a muscle phenotype, confirming that the phenotypes are 
a consequence of gene expression dysregulation. 
Immunostaining at 24 h APF revealed that overexpression of 
Xrp1 in adult myoblasts significantly reduces Stumps 
expression, indicating that Stumps is a downstream target of 
Xrp1. Different studies define Xrp1 as an inhibitor of cell 
proliferation, Xrp1 overexpression can prevent growth [9]  and 
reduce the translation rate [21]. Xrp1 might also play a role in 
the proliferation of adult myoblasts, thus reducing the pool of 
myoblasts from which the founder cells are defined, more 
analyses are needed to conclude if the AMP number is affected.  
Expanding the knowledge on putative targets of Xrp1 should 




Role of muscles in ALS pathology 
 
To this day, the role of muscles in ALS pathogenesis is not very 
clear. The dying-back hypothesis was first described in SOD1-
ALS mouse models [22]; more recently a study on FUS-ALS 
identified a defect in the morphology of NMJs in mice carrying a 
mutation in FUS, and reported that mutant FUS is toxic to muscle 
cells, indicating a gain-of-toxic-function of ALS-mutant FUS [23]. 
However, loss of nuclear FUS function may contribute to FUS-
ALS pathogenesis. Contrary to the cazKO phenotype, the total 
number of muscle fibers in newborn Fus−/− mice was not 
affected [23], this result can be explained by a functional 
compensatory mechanism during development due to the other 
two members of the FET family: TAF15 and EWS,  as previously 
shown in a Fus knock-out mouse model [24].  
My study in Drosophila finds a correlation with a different animal 
model such as zebrafish; loss of fus in zebrafish leads to a 
reduced life span, impaired locomotor behavior, disorganized 
NMJ morphology and a defect in axonal projections from motor 
neurons [25]. 
Interestingly, TDP-43, another RNA binding protein linked to 
ALS, has been described as essential for skeletal-muscle-cell 
differentiation in culture and is required for skeletal-muscle 
regeneration; deletion of Tardbp in C2C12 cells leads to cell 
death and prevents myoblast differentiation [26]. Taken together 
these results suggest a possible role of the muscle in the 
pathology. While a gain of toxic function of the protein is required 
to induce motor neuron degeneration, the loss of function in 
muscle nuclei might lead to gene expression dysregulation, 






Contribution to the ALS field  
 
Even though Drosophila is evolutionarily distant from humans, 
this thesis provides compelling evidence that this tiny creature is 
a powerful tool to understand and evaluate physiological 
functions of a protein involved in a complex neurodegenerative 
disease such as ALS. The efficiency of using such a model lies 
in the availability of methods, in particular the possibility of 
evaluating cell-type specific contribution of a protein or analyzing 
the phenotypes in a short time frame. 
The complementation with different model systems (cellular and 
mouse models) is, without a doubt, indispensable to dissecting 
important information about gene and protein functions and their 
involvement in specific pathologies.  
I would like to highlight the importance of a knock-out approach, 
that provides novel insight into the molecular mechanisms of an 
RNA- and DNA-binding protein. This model contributed to 
correlate gene expression dysregulation and FUS-ALS disease 
and added important knowledge on the role of the Drosophila 
FUS homolog in muscles, that should be further substantiated in 
a mouse model. Moreover, such an approach could in part solve 
the problem of the absence of proper gain of toxic function 
models in Drosophila.  
The challenge of this pathology still sits on the evaluation 
whether gain of toxic functions in the cytoplasm or loss of 
nuclear functions or both of them are involved in the disease. In 
order to reach therapeutic approaches, it is required to increase 
the knowledge on the different molecular pathways in which a 
protein is involved. With this thesis, I hope I could contribute 
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Amyotrophic lateral sclerosis (ALS) is a neurodegenerative 
disease characterized by degeneration of upper and lower motor 
neurons, leading to muscle weakness and paralysis, ultimately 
resulting in failure of the respiratory system and death. 
While 90% of the cases are sporadic, 10% can be attributed to 
specific mutations in several genes, such as SOD1, C9ORF72, 
TARDBP and FUS/TLS. 
Characterization of these genes can provide molecular insight 
into the pathogenesis and thereby, help in finding specific 
treatments that are still not available.  
This thesis focusses on cabeza (caz), the Drosophila homolog 
of FUS/TLS; thanks to the variety of gene manipulation tools, 
Drosophila could be used as a model system to investigate the 
role of the protein not only in the nervous system but also in 
muscles, providing novel information about the different roles of 
the protein. 
 
Chapter 1 provides a general overview of ALS and zooms in on 
one of the proteins involved in the pathology: FUS and its 
homolog in Drosophila caz; in this chapter I introduce the use of 
Drosophila melanogaster as an animal model to study ALS. 
 
In Chapter 2, we provide a new genetic toolkit, that allows cell-
type-specific gene inactivation. The Drosophila Cabeza gene 
was flanked with either FRT or LoxP recombination sites; 
selective expression of FLP and Cre in neurons or muscles 
induced an efficient inactivation of the protein in all neurons or 
muscle cells, respectively, overcoming limitations of the RNAi-
mediated knock-down strategy that produces off-target effects 





null alleles were generated to complement results obtained by 
selective inactivation of the protein. Interestingly, loss of caz 
function resulted in developmental lethality while a milder 
phenotype was observed by selective inactivation of the protein 
in neurons. Due to Cre-toxicity, FLP/FRT emerged as the 
preferred system. Moreover, use of the GAL80 system 
confirmed the efficiency of FRT/FLP, since induction of FLP 
expression from adult stage onwards also showed a clear 
inactivation of the protein in neurons.  
 
Core of Chapter 3 is the identification, by means of a genetic 
screen of the second and third chromosomes, of Xrp1 as novel 
interactor of caz; reduction of Xrp1 gene dosage by 50% suffices 
to rescue the developmental lethality observed in caz mutant 
animals. We found that Xrp1 was up-regulated in caz mutants 
and interestingly, selective knock-down of Xrp1 in neurons is 
sufficient to rescue the mutant phenotypes, confirming the key 
role of caz in neurons. GO analysis of RNA-seq data and 
analysis of Xrp1-interacting proteins confirm a role in DNA repair 
and reveal a novel role in gene expression regulation; indeed, 
caz mutants present gene expression dysregulation, rescued by 
heterozygosity for Xrp1. The DNA binding capacity of Xrp1 
depends on the AT-hook motif, since the introduction of a 
mutation in this motif is not able to induce developmental 
lethality. Bioinformatic analysis did not indicate a clear 
mammalian orthologue, candidates were searched among 
genes encoding proteins with predicted AT-hook motifs.  
 
Chapter 4 describes the novel role of caz in muscle specification 
during metamorphosis. In this chapter, I show that caz mutants 
exhibit adult abdominal muscle defects, with a reduced number 




(DAMs). This adult phenotype corresponds with a reduced 
number of adult founder myoblasts. Selective expression of caz 
in myoblasts rescued the number of founders and DAMs, 
suggesting that caz is required for muscle development. Adult 
founder myoblast selection is mediated by FGF signaling, and 
consistently, selective expression of the FGF receptor Htl or the 
downstream target Stumps in adult myoblasts of caz mutants 
significantly rescued the reduced number of muscles and their 
misorientation. Moreover, immunostaining revealed a reduced 
level of Stumps in adult myoblasts of mutant animals. These 
phenotypes are mediated by increased levels of Xrp1, since 
heterozygosity for Xrp1 fully rescues the number of muscles and 
the misorientation and overexpression of Xrp1 in adult 
myoblasts phenocopies caz mutant phenotypes. The mutation 
in the AT-hook motif does not lead to a muscle phenotype, 
indicating how gene expression dysregulation mediates such 
phenotypes. Furthermore, overexpression of Xrp1, selectively in 
adult myoblasts, strongly reduced Stumps levels in the founders, 
as seen in the caz mutants. These data suggest that caz plays 
a role in selection of founder myoblasts by regulating Xrp1 
levels. 
 
Finally, Chapter 5 includes the discussion of data presented in 
















Amyotrofische laterale sclerose (ALS) is een 
neurodegeneratieve ziekte welke gekenmerkt wordt door 
degeneratie van de bovenste en onderste motorneuronen. Dit 
leidt tot progressieve spierzwakte, verlamming, en uiteindelijk tot 
ademhalingsproblemen en sterfte. 
Hoewel 90% van de gevallen sporadisch is (d.w.z. geen 
aanwijsbare familiegeschiedenis heeft), kan 10% worden 
toegeschreven aan specifieke mutaties in verschillende genen, 
zoals SOD1, C9ORF72, TARDBP en FUS/TLS. 
Karakterisatie van deze genen kan moleculair inzicht geven in 
de pathogenese en op die manier helpen bij het vinden van 
specifieke behandelingen die nog niet beschikbaar zijn. 
Focus van dit proefschrift is cabeza (caz), het Drosophila 
homoloog van FUS/TLS; dankzij het brede spectrum aan gen-
manipulatie instrumenten kan Drosophila worden gebruikt als 
modelsysteem om de rol van het eiwit niet alleen in het 
zenuwstelsel maar ook in de spieren te onderzoeken en nieuwe 
informatie in te winnen over de verschillende functies van het 
eiwit. 
 
Hoofdstuk 1 geeft een algemeen overzicht over ALS en over één 
van de betrokken eiwitten: FUS en zijn Drosophila homoloog 
caz. In dit hoofdstuk introduceer ik het gebruik van Drosophila 
melanogaster als diermodel om ALS te onderzoeken. 
 
In Hoofdstuk 2 maken we gebruik van een nieuwe genetische 
toolkit, waardoor we celtype-specifieke gen-inactivatie mogelijk 
maken. We flankeerden het Drosophila Cabeza gen met FRT- 
of LoxP-recombinatie sequenties; selectieve expressie van FLP 




van het gen in respectievelijk alle neuronen of spiercellen. Deze 
methode is superieur aan RNAi-gemedieerde knock-down 
strategieën die off-target effecten en onvolledige knock-down 
kunnen produceren. Daarnaast werden twee onafhankelijke caz 
nul-allelen gegenereerd om resultaten aan te vullen die waren 
verkregen door selectieve inactivatie van het gen. Een 
interessante waarneming was dat verlies van caz functie 
resulteerde in toegenomen sterfte gedurende ontwikkeling, 
terwijl een milder fenotype werd waargenomen in geval van 
selectieve inactivatie in neuronen. Vanwege Cre-toxiciteit bleek 
FLP/FRT het betere systeem te zijn. Het gebruik van het GAL80-
systeem bevestigde bovendien de efficiëntie van FRT/FLP, 
aangezien inductie van FLP-expressie vanaf het volwassen 
stadium ook een duidelijke inactivatie van het eiwit in neuronen 
liet zien. 
 
Naast de genetische screening van de tweede en derde 
chromosomen is de kern van Hoofdstuk 3 de identificatie van 
Xrp1 als een nieuwe genetische interactiepartner van caz. Een 
reductie van de Xrp1 gendosis met 50% is voldoende om de 
sterfte gedurende ontwikkeling te redden die wordt 
waargenomen bij caz-mutante dieren. We ontdekten een 
verhoogde expressie van Xrp1 in caz-mutanten en interessant 
genoeg is selectieve knock-down van Xrp1 in neuronen genoeg 
om de mutante fenotypes te redden, wat de sleutelfunctie van 
caz in neuronen bevestigt. GO-analyse van RNA-seq gegevens 
en analyse van Xrp1-bindende eiwitten bevestigen een rol bij 
DNA-schadeherstel en onthullen een nieuwe functie in 
genexpressie regulatie. Inderdaad, caz-mutanten vertonen 
ontregeling van genexpressie, wat gered wordt door 
heterozygositeit voor Xrp1. De DNA-bindingscapaciteit van Xrp1 





van een mutatie in dit motief geen sterfte kan induceren 
gedurende ontwikkeling. Bioinformatische analyse geen 
duidelijk zoogdier ortholoog aan, kandidaten werden gezocht 
onder genen die coderen voor eiwitten met voorspelde AT-hook 
motieven. 
 
Hoofdstuk 4 beschrijft de nieuwe functie van caz in 
spierspecificatie gedurende de metamorfose. In dit hoofdstuk 
laat ik zien dat caz-mutanten defecten vertonen in volwassen 
abdominale spieren, met een gereduceerd aantal en incidentele 
misoriëntatie van dorsale abdominale spieren (DAS). Dit 
volwassen fenotype correspondeert met een verminderd aantal 
volwassen ‘founder’ myoblasten. Selectieve expressie van caz 
in myoblasten redde het aantal founder myoblasten en DAS, wat 
erop wijst dat caz nodig is voor spierontwikkeling. Volwassen 
founder myoblast selectie wordt gemedieerd door FGF-
signalering. Inderdaad, selectieve expressie van de FGF-
receptor Htl of diens doelwit Stumps in volwassen myoblasten 
van caz-mutanten redde significant de gereduceerde aantallen 
en misoriëntatie van de spieren. Bovendien onthulde 
immunokleuring een gereduceerd expressieniveau van Stumps 
in volwassen myoblasten van mutante dieren. Deze fenotypes 
worden gemedieerd door verhoogde expressie van Xrp1, 
aangezien heterozygositeit voor Xrp1 het aantal spieren en de 
misoriëntatie volledig redt, en overexpressie van Xrp1 in 
volwassen myoblasten leidt tot en fenokopie van caz mutante 
fenotypes. Mutatie van het AT-hook motief voorkomt inductie 
van een spierfenotype, wat aangeeft dat ontregeling van 
genexpressie zulke fenotypes tot stand brengt. Bovendien 
reduceert selectieve overexpressie van Xrp1 in volwassen 
myoblasten Stumps levels in founder myoblasten, zoals ook het 




rol speelt bij de selectie van founder myoblasten door Xrp1-
niveaus te reguleren. 
 
Ten slotte bestaat Hoofdstuk 5 uit de discussie van de data 
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